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ABSTRACT 
ALI, RAJA M., Masters : June : 2020, Clinical Pharmacy and Practice  
Title: Sleep Patterns among University Students and Insomnia Management in Primary 
Care Settings in Qatar: a Two-Phase Investigation 
Supervisor of Thesis: Monica Zolezzi. 
Insomnia is a public health concern that affects approximately a third of adult 
population worldwide. The aim of this research was to investigate insomnia and its 
management among university students and primary care centers in Qatar using 
quantitative and qualitative methods, respectively. The first phase of this research 
consisted of a cross-sectional quantitative survey to explore the pattern and quality of 
sleep among Qatar University (QU) students using the Pittsburgh Sleep Quality Index 
and the Sleep Hygiene Index. In the second phase, qualitative interviews were used to 
explore the perspectives of healthcare providers (HCPs) working at primary health care 
centers (PHCCs) regarding insomnia and its management. Approximately 70% of QU 
students reported scores consistent with poor sleep quality and 79% reported poor sleep 
hygiene. Students with good sleep hygiene compared to those with poor sleep hygiene 
were about four times more likely to have good sleep quality (OR= 3.66, 95% CI= 2.8-
4.8, p < 0.001). The interviews with 19 HCPs generated five themes, including general 
perspectives on insomnia, view of primary healthcare as the setting for insomnia 
management, current practices for insomnia management at PHCCs, HCPs’ role 
perception, and challenges facing insomnia management at PHCCs. The findings from 
this two-phase investigation revealed that insomnia is common among university 
students in Qatar and that it is associated with poor sleeping habits. HCPs at PHCCs 
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expressed awareness of the magnitude of insomnia as a problem of public health 
significance but appeared to find its management challenging.  
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CHAPTER 1: INTRODUCTION 
1.1. The anatomy and physiology of sleep  
Sleep is one of the fundamental human needs required to maintain physical and 
mental health. Adults need around 7 to 9 hours of sleep per night to preserve their health 
(1). The anatomy of sleep is complex as different parts of the brain are involved in the 
initiation and maintenance of sleep. One of the most important brain parts involved in 
sleep is the hypothalamus, which contains a group of nerve cells responsible for 
maintaining  the balance between sleep and arousal (2). The hypothalamus contains the 
suprachiasmatic nucleus  which senses external stimuli such as light and is responsible 
for regulating different activities in the body, including sleep, based on the circadian 
rhythm (3). The thalamus also plays an important role in arousal by controlling the 
activity levels in the cerebral cortex. Moreover, different structures in the brain stem 
including the medulla oblongata, pons and midbrain represent essential parts of the 
sleep arousal system. The brain stem also contains neurons which connects it with both 
the hypothalamus and the cerebral cortex. Overall, the anterior hypothalamus and basal 
forebrain can be regarded as the sleep center in humans, whereas the posterior 
hypothalamus represents the wake center (2).  
The sleep-wake cycle is mainly regulated by two mechanisms; the reticular 
activating system and the circadian rhythm (4).  The reticular activating system, also 
known as the ascending arousal system, extends from the upper pons to the 
hypothalamus and the base of the forebrain and promotes wakefulness by releasing 
neurotransmitters that activate the thalamus, cerebral cortex and other areas in the 
forebrain (5). The wakefulness maintaining neurotransmitters released by this pathway 
includes norepinephrine, dopamine, serotonin, histamine, glutamate, acetylcholine, 
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peptide neurotransmitter orexin and neuropeptides such as substance P and 
corticotropin releasing factor which are released from the hypothalamus (5). On the 
other hand, the sleep promoting neurotransmitters function by releasing chemicals 
which suppress the activity of the arousal system (5). These neurotransmitters are 
released by clusters of inhibitory neuronal cells present in the ventrolateral preoptic 
area (VLPO) (6). The activity of these neurons is continuous during sleep. It has also 
been suggested that the initiation of sleep could be related to the activation of the VLPO 
neurons by external triggers, most likely adenosine (6). The other important inhibitory 
neurotransmitter is γ-aminobutyric acid (GABA), which is produced by cells in the 
basal forebrain and hypothalamus (2,3). The balance between the arousal and the sleep 
promoting systems is responsible for regulating the transition between sleep and 
wakefulness.  
The circadian rhythm is a 24-hour long cycle of neuronal activity which is 
aligned with environmental light-dark stimuli (5).  Differences in the circadian period 
can lead to variations in the diurnal preferences, and individuals sleeping habits could 
also affect the length of the cycle (3). This sleep-wake cycle is also regulated by 
melatonin which is a hormone secreted by the pineal gland. The secretion of melatonin 
is affected by the amount of environmental light, such that it is induced by darkness 
and inhibited by exposure to ambient light. During night sleep, the core body 
temperature is at its lowest levels while the melatonin at its highest level (4).   
A healthy sleep consists of around 4-6 sleep cycles each night (3). Each cycle 
consists of two stages which are the non-rapid eye movement (NREM) and the rapid 
eye movement (REM) stages. The duration of each cycle ranges between 70 and 120 
minutes (3). This classification of sleep is based on the recording of the 
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electrophysiologic parameters using  polysomnography (5). A typical sleep cycle starts 
with NREM and progresses to the REM stage. NREM stage is further divided into 3 
stages (N1, N2 and N3). N2 is the longer stage of the sleep cycle, followed by N3, 
which is known to be the deep sleep stage; in fact, spending enough time at this stage 
is necessary for the person to feel refreshed during the day. Most of the dreaming occurs 
during the REM phase with rapid eye movement from side to side behind the eyelid 
(7). Generally, REM stage comprises 20-25% of the total sleep time, while NREM stage 
represents around 50-60% (5). The movement from one sleep stage to the other happens 
in a progressive and gradual manner without complete transition from one stage to the 
other (8). 
Sleeping patterns change throughout the lifecycle of an individual. Healthy 
adults usually fall asleep within 10 minutes and sleep for around 7-8 hours per night 
(3,4). Infants and young children require a longer sleep duration. The division of the 
sleep cycle into REM and NREM stages in humans starts at 3 to 6 months of age (3). 
Individuals develop the circadian pattern of sleep and wakefulness at approximately 3 
years of age. During childhood, N3 sleep stage is more prominent and the duration of 
this phase decreases as the person moves from puberty to adulthood (5). Other NREM 
stages become more fragmented in older adults with greater frequency of waking up 
during the NREM sleep stages in this population. Particularly, a reduction in N3-slow 
wave sleep is detected in the elderly (5). During the infancy period, REM accounts for 
50% of the total sleep time and as the person grows into adulthood the percentage of 
the REM stage decreases to represent 20-25% of the night sleep duration.  
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1.2. Insomnia and its classification 
Insomnia has been defined as a persistent complaint of difficulty falling or 
staying asleep and early morning awakenings associated with difficulty returning to 
sleep despite adequate opportunity (9). These symptoms are often accompanied with 
significant impairment in daytime performance and activities. According to the 
Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) and the 
International Classification of Disease, 10th edition (ICD-10), the previously mentioned 
symptoms should occur at least 3 times a week for a minimum duration of 1 month 
(10,11).  In addition, ICD-10 identifies preoccupation with sleepiness and excessive 
worry about the consequences of insomnia during the day as one of the clinical features 
for insomnia (11). 
Insomnia has historically been classified into either a primary or secondary 
insomnia. This classification was introduced to differentiate between insomnia as a 
standalone problem (primary insomnia) as opposed to insomnia that presents as a 
symptom of an underlying medical or psychiatric condition  (secondary insomnia)  (12). 
Disturbances in the neurochemicals controlling the arousal and sleep promoting 
systems could lead to the development of primary insomnia. Primary insomnia is a 
hyperarousal state, particularly somatic arousal, which is identified by an increase in 
muscle tone, sweating and increased heart rate due to peripheral nervous system 
activation (10). Additionally, misalignment of the endogenous circadian rhythm with 
the individual’s desired sleep-wake schedule could also lead to sleep disturbances (5). 
Moreover, some personal factors including the sleep environment and racing thoughts, 
or life stressors could disturb the normal sleep and contribute to the development of 
insomnia (10). 
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However, the latest editions of the diagnostic criteria for insomnia namely the 
DSM-5 and the International Classification of Sleep Disorders 3rd edition (ICSD-3) 
have moved away from this classification (10,13). In the ICSD-3, insomnia was 
classified according to the duration of symptoms into either a short-term insomnia or 
chronic insomnia. In addition, the DSM-5 suggests that insomnia should be viewed as 
an independent medical problem regardless of the presence of other health problems, 
whether medical or psychological (10). Yet both guidelines have specifically 
highlighted the need to take other comorbid conditions into consideration when 
diagnosing and managing insomnia. The choice of the new classification was mainly 
done to avoid the inappropriate management of insomnia when classified as a 
secondary problem and to overcome the difficulties associated with diagnosing 
comorbid insomnia (14). Moreover, the ICSD-3 has included two additional 
classification criteria one for individuals who present with isolated insomnia symptoms 
and the other for short sleepers (<6 hours per night) (13).  
Therefore, the classification of insomnia now is largely dependent on the 
duration of the symptoms and is classified into either acute or chronic. Acute insomnia 
is diagnosed when the symptoms have been experienced for less than 3 months, usually 
associated with a known precipitant like stress or  pain (12). While chronic insomnia is 
diagnosed when it persists for longer than 3 months (11). Additionally, requiring 30 
minutes or longer to either fall asleep or return to sleep after waking up at night is 
considered an abnormal parameter.  
 
 
 
  
6 
 
1.3. Epidemiology of insomnia 
Insomnia is the most common sleep complaint in the general population (15–
17). The prevalence of insomnia has been extensively investigated in the last 40 years 
(12). Overall, studies in the general population suggest that around 30% of adults 
present with at least one of the insomnia symptoms, while 10-13% are estimated to 
suffer from chronic insomnia (16,18). Additionally, only 1-2% of the general 
population are reported to have chronic insomnia without an underlying cause (16). 
Studies from general populations in Western countries have reported an insomnia 
prevalence ranging from 19-37.6% (19–24). Similarly, epidemiological studies from 
Asian countries such as China, Japan and Korea have found a similar prevalence rate 
(13.5-39.4%) in adults (25–29). Limited information is available in the literature on the 
prevalence of insomnia in Arab countries including the Middle East and North Africa. 
The findings of a population study from the Kingdom of Saudi Arabia (KSA) have 
shown higher prevalence rates of insomnia as compared to reports from Western and 
Asian countries. In this study around 78% of the sample reported poor sleep quality and 
more than one-third had insufficient sleep (<7 hours) (30). 
In Qatar, results from a study among professional male soccer players indicated 
that 69% suffered from poor sleep quality, but only 27% fit the criteria for insomnia 
(31). An unpublished population-based study that was recently conducted by the Social 
and Economic Research Institute at Qatar University (QU)  reported a prevalence of 
5.5% among adults, which is much lower than the prevalence found in the Western and 
Asian studies reported above (32).  However, it is noteworthy to mention that this study 
used a relatively strict definition of insomnia by applying the DSM-5 criteria. A review 
conducted by Ohayon in 2002 suggested that the prevalence of insomnia identified in 
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epidemiological studies is influenced by the definition used and found that highest 
prevalence (30%) was often identified in studies that used insomnia symptoms as the 
defining criteria, while the lowest prevalence was associated with the use of the DSM-
diagnostic based criteria (6%) (33) .  
Accumulating evidence from research suggests that some sectors of the 
population are more vulnerable to sleep disturbances than others. These at-risk groups 
include university students, the elderly and individuals with chronic conditions or 
mental illness. Insomnia is a common problem among university students, with a 
reported mean  prevalence of  18.5% (34). University students have irregular sleeping 
patterns with sleep duration of less than 8 hours per night (35). Studies have also 
reported the occurrence of excessive daytime sleepiness in 50% of college students as 
compared to 36% of non-student adults (36). In fact, university students are considered 
a population at higher risk for insomnia due to the stress related to the academic 
workload and assessments to which they are exposed, coupled with their unhealthy 
lifestyles. 
Several epidemiological studies have also consistently shown that insomnia 
prevalence increases with age (18,20,27,29).  A study done among older adults (≥50 
years) from 8 different countries across Asia and Africa reported that 16.6% of the   
sample experienced sleep disturbances. In this study, the probability of  developing 
insomnia increased with increasing age and was more common in females (37). One 
study reported that insomnia was the second most common problem in this population 
with a prevalence of 28% (38). In another study, around one-third of the elderly sample 
reported having insomnia symptoms (39). It has been suggested that changes in sleep 
pattern among older adults which manifests as a decrease in deep sleep and frequent 
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nocturnal awakenings are responsible for the occurrence of frequent sleep disturbances 
accompanied with daytime sleepiness (33,40). This observation could be related to the 
increase in chronic disease burden, polypharmacy and lack of engagement in physical 
and social activities in this age group (39,41). It is estimated that four out of every five 
elderly individuals have at least one chronic medical condition (41). Heart diseases, 
chronic pain, memory problems and depression were found to be commonly associated 
with insomnia in this population (41). 
Insomnia is also a common complaint in individuals with chronic ailments both 
physical and mental (42). It is well known that insomnia and disrupted sleep patterns 
are some of the early symptoms of several mental disorders (43). Studies are now 
suggesting a bidirectional relationship between insomnia and other psychiatric 
illnesses, whereby chronic insomnia is considered as an independent risk factor for 
developing mental illnesses even in healthy individuals (43,44). Specifically, it was 
suggested that insomnia increases the risk of depression by two folds in healthy 
individuals (44).  
Several studies have also shown that long-standing insomnia increases the 
probability of developing chronic medical conditions including hypertension, 
cardiovascular diseases and type 2 diabetes (45,46). In addition, sleep deprivation has 
been identified as a risk factor for premature mortality (40). A previous study has also 
explored its association with early symptoms of cancer (47). 
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1.4. Insomnia in primary care settings 
Insomnia is the second most common complaint in primary healthcare settings 
after pain (12). Primary healthcare centers (PHCCs) are usually the first point of contact 
of patients with the healthcare system due to their accessibility and affordability. In 
fact, studies from different countries have reported that between 22.4-76.5% of patients 
treated at PHCCs present with at least one of the insomnia symptoms (48–57). 
Therefore, healthcare professionals at PHCCs play an important role in the detection 
and management of insomnia as it is common in community dwelling adults, especially 
among individuals with chronic conditions. Indeed, observations from practice have 
confirmed that general practitioners at PHCCs are the first healthcare professionals to 
whom patients convey their sleeping problems (15).  
Chronic insomnia associated with daytime dysfunction is also common among 
insomniacs presenting at PHCCs. A study conducted in Malaysia reported that around 
59% of those with sleep problems had chronic insomnia and that 28.6% of them were 
also complaining of impaired daytime performance (51). It has also been documented 
that insomnia often worsens functional impairment and disability associated with 
other medical conditions (58). A second study done in Italian PHCCs found that more 
than 50% of patients reporting insomnia also complained of associated daytime 
dysfunction (49). The most common daytime complications of insomnia were mood 
disturbances and tiredness during the day. In another study, patients with insomnia 
were twice more likely to have days of restricted activity due to illness and tended to 
spend more days in bed as compared to individuals without insomnia (58). Therefore, 
insomniacs in this study were more likely to have occupational disability as a result of 
taking more sick days leaves.  
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1.5.  Guidelines recommendations on insomnia management  
Treatment options available for insomnia include psychological and 
pharmacological therapies which are given to improve sleep and alleviate disease-
related dysfunction. Insomnia guidelines recommend that patients receive 
psychological therapies either alone or in combination with pharmacological therapies 
as needed.  Table 1 provides a summary of insomnia management recommendations as 
per the most up-to-date international guidelines (59–62). All these guidelines concur 
that cognitive behavioral therapy specifically designed for insomnia (referred to as 
CBT-I) should be the first line treatment. CBT-I consists of a combination of 
behavioral, cognitive and educational interventions including stimulus control, sleep 
restriction, relaxation techniques and sleep hygiene (63). A meta-analysis that assessed 
the benefits and harms associated with non-pharmacological interventions for insomnia 
reported the superiority of CBT-I in improving all sleep related outcomes including 
sleep quality, efficiency and onset latency  in comparison to the control (63). 
Additionally, the improvement in sleep was maintained for up to 6 months after 
treatment. 
As part of CBT-I, the European guidelines for insomnia recommends the 
provision of patient education on healthy sleep habits known as sleep hygiene. Sleep 
hygiene consists of a combination of behavioral practices and environmental conditions 
which improve sleep (9). It is known that unhealthy sleep related habits, such as taking 
daytime naps and consuming stimulants (including caffeine) close to bedtime, are 
common among insomniacs; therefore, sleep hygiene education is considered an 
important element in the management of insomnia (64). A meta-analysis which 
assessed the efficacy of sleep hygiene education in insomnia treatment found a 
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significant improvement in sleep onset latency, sleep fragmentation, total sleep 
duration and insomnia scores indicative of improved sleep when using validated 
questionnaires such as the Pittsburg Sleep Quality Index (PSQI) (65). However, sleep 
hygiene education was significantly less effective than CBT-I. Despite that, the 
evidence on sleep hygiene’s effectiveness remains controversial as the components of 
sleep hygiene recommended are widely variable across studies which makes the 
generalization of the findings more challenging (66).  
The use of hypnotics for insomnia management is recommended if CBT-I alone 
was not effective or if it was not available for patients (59–62). However, these 
medications are recommended to be used for a maximum of 4-5 weeks with close 
patient monitoring (59,60). Long term use of hypnotics is generally discouraged but if 
needed hypnotics could be used for longer than 5 weeks.  
Additionally, some guidelines recommend the use of sedative antidepressants 
for insomnia (60–62). However, the British Association for Psychopharmacology 
(BAP) guidelines for insomnia recommends their use to be reserved for patients with a 
comorbid mood disorder. The use of antipsychotics is not recommended due to their 
side effects and lack of evidence on efficacy for insomnia management (60,61).  
The European, the BAP and the American Academy of Sleep Medicine 
(AASM) guidelines for insomnia do not recommend the use of antihistamines or 
melatonin for insomnia management due to limited efficacy evidence. The AASM 
recommends the use of suvorexant (an orexin agonist) and ramelteon (a melatonin 
agonist) for sleep maintenance and sleep onset insomnia, respectively (61).  
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Table 1. Guidelines’ recommendations for insomnia management 
Guidelines  First line  Second line  Treatments not 
recommended 
American College of 
Physicians guidelines 
(2016) 
CBT-I* is recommended as the 
initial treatment for all adults 
with chronic insomnia disorder. 
(Grade: strong recommendation, 
moderate-quality evidence) 
Short term use of medications 
in combination with CBT-I 
when CBT-I alone is 
unsuccessful. (Grade: weak 
recommendation, low-quality 
evidence) 
None  
European Guidelines 
for Diagnosis and 
Treatment of Insomnia 
(2017) 
CBT-I* is recommended as first-
line treatment for chronic 
insomnia in adults of any age. 
(Strong recommendation, high-
quality evidence) 
 
• Benzodiazepines (BZ) 
and Benzodiazepine 
receptor agonists 
(BZRA,) (<4 weeks). 
(High quality evidence) 
 
• Sedative antidepressants 
for short term use. 
(Moderate-high quality 
evidence) 
• Long term use of 
BZs/BZRAs.  
• Long term use of 
sedating 
antidepressants** 
• Antipsychotics** 
• Antihistamines**  
• Melatonin (low quality 
evidence).  
• Phototherapies (e.g. 
valerian).  
• Alternative and 
complementary 
therapies (e.g. 
aromatherapy).   
British Association 
for 
Psychopharmacology  
(2010) 
- CBT-I* package is the 
first line of therapy for 
insomnia.  
(High quality evidence) 
 
- CBT-I* recommended 
when tapering hypnotics  
 
 
 
• Hypnotics might be used 
after considering the 
safety, efficacy and onset 
for action of the 
medication. (High quality 
evidence) 
• Long term use of 
hypnotics is allowed as 
needed. Withdrawal is 
recommended. 
• Antidepressants: 
recommended at the 
existence of a comorbid 
psychiatric disorder.  
• Antipsychotics: not a first 
line treatment for 
insomnia (side effects).  
• Antihistamines  
American 
Academy of Sleep 
Medicine (2017)  
 
 
• Suvorexant is recommended for sleep maintenance in individuals 
with chronic primary insomnia. (Weak) 
• Ramelteon for sleep onset insomnia 
• BDZs and Z-drugs (Benefits outweighs the risks). (Weak) 
• Doxepin (Benefits outweighs the risks) 
• Diphenhydramine** 
• Melatonin**   
• Tryptophan   
• Valerian  
• Trazodone** 
• Tiagabine***  
*CBT-I: Cognitive behavioral therapy for insomnia 
**Lack of evidence on efficacy  
***Harm outweigh the benefits 
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1.6.  Study rationale and significance  
Insomnia is a public health problem that affects around one third of adults in 
the general population which is particularly common among university students and 
individuals accessing primary health care services. Insomnia is a public health concern 
and a burden to society as it affects the overall performance of individuals and impairs 
their physical and mental health. Sleeping problems are also associated with serious 
consequence, such as increased rates of motor accidents, lower productivity and work 
absenteeism (28,40). Therefore, identifying the extent of insomnia distribution and 
factors contributing to its development in these populations are necessary before 
designing interventions to address the problem more effectively.   
It was recently reported that around 5.5% of the adult population in Qatar has 
insomnia (32). Daytime sleepiness was found to be common among patients at PHCCs 
in Qatar and around one third of PHCCs’ attendants were reported to have depression 
or anxiety (67,68). Likewise, depression is common among teenagers in Qatar as it was 
previously shown that around one third of Qatari adolescents at secondary schools have 
clinical depression (69). Considering the established link between depression and sleep 
problems it is possible that adolescents may also be at higher risk of experiencing 
insomnia. Moreover, if depression and related sleep problems are not resolved early, 
these may be carried on during their study at university.  
Qatar University (QU) is the largest national university in the country to which 
thousands of students are enrolled every year; the majority of which are Qatari high 
school graduates. The estimated number of students at QU as of Fall 2019 was 20,000 
(70). Students are distributed across ten different colleges, including: Arts and Sciences, 
Business and Economics, Engineering, Education, Law, Medicine, Pharmacy, Health 
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Sciences, Sharia and Islamic Studies and Dental Medicine. The university also offers a 
Foundation Program, designed for new students who do not acquire the mandatory 
requirements for enrollment in specific colleges. The number of students and the 
variability in both student populations and academic specialties offered makes QU an 
appropriate site for evaluation of sleep problems among university students in Qatar.  
The healthcare system in Qatar comprises public, private and semi-private 
entities. The leading healthcare provider in the country is Hamad Medical Corporation 
(HMC) which currently consists of 13 hospitals, including the Mental Health hospital 
(71). Primary Healthcare Corporation - which is a public institution - is the main 
provider of primary care services in Qatar, through its twenty seven healthcare centers 
distributed in different regions across the country (72,73). PHCCs are easily accessible 
to all the population in Qatar and therefore, for individuals suffering from insomnia, it 
is expected to be the first point of contact with the healthcare system. The healthcare 
utilization seems to be more common among insomniacs as it was previously shown 
that individuals who visited a doctor two times or more in a one month period were 
50% more likely to have a sleep problem (41). The Ministry of Public Health (MoPH) 
is the primary authority in the country which regulates both the public and the private 
healthcare sectors (74).  
Mental health services are mostly reserved to secondary healthcare institutions, 
more specifically to HMC’s psychiatric hospital. However, in  recent years the role of 
primary care in the management of mental illnesses has been expanded to PHCCs, in 
line with the main goals of Qatar’s National Mental Health Strategy (73). This strategy 
aims for primary health care to become the foundation for delivering mental health 
services, including early identification and treatment of mental disorders. To achieve 
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this goal, around sixty one physicians at PHCCs in Qatar received advanced mental 
health training (74). Mental healthcare services have been integrated into PHCCs as of 
February 2019 which includes support clinics run by psychologists and a once weekly 
mental health clinic run by a psychiatrist (75). Although it is unclear if general 
practitioners at PHCCs received specialized training on sleep medicine, it is likely that 
they acquired basic skills needed to identify and manage insomnia through their mental 
health training program. This will not only improve the early identification of insomnia 
but will also facilitate the introduction of early interventions to decrease the burden of 
insomnia and the consequences associated with delayed treatment.  
Currently, many of the medications used for insomnia treatment are not 
available on the PHCCs’ formulary and are only available at specialized hospitals or 
through psychiatrists at mental health clinics. Medications are affordable at public 
hospitals and PHCCs in Qatar as the cost of medications and other healthcare services 
are subsidized by the government (76). At PHCCs, physicians are involved in the 
diagnosis and the treatment of various disease conditions including mental illnesses 
while pharmacists’ role remains largely limited to the traditional medication dispensing 
and to a lesser extent education and counseling on medications. Therefore, it is 
important to explore how health care providers (HCPs) at PHCCs treat patients 
presenting with insomnia complaints considering the above realities in relation to 
insomnia management. 
Additionally, considering that most individuals with chronic conditions such as 
diabetes, hypertension and cardiovascular diseases, who are also at higher risk for 
insomnia, are treated at PHCCs, it is important to understand the viewpoints of HCPs 
who treat these patients. Furthermore, exploring the influence of the different 
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educational and cultural backgrounds from which HCPs’ come from on insomnia 
management is indeed important.  
Overall, there is a paucity of research information in the published literature 
about sleep problems in Qatar. No previous studies in Qatar have focused on the 
sleeping patterns and habits among university students. Additionally, insomnia 
management in primary care has not been sufficiently explored, neither in Qatar nor in 
other Arab countries. Thus, this investigation will contribute towards the goal of Qatar’s 
mental health strategy to shift the management of mental health conditions to PHCCs. 
 
 
1.7. Study objectives  
The main aim of this study is to explore the prevalence of insomnia among 
university students and to describe the approaches followed by healthcare providers for 
insomnia management at PHCCs. To achieve this aim, the following are the objectives 
of the study:  
 
1.7.1.  Objectives for phase 1 of the study 
The specific objectives of this phase of the study were to explore:  
i. Sleeping patterns and the prevalence of sleep problems, particularly 
insomnia among university students in Qatar.  
ii. Common sleep hygiene behaviors and practices among QU students. 
iii. Factors that contribute to the development of insomnia in university 
students.  
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1.7.2. Objectives for phase 2 of the study 
The objectives of this phase of the study were to explore: 
i. The overall perspectives of general practitioners and pharmacists on 
insomnia as a health concern.  
ii. The assessment, diagnosis and management of insomnia at PHCCs 
iii. HCPs’ perceptions of their role in the management of sleep problem at 
PHCCs. of insomnia.  
iv. Barriers for the optimal care of patients with insomnia presenting at 
PHCCs.  
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CHAPTER 2: LITERATURE REVIEW 
This chapter provides an overview of the current literature findings in relation to 
insomnia starting with reviewing the prevalence of insomnia briefly in the general 
population and more extensively in university students. Next, a systematic review of 
the available instruments for assessing insomnia symptoms or sleep hygiene will be 
presented. Lastly, this chapter will explore the literature related to HCPs’ perspectives 
and experiences with insomnia management in primary healthcare centers.  
 
2.1. Insomnia in university students  
2.1.1. Sleeping patterns and prevalence of insomnia among university students 
2.1.1.1. Insomnia prevalence  
According to a systematic review of seven studies published in the period 
between 2000 and 2014, the mean prevalence of insomnia among university students 
was identified as 18.5% (95% CI =11.2-28.8%) (34). However, the prevalence reported 
in the literature is variable both within and beyond the range reported in this study.  
Poor sleep quality and insomnia were found to be common among university 
students from Asian countries. A study which was conducted among 400 full-time 
students from a university in Hong Kong showed that around 58% of the participants 
had poor sleep quality (77). While the prevalence of sleep problems among Indian 
university students was found to be 43.1% (78). Higher prevalence rates were reported 
among university students in Pakistan, with 60.5% of them having poor sleep quality 
(79). On the other hand, only around 15% of Japanese graduate students were found to 
have insomnia with 4% complaining of excessive daytime sleepiness (80). 
Furthermore, the prevalence of sleep problems among Iranian university students was 
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highly variable as it ranged between 21.5 and 62% in two studies (81,82).  
Large number of studies reporting prevalence rates of insomnia in university 
students come from the United State (US). A Study reported that around that 12-14% 
of the university students  had clinical insomnia, while 40-45% were reported to have 
subclinical insomnia (83). Prevalence rates, ranging from 9.4-16% have been reported 
in other studies with large (1845 students) and small samples (191 students) (84–88). 
Interestingly, in  one of these studies, 26.9% of the students met the insomnia criteria 
despite not reporting insomnia while another 6.5% complained of insomnia but failed 
to meet the defined criteria (87). Fewer studies have reported higher prevalence of 
insomnia among university students (89,90). In one of these, around one third of 
university students had poor sleep quality (89). The other was a large study which 
included more than 7000 students from 6 different universities in the US, in which  62% 
of the participants were identified as poor sleepers (90).  
Similarly, studies from European countries have confirmed that a significant 
number of university students from European countries have insomnia. In the United 
Kingdom (UK), 46% of university students perceived their sleep as bad or fairly bad 
(91). Similarly, the prevalence of insomnia among  Lithuanian and  Norwegian students 
were reported to be 59% and 30.5%, respectively (92,93). On the other hand, only 7.7% 
of German university students were found to have insomnia in a study with a sample 
of 2196 participants (94). However, one third of the students in this study reported 
having intermittent sleep for at least 3 days a week in the previous month.  
In addition, a study from New Zealand indicated that 39.4% of the students had  
persistent sleep problems (>1 month) (95). However, only 8.8% of them were found to 
have primary insomnia. Moreover, studies from  Brazil have shown that sleep problems 
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were very common among university students and around 60-95.3% of the students had 
poor sleep quality (96,97). Despite that, around two thirds of the study sample reported 
a short sleep latency of 15 minutes and a sleep duration not less than 6 hours (97).  
Several studies have assessed the prevalence of insomnia in some African 
countries. Studies from Ethiopia have consistently shown that more than 50% of 
university students had poor sleep quality (55.8-61.6%) (98,99). Likewise, around 50% 
of Nigerian university students were shown to have poor sleep quality in a study that 
included 505 students (100).   
A limited number of studies have assessed the prevalence of insomnia among 
university students in Arab countries and the findings are summarized in Table 2. Sleep 
problems were frequently reported in this population and most students’ complaints 
were related to difficulty initiating or maintaining sleep and having an interrupted sleep 
pattern (101–103). Sleep insufficiency was a common problem among university 
students and sleep durations of 5.71 and 6.48 hours were reported from KSA and 
Jordan, respectively (104,105). Poor sleep quality and insomnia were also prevalent 
among Arab university students with the reported prevalence ranging between 8 and 
85% (104–111).  
2.1.1.2. Sleep duration 
Many studies in literature have suggested that university students are sleep 
deprived as many of them do not get the recommended 7-9 hours of sleep which are 
necessary for replenishing the body’s energy (1). A meta-analysis of  57 studies which 
included university students from China reported that around 44% of the students slept 
for less than 7 hours while around 26% of them required more than 30 minutes to fall 
asleep (112). Additionally, around 28% of university students in India were found to 
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be sleep deprived, while 72% of Pakistani students slept for less than 7 hours and 33% 
needed longer than 30 minutes to fall asleep (78,79). Several studies from the US and 
European countries have collectively shown that at least one third of university students 
sleep less than 7 hours per night (89,91,99,100). Similarly, insufficient sleep was 
common among Arab university students, as around 50% of Iraqi students and 12% of 
Lebanese students were reported to sleep < 7 hours per  night (106,113).  Additionally, 
a significant proportion of university students (15-43%) reported facing difficulties in 
falling asleep within 30 minutes of going to bed, while others complained of frequent 
awakenings (78,92,94,107,109,112).  
 
 
Table 2. Prevalence of insomnia and sleep complaints among Arab university students  
Country  Study population Prevalence of insomnia  References 
Lebanon University students  Insomnia: 37-59%.  
Clinical insomnia: 10.6%  
Subclinical insomnia: 61.5% 
(106–108) 
Jordan  Nursing students 
 
Medical Sciences’ 
students  
Poor sleep quality: 85%  
Insomnia: 75.9% 
Clinical insomnia: 26%  
Subclinical insomnia: 49.9%  
(105,111) 
 
Palestine University students Poor sleep quality: 9.8% (109) 
Kuwait University students  Complaints of insomnia symptoms: 
 4.1-32.2% 
(101) 
Kingdom of 
Saudi Arabia  
Female university 
students  
 
Medical students  
Moderate clinical insomnia: 8%. 
 Subclinical insomnia: 42% 
 
Poor sleep quality:25-67%  
Insomnia symptoms: 33% 
(104,114–117) 
United Arab 
Emirates  
University students  Poor sleep quality: 67.2%  (110) 
Bahrain  University students  Poor sleep quality: 14% 
Interrupted sleep: 41%  
(102) 
Egypt  University students 
and employees  
 
Medical students  
Insomnia: 7-69%  
Poor sleep quality: 53% 
 
(103,118–120) 
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An international study that included 19,417 university students from 26 
different countries in Asia, Africa and the Americas reported  a mean sleep duration of 
7.07 hours (121). According to this study, students from Southeast Asia and sub-
Saharan Africa had the shortest sleep duration (6.82 and 6.97 respectively). Likewise, 
a study from the US has shown that 62% of the students reported sleeping for 7-9 hours 
per night , yet around 43% of the students required more than 30 minutes to fall asleep 
(90). Sleep duration was significantly correlated with insomnia severity, as it was found 
that students who slept less were more likely to have worse insomnia symptoms 
(93,111). Additionally, individuals with short sleep duration, intermittent sleep and 
those who wake up late were at least three times more likely to develop insomnia (94).  
2.1.1.3. Junior versus senior students 
 Young students who graduate from school and enter university are often 
subjected to psychological stress which is associated with the change in their lifestyle 
and the new responsibilities (79). Several studies have shown that students were more 
likely to have worse insomnia during their early years in the university (91,119). The 
stress in university students is often caused by different factors including academic 
burden, pressure to succeed and worries about the unknown future, and this increases 
their risk of developing sleeping problems (79).  
A study that assessed the prevalence of insomnia among newly enrolled 
students to a university in Taiwan found that around 55% of the students had poor sleep 
(122). Likewise, it was reported that first year university students from the UK were 
1.4 times more likely to have poor sleep quality compared to their senior colleagues 
(91). Moreover,  a study that included Egyptian university students reported  worse 
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stress in early years of education which is often associated with poor sleep (119).  
 
2.1.1.4. Factors associated with insomnia among university students  
Accumulating evidence in the literature has shown that female students tend to 
have worse sleep quality and are more likely to have insomnia (78,84,85,87,90,122). 
Yet other studies failed to find  an association between gender and sleep quality 
(99,100,111). Surprisingly, some studies are suggesting that males might be at higher 
risk for poor sleep quality than females (82,107).  
A correlation between insomnia and mental disorders in this population has 
been consistently reported in the literature and a recent study found that students with 
mental disorders are three times more likely to have insomnia compared to their healthy 
colleagues (87,88,98). Additionally, anxiety and depression were the most commonly 
linked conditions with insomnia (90,91,96,100). Mental disorders were also associated 
with increased use of medications and worse daytime dysfunction.  Furthermore, a 
significant association was found between the perceived stress and poor sleep quality 
among university students (100,116,123). Similarly, a study conducted among 
Egyptian medical students found that stress, anxiety and depression were significantly 
associated with insomnia (119). Additionally, more severe insomnia was found in 
students affected by stress, anxiety and depression. Likewise, a study conducted among 
Ethiopian university students found that the level of perceived stress is associated with 
increasing scores of poor sleep quality (99). It was reported that around 59% of 
Ethiopian university students were subjected to stress related to their academic 
performance and examinations (98). This finding supports the notion that stress is 
associated with sleeping problems and mental disorders. Additionally, receiving  less 
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social support and being at risk for psychiatric morbidity were predictive of poor sleep 
quality (122).  
A number of studies in the literature have suggested that medical students are 
at higher risk for sleep problems as compared to students in other study disciplines. The 
findings of a  meta-analysis  has shown that medical students were more likely to have 
short sleep duration as compared to non-medical students (112). A review of the 
literature found that the prevalence of  insomnia in medical students ranged between 17 
and 40.6% (124). Excessive daytime sleepiness was also common among this group of 
students and ranged between 30.6% and 90% in the included studies.  
Similar findings were reported by students from different universities in Arab 
countries. Results from several studies conducted among medical students from Egypt 
have found that  53% of students had poor sleep quality, while insomnia prevalence 
ranged between 28 and 69% (118–120). Additionally, around half of the sample 
(48.7%) reported bad daytime dysfunction and 29% experienced excessive daytime 
sleepiness (118,120). One third of medical Saudi students were shown to have insomnia 
symptoms in one study, while  another study showed that 63.4% of the students had a 
sleep disorder (116,117). Also, 40.2% of medical students in Bahrain reported going to 
university without sleep at least once a week (125). Moreover, the prevalence of 
excessive daytime sleepiness in this population was reported to range between 36.6% 
and 56.9% (116,117,126). Similarly, most Iranian medical students (71%) were 
reported to have poor sleep quality (127). On the contrary, only 25% of Saudi female 
medical students reported poor sleep quality (115). 
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2.1.2.   Sleep hygiene patterns among university students 
Unhealthy sleep habits are common among university students. It was reported 
that university students have worse sleep hygiene than the general healthy population 
(83). Interestingly, a significant association was found between sleep quality and sleep 
hygiene practices; indicating that students with poor sleep hygiene are more likely to 
have poor sleep quality (77).   
University  students often have irregular sleep schedules with sleep durations 
that differ significantly between weekdays and weekends (84,85,98,112). Most 
university students usually get more sleep during weekends as compared to weekdays. 
Going to bed late was one of the most common sleep habits among Saudi university 
students, of whom 43% reported doing that most days of the week (115). It was also 
suggested that students might sometimes go to university after staying awake all night, 
as in one study around 28% of Bahraini university students reported going to campus 
without sleep at least once a week (102). Several factors including skipping breakfast, 
drinking tea and internet use significantly predict poor sleep quality in university 
students (122).  
Studies from different countries have consistently shown that taking daytime 
naps is a common habit among university students. A meta-analysis has shown that 
around 86% of Chinese university students usually have an afternoon nap (112). 
Similarly, around 58% of students at a Palestinian university reported having daytime 
naps at least once a week (109). While, between 49% and 60% of Saudi medical 
students reported taking daytime naps after school, and 23% of them indicated that this 
was a daily habit (116,117). Studies have also shown that daytime naps tend to decrease 
nocturnal sleep duration to less than 7 hours per night (79).  
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The consumption of stimulant drinks especially caffeine containing products is 
a common practice among university students in Arab countries. A study from Lebanon 
has shown that 97% of the students consumed caffeinated beverages (128). Daily 
consumption of caffeine was reported by around 85 and 65% of  Egyptian and Saudi 
university students, respectively (116,118). Drinking caffeinated beverages  late at  
night was also frequently described by university students from Arab countries 
(115,128). In addition, around one third (33.4%) of  Saudi medical students reported 
consuming energy drinks regularly in the previous 2 months (129). 
 Students often use energy drinks to compensate for their lack of sleep and many 
students indicated that they often use these drinks to stay awake for longer periods and 
to boost their energy for studying (129). The frequency of consumption was found to 
increase with age and one study have shown that around  47% of students older than 24 
years consumed caffeinated beverages more than 3 times a day (128). This study also 
reported an increase in the use of caffeinated drinks in response to increased academic 
pressure and workload. The consumption of  energy drinks 4 times or more per week 
was also associated with worse sleep quality as around one third of regular energy 
drinks’ users were found to develop insomnia (29.5%) (79,129). 
Caffeine consumption significantly predicted poor sleep quality among students 
(116,118). It has also been reported that among university students, the consumption of 
more than 6 cups of coffee per day was associated with increased stress levels (119). 
Furthermore, frequent consumption of simulants in most days of the week was found 
to delay the sleep onset by more than 30 minutes (79). Several studies have also linked 
smoking with worse sleep quality among university students (79,81,91,106). 
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Electronic devices are one of the life necessities nowadays, especially among 
younger generations. The use of electronic devices is common among university 
students. In one study it was found that around 70 and 90% of  university students use 
laptops and smart phones, respectively, for longer than 3 hours a day (130). The use of 
electronic devices has been associated with insomnia development in this population 
(130). Increased use of mobile phone, television, DVD and music player were also 
linked with the incidence of poor sleep quality among university students (79,114). 
Addiction to cell-phone was reported to be associated with increasing the likelihood of 
poor sleep quality by 4.5 folds in one study (82). It was also reported that students who 
used smart phones for longer than 6 hours daily were more likely to have insomnia 
(130). It seems that the use of  electronic devices before sleep is a common habit among 
university students (114) However, the use of these devices for 1 hour before sleep most 
days of the week (4 days or more) was  significantly associated with a delayed sleep 
onset by more than 1 hour (79). Furthermore, listening to music at night was 
significantly related to  poor sleep quality (127).  
 
 
2.1.3. Consequences of insomnia among university students  
Students deprived of sleep during the night often experience excessive daytime 
sleepiness as a compensation for their lack of night-time sleep. The reported prevalence 
of excessive daytime sleepiness among university students ranged between 4 and 90% 
(80,91,116,117,120,124,126). Insomnia in this population have also other detrimental 
consequences as several studies have documented a negative impact on students’ day-
time performance and quality of life (87). Sleep deprivation affects students’ cognitive 
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functioning and attention during classes and examinations (120,131). Lack of sleep 
affects and compromises the individual’s memory, learning ability and performance of 
complex mental tasks. As a result, insomniac students are usually sleepy during class, 
can easily get distracted while studying and are less likely to actively participate in class 
(110,120). It was also reported that students with worse insomnia are more likely to 
have study related headache (120).  
Other complications of sleep problems include fatigue, university absenteeism 
and accidents (80). One study found that students with worse sleep quality were more 
likely to miss one class or more in comparison to students with good sleep quality (110). 
In another study, around 75% of the students reported daytime consequences of sleep 
insufficiency including fatigue in the morning and excessive daytime sleepiness with 
lower concentration (113). Similarly, in another study around 55% of the students 
reported  tiredness,  and 72% had daytime sleepiness during lectures at least once a 
week (109).  
Some studies have also linked insomnia to lower academic performance, 
findings indicate that college students who sleep for longer duration or those with better 
sleep quality were more likely to have higher grade point average (GPA) (84,116,132). 
Likewise, another study suggested that excessive daytime sleepiness was associated 
with worse academic performance (126). However, the effects of insomnia on academic 
performance remains controversial as other studies were not able to find a significant 
association (79,87,98,105,109). Although the link between insomnia and academic 
performance is not yet clearly established, examinations and assessments were reported 
to be the main factors that affect university students sleep (102). In a similar context, it 
was shown that students perceived sleep quality was lower during examination period 
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as compared to the non-examination periods (28% and 55.2%, respectively) (115). 
The use of sleep aids was found to be more common among university students 
with insomnia (87,100). It has also been suggested that increased use of sleeping pills 
negatively affects the academic performance by resulting in worse GPA scores (115). 
Poor sleep has also negative effects on the students’ quality of life. This finding 
was shown through several studies which suggested that individuals with worse sleep 
quality often perceive their quality of life to be poor and are usually  pessimistic about 
their achievement in university and other aspects of their lives (92). This was supported 
by the findings of another study done among Lebanese university students which 
concluded that higher insomnia scores were often associated with poor quality of life 
(133).  
 
 
2.2. Exploration of instruments assessing insomnia symptoms and sleep hygiene 
practices among adults  
Polysomnography is considered the gold standard method for the assessment of 
sleep problems. However, the routine use of polysomnography for the diagnosis of 
insomnia in clinical practice is impractical since it is expensive, requires special 
equipment and facilities with qualified staff (134). Instead, a variety of self-reported 
sleep instruments have been developed to assess insomnia symptoms (134,135). 
However, a wide range of sleep instruments are available, and it is important to 
determine which are the most appropriate and robust to be used in the context of clinical 
practice or in sleep research. A previous systematic literature review identified 22 
instruments which assess different sleep-related domains in the adult population (136). 
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In other similar reviews, authors evaluated studies which developed instruments 
assessing multiple sleep disorders or those measuring sleep disturbances in specialized 
populations such as adolescents (137,138). Yet, none of these reviews focused on 
instruments that assess only insomnia.  In these reviews, there was also insufficient 
evaluation of the psychometric properties of the instruments that were identified, and 
none of them included instruments which assess sleep hygiene practices in adult 
population. Therefore, as part of this research, a systematic review of the literature on 
subjective instruments assessing different aspects of sleep and sleep hygiene in the adult 
population was conducted. This review also aimed to identify sleep instruments 
available in Arabic language. 
 A comprehensive systematic search of five databases was undertaken, 
including PubMed (1966- April 2018), EMBASE (1980- April 2018), ProQuest Central 
(1947-2018), SCOPUS (1966-April 2018), and Google Scholar (till April 2018) 
(detailed search for PubMed and EMBASE are displayed in Appendix A). Grey 
literature was also searched by reviewing conference proceedings and abstracts of the 
Canadian Sleep Society and the AASM published in the period between January 2014 
and December 2017. Additionally, a hand search of the bibliographies of the articles 
identified through the electronic database search was undertaken. Search terms used in 
the databases were classified into three categories related to: sleep dysfunction 
(Category A), the instrument for assessment (Category B), and validation and 
psychometric properties (Category C). Terms from Category C were not used in 
databases such as PubMed which offered “validation studies” as one of the limits or 
filters. Publication language was limited to English and no limits were imposed on the 
publication year. In addition to the English search, two separate searches were 
  
31 
 
conducted to identify sleep instruments developed in or translated into Arabic language. 
The first used the same search terms as those in the original search, in addition to the 
word “Arabic”. The second was conducted in Arabic language in the following 
databases: PubMed, Google Scholar and Dar Al-mandumah using the same search 
terms as those used in the original search. 
The inclusion criteria for this systematic review of the literature was limited to 
studies reporting the psychometric properties of instruments and questionnaires 
assessing characteristics of sleep (quality, quantity, nocturnal awakenings), daytime 
consequences of poor sleep, or sleep hygiene in the adult population and which were 
completed by self-report.  Studies evaluating instruments designed to measure sleep 
disorders other than insomnia (e.g. obstructive sleep apnea, restless leg syndrome, etc.) 
and those using sleep items as subdomains of an instrument assessing a condition other 
than insomnia were excluded from analysis. Additionally, studies which focused on 
pediatric/geriatric populations, describing instruments designed to be completed by 
clinicians or caregivers, using instruments developed in languages other than English 
or Arabic, or describing instruments not psychometrically validated were also 
excluded.  
After obtaining article citations from the different databases, duplicates were 
removed. Titles and abstracts of the articles were initially screened for relevance. Full 
text of eligible articles was obtained and screened against the inclusion and exclusion 
criteria. Articles which successfully passed full-text screening phase were included in 
the final analysis. Data were extracted from these studies in accordance with eight key 
attributes established by the Scientific Advisory Committee of the Medical Outcomes 
Trust (SAC-MOT) (139). The extraction tool acquired from the SAC-MOT attributes 
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included the following components: instrument’s name, authors, conceptual framework 
(domains and purpose), psychometric properties, validation population, general 
description of the instrument (number of items, scale, scoring, response format, 
burden), in addition to cultural and linguistic adaptation. The psychometric properties 
were extracted from studies describing the validation of the original (English or Arabic) 
version of the instruments. The psychometric properties extracted from the validation 
studies included validity, reliability, responsiveness, and interpretability. Validity is a 
measure of an instrument’s accuracy in assessing the constructs it was developed to 
measure, whereas reliability evaluates an instrument’s consistency in determining these 
constructs (140). In addition, responsiveness provides useful information regarding the 
instrument’s ability to detect clinically meaningful changes in sleep parameters, 
whereas interpretability reflects the degree to which an instrument’s score could be 
translated into a clinically meaningful classification. As part of this study, instruments’ 
attributes related to the validation sample were also extracted. Data extraction was done 
by the MSc student (RA) and reviewed by the primary supervisor (MZ).   
The quality of the instruments obtained was assessed according to the SAC-
MOT criteria described previously and the quality criteria developed by Terwee et al. 
(139,141). However, the criteria for the floor and ceiling effects and the agreement 
component of the reproducibility which are included in the Terwee et al. quality criteria 
were not considered in the evaluation of instruments’ quality because these components 
were rarely reported in the validation studies. In addition, for the criteria regarding test-
retest reliability, criterion and construct validity, the Pearson’s correlation coefficient 
was extracted from the included studies to describe the extent of correlation between 
the instrument in question and the reference instruments for the validity measures and 
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between the two responses in case of reliability.     
After removal of duplicates, 4,453 citations were retrieved from the search as 
shown in Figure 1. One hundred and seven articles were deemed suitable for inclusion 
in the review. These articles included 31 distinct sleep instruments. Of the 107 articles 
included, 47 discussed the validation process of the instruments in English, while the 
remaining 60 articles reviewed the translation and cultural adaptation of these 
instruments into a variety of languages and populations.  The two additional searches 
done to find sleep instruments in the Arabic language did not identify any additional 
results other than those derived from the original search. Table 3 summarizes the results 
of the validation studies (n=47) related to the 31 sleep and sleep hygiene instruments 
included in this review. The table also describes the psychometric properties of the 
instruments and the characteristics of the populations in which they were validated. 
Furthermore, Table 4 provides a detailed description of the characteristics of the 31 
instruments.    
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Figure 1. Flow chart of the systematic review
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Additional records identified 
through other sources 
(n = 0) 
Records after duplicates removed 
(n = 4,453) 
Records screened 
(n = 4,453) 
Records excluded 
(n = 4,349) 
Full-text articles assessed 
for eligibility 
(n = 104) 
Full-text articles excluded, 
with reasons 
(n = 30) 
Reasons for exclusion: 
▪ Full text not available 
▪ Article is not in English 
or Arabic   
▪ The tool is assessing a 
different construct 
▪ The tool assessing 
other disorders  
▪ Not a validation study  
▪ The article describes 
the validation of item 
banks  
▪ The tool is for a 
specialized population 
▪ English version not 
validated  
 
Studies included in 
qualitative synthesis 
(n = 107) 
Records identified 
through hand 
search search 
(n=33) 
  
35 
 
Table 3. Studies testing the psychometric properties of extracted instruments   
Author, year Instrument  Sample  Psychometric properties 
Validity  Reliability Responsiveness and 
Interpretability  
Pallesen et al., 
2008 
The Bergen 
insomnia scale 
(BIS) 
University students 
 
Community sample 
 
Patient sample 
Convergent and discriminant:  
BIS significantly associated with Athens Insomnia scale 
(r=0.79) and the Pittsburgh sleep quality index (r=0.73).  
 
BIS had lower correlation with Beck depression and anxiety 
inventories (r=0.55 and 0.32 respectively).  
Internal consistency: 
Students (n=320): α= 0.79 
Community (n=5,000):   
α= 0.87 
Patient sample (n=225):  
α= 0.80 
-Test retest (after 2 weeks) 
Students (n=200): r = 0.77 
NR 
Yeh et al., 2012 The Insomnia 
Screening Scale 
(ISS) 
Study 1: (n=162) 
Adults 
Participants with 
primary insomnia and 
healthy participants 
 
Study 2: (n=262) 
Community sample 
(paediatrics, adults 
and elderly) 
Concurrent/criterion validity: 
- ISS (Insomnia symptoms subscale) significantly correlated 
with Insomnia severity index (ISI) and Pittsburgh sleep 
quality index (PSQI): (r =0.87 and r =0.85 respectively). 
- ISS (daytime functioning) significantly correlated with ISI 
and PSQI (r =0.63 and 0.68 respectively)  
 
- Sleep environment domain negatively correlated with PSQI 
and ISI: (r = - 0.31 and - 0.25 respectively).  
- Sleep opportunity negatively correlated with ISI and PSQI 
was expressed as: (r = – 0.37 and r = – 0.41, respectively).  
- External validity: community sample, 13.36% (inadequate 
sleep opportunity and sleep environment), and 37.02% met the 
criteria of insomnia and daytime function. 
Internal consistency: 
-Insomnia symptoms: α =0.98 
-Daytime function: α=0.94 
-Sleep environment:  α = 0.90 
-Sleep opportunity: α=0.87 
Interpretability: 
ISS demonstrated sensitivity 
and specificity of 0.89 and 0.59 
respectively 
 
Cut-off scores:  
-Sum of sleep environment and 
opportunity subscales scores= 
27 
-Sum of insomnia symptoms 
and daytime functioning 
subscale scores=42 
 
Kato T., 2013 Sleep Quality 
Questionnaire 
(SQQ) 
Full-time employees 
and college students. 
Content validity: confirmed by two Japanese experts in stress 
research. 
Convergent validity: (n=370) 
SQQ subscales (Sleep difficulty and daytime sleepiness) with 
MOS sleep scale1 (rs = 0.37 and 0.43, p< 0.001). 
The Daytime Sleepiness score with Epworth Sleepiness Scale 
(ESS) score (r = 0.47, p < 0.001). 
 
Incremental validity: (n=346) 
SQQ subscales with the GHQ-122, CES-D Scale3, FSS4, and 
SWLS5 scores significant ΔR2 scores (0.403, 0.313, 0.408 and 
0.054 respectively) with p< 0.001. 
Internal consistency: 
For Daytime sleepiness in 
student 
 (α= 0.83) and in employee 
sample (α=0.84). 
For Sleep Difficulty 
subscale were (0.74) for 
the student sample and 
(0.77) for the employee 
sample. 
 
Test-retest (over 8 weeks) 
Daytime Sleepiness 
subscale (r=0.76)  
Sleep Difficulty subscale 
(r=0.79) 
NR 
  
36 
 
 
Table 3. Cont. Studies testing the psychometric properties of extracted instruments   
Author, year Instrument  Sample  Psychometric properties 
Validity  Reliability Responsiveness and Interpretability  
Levine et al., 
2003 (study a) 
 
Levine et al., 
2003 (study b) 
Women’s Health 
Initiative 
Insomnia Rating 
Scale (WHIIRS) 
Postmenopausal 
women 
Content analysis: 
The WHIIRS items corresponded to most of insomnia 
characteristics noted in the nosologies (e.g.  International 
Classification of Sleep Disorders) and the literature. 
 
Construct validity: 
The correlation between the CES-D3 and the WHIIRS 
was small r =0.29  
-The WHIIRS mean in the largest CES-D3 category (M 
=10.3 for Category 12) was 1.8 times that in the smallest 
depression category (i.e., M =5.7 for Category 0) 
-The SF-3630 subscales were also linearly related to the 
WHIIRS Cohen’s f value was 0.273, (p < 0.0001).  
-For night sweats and hot flushes with WHIIRS, the 
values of Cohen’s f were, respectively, 0.205 and 0.157. 
Internal consistency: 
α = 0.786. 
-89.3% of the samples had 
reliability coefficients ≥ 
0.75 
 
Test-retest: 
Same day administration 
(r =0.96) 
Tests after >1 year (r 
=0.66) 
NR 
Drake et al., 
2014 
Restorative sleep 
questionnaire 
(RSQ) 
Community based 
sample 
 
Patients with primary 
insomnia 
 
Non-refreshed 
sleepers (NRS) 
Content validity: 
-Key concepts developed through patient focus groups 
and patient interviews. Concepts reviewed by two expert 
panels. 
Convergent/divergent: 
-RSQ-Daily (RSQ-D) with Leeds Sleep Evaluation 
Questionnaire scores: Positive and significant correlation 
with all domains (r ≥0.40, p ≤0.006) except for Getting to 
Sleep scores (r = 0.27; p= 0.079) 
-RSQ-D with Subjective Sleep questionnaire: 
Sleep quality (r = 0.59; p < 0.001); TST31 (r = 0.32; p= 
0.036) 
-RSQ-D with vitality questionnaire: (r = 0.61; p< 0.001). 
 
-RSQ with PSG: Latency to persistent sleep (r ≥0.20), 
TST32 and sleep efficiency (r ≥0.26), WASO32 (r ≤0.020) 
and total wake time (r ≤0.26) significant P-value. 
Internal consistency: 
RSQ-D: α= 0.91 
RSQ-W: α= 0.90 
 
Test-retest (responses on 
consecutive days 
measures) 
 
RSQ-D and RSQ-W: r 
>0.80 
 
NR 
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Table 3. Cont. Studies testing the psychometric properties of extracted instruments   
Author, year Instrument Sample  Psychometric Properties 
Validity Reliability  Responsiveness and 
Interpretability  
Buysse et al., 
1989 
 
 
Grandner et 
al., 2006 
 
 
Backhaus et 
al., 2002 
Pittsburgh sleep 
quality 
index (PSQI) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- Group I: healthy 
control subjects 
(n=52) 
- Group 2: patients 
with major 
depressive disorder 
(n=34). 
- Group 3: Clinical 
sample physician-
referred outpatients 
at the Sleep 
Evaluation Center 
 (n = 45)   
 
 
-Non-clinical sample 
(younger and older 
adults) 
 
 
-Primary insomniacs  
 
- Healthy controls 
Discriminating between patients and controls: 
-Global PSQI scores differed significantly between 
groups and a significant difference was found between all 
patient groups and individuals in the healthy control 
group.   
 
-Patients with DIMS6 had significantly higher scores than 
patients with Disorders of Excessive Somnolence DOES7 
patients. A significant difference in PSQI components’ 
scores were found between the control group and both 
DIMS6 and depressed groups. PSQI scores also differed 
on 3 components (sleep disturbances, daytime 
dysfunction, and sleep quality) with DOES7 patients.   
 
- A significant difference in all PSQI component scores 
except sleep disturbance were identified between DOES7 
and DIMS6 patients. While DOES7 and depressed patients 
differed on all components’ scores except sleep 
disturbance and daytime dysfunction. 
 
Diagnostic validity: 
(Buysse et al., 1989) 
A cutoff score of 5 in the global PSQI scores correctly 
determined the sleep quality for 88.5 participants (kappa 
= 0.75, p < 0.001) reporting a sensitivity of 89.6% and a 
specificity of 86.5%.  
 
(Backhaus et al., 2002) 
- PSQI global score > 5 resulted in a sensitivity of 98.7 
and specificity of 84.4 
 
Criterion/concurrent validity:  
(Buysse et al., 1989) 
PSQI scores and PSG: 
- Significant positive correlation between PSG and PSQI 
only for sleep latency (r =0.33, p < 0.001) 
Internal consistency: 
 Overall:  α = 0.83 (Buysse et al., 
1989) 
  Overall:  α = 0.85 (Backhaus et al., 
2002) 
 
 
Test-retest: (Buysse et al., 1989)  
-Test retest (around 28 days from the 
first time) the global PSQI scores was 
r = 0.85 (p< 0.001). 
 
- Component scores:  
r = 0.84 - 0.65 (p< 0.001 for each 
component score). 
 
Test retest: (Backhaus et al., 2002) 
Overall: (r =0.87, p= 0.000) 
-Short interval (2 days): 
r =0.90, p=0.00 
 
-Longer interval (45.6 ± 18 days): 
r =0.86, p= 0.000 
Interpretability:  
Can distinguish between 
“good” and “poor” 
sleepers. The cut-off point 
is 5.  
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Table 3. Cont. Studies testing the psychometric properties of extracted instruments   
Author, year Instrument Sample Psychometric Properties 
Validity Reliability Responsiveness and 
Interpretability 
 Pittsburgh sleep 
quality 
index (PSQI)  
 
Continued.  
 PSQI global score and PSG: 
- Objective sleep latency (r = 0.20, p< 0.01), weak 
correlation 
- The global PSQI score correlated only with REM% in 
controls (r = 0.34, p< 0.006) and number of arousals in 
depressives (r = 0.47, p< 0.002). 
 
(Backhaus et al., 2002) 
- PSQI was highly correlated with sleep log data (r =0.81, 
p= 0.000 for sleep duration and r =0.71, p< 0.001 for 
sleep onset latency.  
-The correlations between PSQI and polysomnographic 
data was significant and lower ranging between r = -0.32 
to -0.33).  
 
Construct validity: 
PSQI with actigraphic measures of sleep: lack of 
significant association (r ≤0.13).  
PSQI with sleep diary: (significant correlation)  
-Sleep efficiency (r = -0.562, p< 0.01), TST31 (r = -0.307, 
p< 0.01), WASO32: (r = 0.262, p< 0.01),  
 
-Sleep latency: r = 0.480, p< 0.01  
-CESD3: r = 0.305, p< 0.01 
  
Bastien et al., 
2001 
 
 
 
Morin et al., 
2011 
 
Insomnia severity 
index (ISI) 
 
Study 1: 
Patients with a chief 
complaint of 
insomnia (n=145). 
 
Study 2: (n=78) 
Insomnia patient 
involved in a study 
assessing the  
 
Criterion/concurrent validity: 
ISI items with sleep diary variables: 
-Sleep onset latency (r = 0.38), WASO32 (r = 0.35) and 
Early morning awakening (r =0.35). 
-Total ISI score and the sleep efficiency variable (r = -
0.19)  
 
-ISI and sleep diary components  
r = 0.32- 0.55 at baseline and r = 0.50 to 0.91 post-
therapy (all p values < 0.05). 
Study 1: 
Internal consistency: 
α = 0.74.  
 
Study 2: 
Internal consistency: 
The internal reliability coefficients did 
not change significantly from baseline 
to follow up (0.76 to 0.78, 
respectively).  
Responsiveness: 
A significant reduction in 
ISI score was detected 
post-treatment in patients’ 
(8.9 vs. 15.4) and 
clinician's versions (7.7 vs. 
17.7). 
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Table 3. Cont. Studies testing the psychometric properties of extracted instruments   
Author, year Instrument Sample Psychometric Properties 
Validity  Reliability  Responsiveness and 
Interpretability  
 Insomnia severity 
index (ISI) 
 
Continued.  
efficacy of cognitive 
behavioral therapy. 
 
Morin et al., 2011 
 
- Community 
sample     
      (n= 959) 
 
- Clinical sample 
(n=183) 
- ISI variables with PSG variable: 
Correlation ranged between r = 0.07 to 0.45 at pretreatment, 
and r =0.23 to 0.45 at post-treatment. Only the correlation for 
SOL8 variable was significant at pretreatment, whereas all 
correlations, except one were significant at post-treatment (p< 
0.05).  
 
-The correlations between the patient's and the clinician's 
versions of the ISI at the two assessment periods were all 
significant (p values < 0.01). Furthermore, the correlations 
between the patient's and the significant other versions of the 
ISI were also significant at the two assessment periods (p 
values < 0.01). 
 
-Predictive validity: 
The clinician's ratings predicted best the patient's ISI total score 
at baseline, while post-treatment, both clinicians’ rating and the 
sleep diary data were equally predicted the patient's total ISI 
score. 
R2= 0.37 (p< 0.05) at pretreatment, clinician: (β= 0.52) 
 
R2= 0.61 (p< 0.05) at post-treatment, clinician: (β= - 0.52) 
Sleep diary: (β= - 0.34) 
 
Content validity: 
A principal component analysis, using varimax rotation, 
explored the ISI content validity, (i.e. relation of the items to 
the concept) and the extent to which its components 
corresponded to diagnostic criteria of insomnia.  
Morin et al., 2011 
Community:  
(Cronbach α = 0.90)  
 
Clinical samples: 
 (Cronbach α = 0.91). 
ISI sensitivity to detect 
clinical improvement 
(n=146) 
 
Moderate improvement in 
insomnia was identified as 
a reduction in ISI score by 
> 7 points (60% 
sensitivity, 70% 
specificity).  
 
Marked/ higher 
improvement in sleep was 
identified as a decrease in 
ISI score by > 8 points 
(64% sensitivity, 80% 
specificity). 
 
 
 
Interpretability: 
The scores of the ISI 
represent the following:  
 
0–7: lack of insomnia, 
 8–14: Subthreshold 
insomnia 
 15–21: Moderate 
insomnia 
 22–28: Severe insomnia. 
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Table 3. Cont. Studies testing the psychometric properties of extracted instruments   
Author, year Instrument Sample Psychometric Properties 
Validity Reliability Responsiveness and 
Interpretability 
 Insomnia severity 
index (ISI) 
 
Continued. 
 Morin et al., 2011 
Diagnostic validity: 
- Subthreshold insomnia:  
A cutoff score of 8:  
Sensitivity of 95.8% and 99.4% in the Community and 
Clinical samples respectively, and with specificity of 
78.3% and 91.8%. 
 
- Moderate to severe insomnia: 
-A cutoff score of 15  
Specificity of 98.3% and 100% in the Community and 
Clinical samples, respectively, with a sensitivity of 47.7% 
and 78.1% respectively.  
 
- Community sample: cut point of 10 (86.1% sensitivity 
and 87.7% specificity).  
- Clinical sample, cut point of 11 was associated with 
97.2% sensitivity and a perfect 100% specificity. 
 
Construct validity (convergent): 
- Insomnia severity on the ISI was positively correlated 
with the corresponding diary variable. 
 -The ISI total score and the PSQI total score: r = 0.80, p< 
0.05. (positive, significant correlation) 
 
- Significant relationships were found with measures of 
anxiety and depression, different dimensions of fatigue. 
Significant correlations were also discovered with the SF-
129, with a stronger association identified with the Mental 
components of the measure than with the Physical Health 
component. 
 
 Morin et al. (2011) 
suggested clinically 
significant insomnia could 
be identified by ISI scores 
>10 in community samples 
and scores >11 in clinical 
settings.  
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Table 3. Cont. Studies testing the psychometric properties of extracted instruments   
Author, year Instrument Sample Psychometric Properties 
Validity  Reliability  Responsiveness and 
Interpretability 
Jenkins et al., 
1988 
 
Nassermoaddeli 
et al., 2005 
 
Jerlock et al., 
2006 
The Jenkins 
Sleep Scale (JSS) 
-Air traffic 
controllers (n=250 
men; 25- 49 years 
old) 
 
-Patients recovering 
after from cardiac 
surgery (500 
patients).   
Construct validity: 
Spielberger’s state anxiety: r=0.37 
POMS10-Depression: r =0.35 
POMS10- Hostility: r =0.29 
POMS10-Vigor: r = -0.24 
POMS10-Fatigue: r =0.46 
Positive well-being: r = - 0.22 
Internal consistency: α= 0.79  
Test-retest reliability: r=0.59 
 
Jerlock et al., 2006 
Internal consistency: α= 0.80 
 
Nassermoaddeli et al., 2005 
Internal consistency: α= 0.77 
NR 
Soldatos et al., 
2000 
 
 
 
Soldatos et al., 
2001  
 
Athens Insomnia 
Scale (AIS) 
 
299 subjects 
Consisting of: 
 
1-Primary 
insomniacs 
 
2- Psychiatric 
patients (both 
inpatients and 
outpatients) 
 
3-Healthy subjects 
External validity: 
Sleep problems scale with: 
AIS-8: r = 0.90, p<0.001 
AIS-5: r = 0.85, p<0.001 
 
Soldatos et al., 2001  
Diagnostic validity: 
- AIS in general population, for a Cut-off score of 6 only 
1% of those responders with insomnia are misdiagnosed 
 (i.e. NPV11= 99%), whereas 41%(PPV12=41%) of those 
who score 6 or higher will be meeting the diagnostic 
criteria for insomnia 
- For psychiatric population: 8% (NPV11=92%) and 
(PPV12=86%). 
-A total score of 6 or higher in the AIS was shown to 
correctly identify 90% of the study subjects as suffering 
or not from ‘‘nonorganic insomnia’’ according to ICD-
10, with a sensitivity of 93% and specificity of 85%. 
Internal consistency: 
AIS-8: α= 0.89, AIS-5: α=0.87 
 
Test retest (n=194): 
AIS administered two times, one 
week apart. 
AIS-8: r = 0.89, p<0.001 
AIS-5: r = 0.88, p<0.001 
Interpretability: 
Cut-off score of 6 
General population 
(NPV11= 99%, 
PPV12=41%) 
Psychiatric population 
(NPV11=92%, 
PPV12=86%) with 
sensitivity (93%) and 
specificity (85%). 
-A total score of 6 or 
higher in the AIS was 
shown to correctly identify 
90% 
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Table 3. Cont. Studies testing the psychometric properties of extracted instruments   
Author, year Instrument  Sample  Psychometric properties 
Validity  Reliability Responsiveness and 
Interpretability  
Broman et al., 
2008 
 
 
Westergren et 
al., 2015 
 
Minimal 
Insomnia 
Symptom Scale 
(MISS) 
1379 randomly 
selected subjects (20-
64) were included in 
the study (Sweden). 
Criterion validity: 
The correlation between BNSQ13 question about sleep quality and 
MISS total score high with r =0.76. 
 
Westergren et al., 2015 
A lower difference in score was observed between adult and elderly 
groups with the use of the cut-off score ≥6.  
Internal consistency: 
Total: α=0.73 
 
Test retest reliability: 
(6 months apart)  
High correlation was 
found with an ICC14 
of 0.79.  
 
 
Responsiveness: 
Sensitivity to change 
Paired t tests revealed that there 
was a strong trend for an 
increase score (m=+0.80; t=2.0; 
p=0.053) in subjects who 
deteriorated while there was a 
significant decrease (m =-1.06; t 
=2.9; p<0.01) in subjects who 
improved. 
 
Interpretability: 
A cut-off score of ≥6 on the 
MISS identify insomniacs in the 
general adult population 
(sensitivity 0.82; specificity 
0.86), PPV12 0.44; NPV11 0.97 
Espie et al., 
2000 
 
 
Edinger et al., 
2001 
 
 
Chung et al., 
2016 
Dysfunctional 
Beliefs and 
Attitudes about 
Sleep Scale 
(DBAS) 
 
Chronic insomniacs  
 
Normal subjects 
 
Insomniac  
 
 
Individuals with 
insomnia derived for 
a randomized 
controlled trail of 
self-help CBT-I16. 
DBAS 10 with DBAS-30: good correlation (r =0.826). 
-Total score: DBAS-10 and SDQ (r = 0.28) 
 
Edinger et al., 2001 
Construct/ convergent validity: 
-DBAS with DBAS-10: Normal sleepers: r =0.84, Insomniacs: r 
≥0.80 
 
Discriminative validity: 
Insomnia sufferers (mean DBAS 35.5, SD15 10.5) had significantly 
higher (F (1, 136) = 28.2, p< 0:0001), or more pathological scores on 
the full DBAS than did our normal sleepers (mean DBAS 26.4, SD 
9.7). 
 
- DBAS-10 scores of our insomnia sufferers (mean DBAS-10 43.3, 
SD 15.0) were significantly (F (1,136) = 15.9, p< 0:0001) higher 
than those shown by our normal sleepers (mean DBAS-10= 33.5, SD 
14.0). 
DBAS 30: 
Internal consistency: 
-Overall:  α = 0.72 
-Only two subscales 
achieved 
significance: 
1) “misattributions or 
amplifications of the 
consequences of 
insomnia”; α= 0.77 
2)Subscale 4: 
“diminished 
perceptions of control 
and predictability of 
sleep;” α= 0.41. 
 
DBAS-10: 
 
Responsiveness: 
-Changes in DBAS score 
following treatment were 
statistically comparable (F 
(2,68) = 2.33, p< 0.10) for all 
three treatment groups CBT, 
relaxation training (RT) or 
placebo control (PC). 
- DBAS-10 changes did differ 
statistically across the three 
treatment groups (F (2, 68) = 
4.69, p< 0.025). 
-Post hoc comparisons, showed 
that the CBT-treated insomniacs 
showed significantly greater 
decreases on the DBAS-10.  
 
 
 
  
43 
 
 
Table 3. Cont. Studies testing the psychometric properties of extracted instruments   
Author, year Instrument Sample Psychometric properties 
Validity Reliability Responsiveness and 
Interpretability 
 Dysfunctional 
Beliefs and 
Attitudes about 
Sleep Scale 
(DBAS) 
 
Continued.  
 Chung et al., 2016 
Criterion/ concurrent validity: 
- DBAS total was significantly correlated with several subscale 
scores of ISI and PSQI total scores, HADS-anxiety17 and 
HADS-depression17 subscale scores.  
- The DBAS-10 “immediate consequences” subscale had 
significant correlation with ISI and HADS-anxiety subscale but 
was not related to HADS-depression subscale. 
- The DBAS-30 and DBAS-16 “sleep expectation” subscales 
were only significantly correlated with ISI total score. 
-Internal consistency:  
α = 0.69 
-Internal consistency 
for factors I and II 
were 0.73 and 0.60. 
 
Edinger et al., 2001  
Internal consistency: 
DBAS 30: Normal 
subjects: α = 0.81 
Insomniacs; α ≥0.71 
 
DBAS-10: Normal 
subjects:  α= 0.70, 
Insomniacs: α ≥ 0.53 
 
Chung et al., 2016 
Internal consistency: 
DBAS-30, DBAS-16, 
and DBAS-10 with 
Cronbach α of 0.81, 
0.80, and 0.73, 
respectively. 
Significant changes from pre-to 
post treatment were found only 
for Factor 2 (F (2; 68) = 5.05, p 
<0.05). 
 
- Significantly greater reduction 
in DBAS scores was found in 
participants allocated to CBT-
I16, except the DBAS-30 
“attributions” subscale and 
DBAS-16 “medication” 
-Participants who had improved 
in ISI scores by ≥ 8 points had 
significantly greater changes in 
DBAS total scores and on 
DBAS-30 and DBAS-10 
subscale scores compared to 
those who had not improved 
scores.                                                                                                                                                                                                         
 
Espie et al., 
2014 
Sleep Condition 
Indicator (SCI) 
Samples from 5 
validation studies: 
- The Great British 
Sleep Survey 
(GBSS): adults > 18 
 
-The GBSS+18 
  
-TV sample  
-Glasgow Science 
Centre data (n=256)  
Content validation: 
- The DSM-5 was used to develop the questionnaire, 
consultations were conducted, and a draft was published on the 
American psychiatric association website.  
 
Concurrent/criterion validity: 
- SCI was negatively associated with the score of sleep quality 
questionnaires including PSQI (r = −0.734) and the ISI  
(r = −0.793).  
 
Internal consistency: 
- Cronbach’s α = 
0.857 (the 
GBSS18) (range 
of α-if-item-
deleted 0.822–
0.860).  
 
Interpretability: 
A cut-off ≤16, was able to 
identify 89% of patients who 
had insomnia (ISI scores of 
≥15).  
However, an SCI score of >16 
was able to exclude 82% of 
individuals without insomnia.  
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Table 3.  Cont. Studies testing the psychometric properties of extracted instruments   
Author, year Instrument Sample Psychometric properties 
Validity Reliability Responsiveness and 
Interpretability 
 Sleep Condition 
Indicator (SCI) 
 
Continued.  
- A randomized 
controlled trial 
(RCT) sample 
(n=164) 
 placebo-controlled 
evaluation of CBT16 
for insomnia. 
- Sleep condition was significantly associated with physical and 
mental health (r =0.222 and r =0.335 respectively).  
 
- Using the HADS17 scale, SCI was negatively correlated with 
symptoms of depression (r =−0.426) and anxiety (r =−0.400). 
But was higher than the associated detected in the RCT sample 
study (depression (r = −0.267), anxiety (r =−0.236) and stress (r 
= −0.263)). 
 
Concurrent and diagnostic validity: 
A cut-off score ≤16 was diagnostic for 89% of individuals who were 
identified as insomniacs on the ISI scale (scores of ≥15), with a 
capacity of correctly classifying 82% of non-insomniacs. 
 
These findings support the concurrent validity for the SCI and 
confirming that a score of ≤16 on the SCI could identify insomniac 
patients.  
- GBSS+ 
sample18 
(α=0.865). The 
mean corrected 
item-total 
correlation was 
moderate (r 
=0.620). 
 
Lee, 1992 
 
Lee, 2007 
General Sleep 
Disturbance Scale 
(GSDS) 
 
Female nurses in 
different shifts 
(permanent day shift, 
permanent night shift 
and rotating shifts) 
N=760  
 
Parents of infants 
hospitalized in the 
intensive care unit 
(n=44). 
Lee, 2007 
Content validity: Evaluated by multidisciplinary reviewers  
Criterion/concurrent validity: 
Sleep diary: 
For both the Chinese and English versions, higher GSDS scores 
were correlated with lower subjective sleep quality in sleep diaries (r 
= 0.41), higher morning fatigue levels (Chinese version: r = 0.42, p= 
0.05; English version: r = 0.56, p = 0.006). 
2-Wrist actigraphy: 
less sleep efficiency (Chinese version: r = - 0.26; English version: r 
= - 0.42). 
 
Criterion/ predictive validity: 
The participants’ GSDS mean scores were positively correlated with 
their morning fatigue levels (Chinese version, r = 0.42, p = 0.05; 
English version, r = 0.56, p = 0.006), supporting the predictive 
validity of the GSDS. 
Lee, 1992 
Internal consistency: 
-Overall: α = 0.88 
-Subscales of quality 
of sleep, daytime 
sleepiness, and use of 
sleep aids were 0.62, 
0.79, and 0.82, 
respectively. 
 
Lee, 2007  
Internal 
consistencies: 
Overall: Chinese 
version (α= 0.81) 
English version (α= 
0.85) 
 
NR 
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Table 3. Cont. Studies testing the psychometric properties of extracted instruments   
Author, year Instrument  Sample  Psychometric properties 
Validity  Reliability Responsiveness and 
Interpretability  
Fung et al., 
2014 
Daily Cognitive 
Communication 
and Sleep Profile 
(DCCASP) 
University students’ 
university of Toronto 
(n=59). 
 
 
 
 
 
Criterion validity: 
Sleep quality domain of DCCASP with sleep quality 
domain PSQI: 
-Adequate criterion validity for the Sleep Quality domain 
Of the DCCASP was established by the Sleep Quality 
domain of the PSQI, with rs = 0.398 (p< 0.001).  
-Positive correlation between sleep quality and each of 
the DCCASP domains: rs (0.38-0.55) (p< 0.0001). 
-Internal consistency: 
 Cronbach's α = 0.864 to 0.938 
for the seven domains of the 
questionnaire.  
 
-Test-retest (2 weeks apart) 
Concordance Correlation 
Coefficient (CCC) of each 
domain of the DCCASP range 
between (r = 0.548 to 0.742). 
NR 
Abdel-khalek, 
2008  
The Arabic Scale 
of insomnia 
(AIS) 
 
Students and 
employees   
Content validity:  PhD holding faculty members and 
master students assessed the validity of the instruments.  
 
Construct:  
Convergent validity: AIS was significantly correlated 
with Arabic sleep disorders scale and Jenkins sleep scale 
with a correlation range of (r= 0.56-0.94, p<0.001). 
Internal consistency: 
Range: 0.84-0.87  
 
Test-retest reliability (1 week 
apart):  
0.70- 0.83 
NR 
Morrone et al., 
2017 
Maugeri Sleep 
Quality and 
Distress 
Inventory 
(MaSQuDI-17) 
Outpatients 
evaluated for sleep 
disorders in 
Sleep Centers of 
Northern Italy 
 
Convergent validity and discriminant :(p< 0.001 for all) 
r2 = 0.5 with the PSQI  
r2 = 0.15 with ESS  
r2 = 0.39 with anxiety as measured by A-D19 schedule 
r2 = 0.52 with depression as measured by A-D19 schedule 
 
-Discriminating capacity: 
- Mean score for healthy and patient groups were 9.31 
and 14.15 respectively; and difference between the two 
achieved statistical significance (p< 0.001). 
- Differences corresponded significantly with the 
underlying disease condition (normal subject vs. OSAS20 
or INS21 or BSD22 group of subjects p < 0.001). 
Internal consistency: 
α= 0.896 
NR 
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Table 3. Cont. Studies testing the psychometric properties of extracted instruments   
Author, year Instrument  Sample  Psychometric properties 
Validity  Reliability Responsiveness and Interpretability  
Johns M., 
1991 
 
 
 Johns M., 
1992  
 
Johns M., 
1994 
Epworth 
Sleepiness scale 
(ESS) 
-Control (n=30)  
 
-Individuals with 
sleep disorders 
(n=150) 
 
Third year medical 
students (n=104) 
 
OSA 23 patients 
treated with CPAP24 
 
Patients who had  
MSLT25 (n=44) 
 
Spouses of 
participants who 
completed ESS 
(n=50) 
Discriminating capacity:  
-Significant differences in ESS scores between the seven 
diagnostic groups were detected (F= 50.00; df= 6,173; p< 
0.0001).  
-Sleepiness scores were higher in patients with OSA23, 
narcolepsy and idiopathic hypersomnia than controls (p< 
0.001) and primary snorers (p< 0.001) (statistically 
significant findings).  
 
-Criterion validity:  
ESS (total score) with MSLT14: 
-Mean Sleep latency (SL): (rho = -0.42, (p< 0.01). 
[Significant negative correlation] 
-When the correlation between mean SL with ESS 
individual item scores was assessed only 3 items were 
significantly correlated (p<0.05) which were: 
The likelihood of dosing off "when sitting, inactive in a 
public place" (rho= -0.44), when "sitting quietly after 
lunch without alcohol" (rho= -0.34) and when "in a car, 
stopped for a few minutes in the traffic" (rho= -0.41). 
 
Predictive validity: 
-All eight item scores as predictors of the mean SL in the 
MSLT14 was statistically significant (r = 0.639, p = 0.01). 
- Items 3 (r= -0.44, p<0.01) and 8 (r= -0.41, p= 0.01) 
were significant independent predictors.  
Internal consistency: 
α = 0.88 (patients) 
α = 0.73 (students) 
 
Test-retest reliability: (5 
months apart) 
-For 87 students: r = 0.822 
(p< 0.001). 
 
-Patient-Spouse paired 
item correlation: (mean 
rho = 0.57, p< 0.001). 
 
- The paired (patient-
Spouse) total ESS scores 
correlation (high) 
(rho = 0.74, n = 50, p< 
0.001) 
 
 
Responsiveness: 
After 3 months of treatment with 
CPAP24: 
Treatment with nasal CPAP24 in 54 
individuals with OSAS20 was 
associated with a change in ESS 
scores by 7.0 ± 5.2 (SD) following 
therapy, which was statistically 
significant (t =-9.59, df = 53, p< 
0.001).  
 
 
 
Akerstedt et 
al., 1990 
 
Reyner, et al., 
1998 
Karolinska 
sleepiness scale 
(KSS) 
8 male subjects 
 
 
Criterion validity: 
KSS with VAS26: 
-Minimum and maximum sleepiness: the scale values 
were 8.6 (0.3) vs 3.1 (0.6) and 89 (7) vs 34 (6) for the 
KSS and VAS26, respectively. The highest score on the 
KSS was relevant to the verbal anchor “extremely  
sleepy, fighting sleep” levels while the lowest value 
corresponded with “alert”.  
- The association between subjective sleepiness and the 
EEG27/ EOG28 variables (r =0.29-0.65, p<0.05).  
 
NR  NR 
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Table 3. Cont. Studies testing the psychometric properties of extracted instruments   
Author, year Instrument Sample  Psychometric properties 
 Validity Reliability  Responsiveness and Interpretability 
 Karolinska 
sleepiness scale 
(KSS) 
Continued.  
 -Significant differences in various levels of subjective 
sleepiness were identified for all variables, except theta 
activity- during the test conducted under ambulatory 
conditions. A significant difference between maximum 
and minimum sleepiness was detected (Wilcoxon, z > 
2.20, p<0.05).  
 
-No changes were identified in the EEG27/EOG28 before 
level 7 was reached on the KSS scale. For the test session 
with closed eyes, a significant variation was identified 
only with slow rolling eye movement (x2 = 13.6, p<0.01). 
 
- Increasing KSS levels were highly significantly 
correlated with an increased likelihood of falling asleep 
(Pearson’s r = 0.78; df = 1043; p= 0.001). 
  
Weaver et al., 
1997 
 
 
 
 
Weaver et al., 
2009  
 
Functional 
outcomes of sleep 
questionnaire 
(FOSQ) 
 
FOSQ-30: 
Sample 1 (n = 153)  
Healthy individuals 
presenting with sleep 
complaint  
 
Samples 2 (n = 24) 
and 3 (n = 51): 
Patients with OSA29  
 
FOSQ-10: 
Sample 1: (n=155) 
Participants with 
moderate to severe 
OSA29 on CPAP24  
 
Sample 2: (n = 51) 
CPAP24-treated 
OSA29 patients 
Normal subjects 
FOSQ-30: 
Face validity: 
Seven judges with expertise in the areas of functional 
status instrument development and sleep problems rated 
the clinical relevance of each item and the instrument to 
DOES7. 
  
Content validity: 
Determined by the proportion of items receiving a rating 
of at least three or four across all judges. 
 
Construct validity: 
-Subscale-to-subscale correlations range: r = 0.52-0.86 
-Subscale-to-global FOSQ score intercorrelations ranged 
from r = 0.78-0.86. 
 
Concurrent/criterion validity: 
-FOSQ-30 global score with SIP29 total score (n=24): 
(r = -0.50, p≤0.05) 
-FOSQ-30 global with SF-3630 sub-scales (n=51): 
No significant correlation 
FOSQ-30: 
Internal 
consistency(n=153): 
-Total:  α = 0.95 
-Subscales (α = 0.86 to α 
= 0.91) 
- Item to total correlation 
range:  
  0.35-0.73 
 
Test retest reliability 
(n=32): 
(Within 1 week) 
- Global score: r = 0.90 
- Individual subscales 
ranged from 
 r = 0.81 to r = 0.90 
 
FOSQ-10: 
Internal consistency: 
 α = 0.87 
Responsiveness: 
Clinically significant changes in total 
scores for FOSQ-30 and FOSQ-10 
measures were detected after CPAP24 
treatment, (p<0.0001). 
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Table 3. Cont. Studies testing the psychometric properties of extracted instruments   
Author, year Instrument 
 
Sample Psychometric properties 
Validity Reliability  Responsiveness and Interpretability 
 Functional 
outcomes of sleep 
questionnaire 
(FOSQ) 
 
Continued.  
 
 
 -FOSQ-30 global score with SF-3630 role emotional functioning 
sub scale (r=0.46, p≤.01)   
-FOSQ activity level sub scale significantly correlated with SF-
3630 physical functioning subscale. 
- The FOSQ social outcome subscale was significantly correlated 
with the SF-3630 social function sub scale (r =0.36, p≤ 0.05) and 
SF36 mental health subscale (r =0.38, p≤0.01). 
-Discriminant validity: 
-Mean of FOSQ global score discriminated between normal 
sleepers and those with sleeping problems: (68.05 ± 21.24 and 
89.59 ± 8.64 respectively with p= 0.0004) 
(T157 = -5.88, p= 0.0001). 
 
FOSQ-10: 
Criterion validity: 
Global scores comparison: 
-A significant association was identified between the global score 
of FOSQ-10 and FOSQ-30 both before and after treatment with 
CPAP24 (r = 0.96, p< 0.0001) and (r =0.97, p< 0.0001) 
respectively.  
 
Known group validity:  
-A significant difference in total FOSQI-10 score was identified 
between OSA group23 and normal patients (t = 8.65, p< 0.0001).  
  
David, 2008 Occupational 
impact of sleep 
questionnaire 
(OISQ) 
 
Community 
sample: 
Age:25-50 
years.  
 
Primary 
insomniacs 
according to 
the DSM IV 
(n=43) 
criteria and 
43 controls 
Criterion validity: 
- Positive, significant correlation was shown between OISQ and 
PSQI scores (mean r = 0.59, p<0.001)  
 
- Sleep diary variable: 
Work assessment scores negatively correlated with mean TST31 
(r = -0.47, p<0.001) and mean SE (r = -0.56, p<0.001), and 
significantly and positively with mean WASO32 (r =0.66, 
p<0.001). 
-Significant negative correlation with SF-3630 subscales ranging 
from r =- 0.21 to -0.62, p< 0.001.  
Internal consistency: 
α = 0.93 
 
Stability: 
A mean difference of 10.82 
between groups across 2 time 
points was found resulting in 
a significant main group 
effect (F = 12.52, p< 0.001).  
A consistent decrement of 
10% is seen in insomniacs 
compared to control.  
NR 
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Table 3. Cont. Studies testing the psychometric properties of extracted instruments   
Author, year Instrument 
 
Sample Psychometric properties 
Validity Reliability  Responsiveness and 
Interpretability 
Bell et al., 
2011 
The Sleep 
Functional Impact 
Scale (SFIS) 
Primary insomniacs 
 
Healthy volunteers  
Content validity: 
Face to face interviews with patients. 
Convergent/divergent validity: (p< 0.0001) 
-SFIS with ISI composite score: (r =0.82), SFIS with PSQI 
composite: (r =0.78), SFIS with FOSQ composite: (r = -
0.69), SFIS with ESS total: (r =0.46), SFIS with MOS1- 
sleep problems indices (I and II): (r ≥0.74), SFIS with MOS1 
breathing and Snoring subscales:    (r =0.26 and 0.27 
respectively). 
-WPAI–GH33 Subscales (r ≥0.31).  
 
Known group validity (n=430): 
-Higher SFIS score in the insomnia group compared to 
control (t=19.36, p<0.0001), effect size=2.05 
-Lower SFIS scores for those reporting good sleep compared 
not reporting good sleep. 
t = -12.18, p< 0.001 (effect size = -1.04) 
-Higher SFIS score for participants with reporting worse 
sleep on PSQI, t =17.06, p< 0.0001 (effect size = 2.33). 
Internal consistency: 
All the sample: α= 0.97 
Insomniacs= α= 0.95 
 
NR 
Espie et al., 
2000 
 
Sleep Disturbance 
Questionnaire 
(SDQ) 
 
Chronic insomniacs The factors score of SDQ correlated with the SDQ total 
(0.31 to 0.88). 
 
Internal consistency: 
α= 0.67 
 
NR 
Regestein et 
al., 1993 
 
 
Pavlova et al., 
2001 
 
Hyperarousal Scale 
(H-scale) 
 
-Primary insomnia 
patients 
-Hypersomnia 
-Delayed sleep 
syndrome 
-Normal subjects 
-Patients with refractory 
insomnia 
Criterion validity: 
-H-Scale with neuroticism scale and extroversion-
introversion scale: no significant correlation 
-Higher EEG27 activity in insomniacs compared to normal 
subjects (p<0.05). 
-Significant correlation between hyperarousal score with 
alpha and non-alpha EEG27 activity: (r ≥0.38, p≤ 0.03). 
 
Discriminating capacity: (Pavlovaa et al., 2001) 
- The insomnia group had a mean Hyperarousal total score 
significantly higher than the normal group (F = 20.7; p< 
0.0001). 
NR NR 
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Table 3. Cont. Studies testing the psychometric properties of extracted instruments   
Author, year Instrument  Sample Psychometric Properties 
Validity  Reliability  Responsiveness and 
Interpretability 
Kallestad et 
al., 2010 
Insomnia daytime 
worry scale 
(IDWS) 
Undergraduate students 
and senior high school 
students (Norway) 
Predictive validity: 
The IDWS predicted insomnia severity over and above the other 
variables, accounting for an additional 12% of the variance. 
 
-In IDWS factor 1 (lack of energy) and IDWS factor 2 (danger) 
were entered simultaneously in Step 7 of a new hierarchical 
regression analysis, both factors predicted insomnia severity. 
 
The internal consistency: 
Cronbach’s alpha 
coefficients were 
calculated: total scale α 
=0.93, 
lack of energy α = 0.94 
danger α =0.75. 
NR 
Tang & 
Harvey, 2004 
 
 
Jansson-
Fröjmark et 
al., 2011 
 
 
Anxiety and 
Preoccupation 
about Sleep 
Questionnaire 
(APSQ) 
  
110 university students 
(41 of them have 
insomnia as determined 
by PSQI score). 
 
 
Community dwelling 
sample from two 
counties in Sweden. 
 
-Classified according to 
sleep patterns into: 
1) Insomniacs 
2) Poor sleepers 
Normal sleeper 
Criterion/concurrent validity: 
The correlation with PSQI (r = 0.44, p< 0.0001)  
 The correlation with BAI34 (r = 0.37, p< 0.0001) 
This indicates that higher scorers on the APSQ were associated 
with higher scores on PSQI (poorer sleep quality) and BAI34 
(worse anxiety).  
 
Jansson-Fröjmark et al., 2011 
Discriminant validity: 
The 10 APSQ items, the total scale score and the two factors of 
the scale significantly discriminated between the three groups (F 
= 97.67 –245.12, p<0.001 in all instances), the total scale (F = 
296.99, p<0.001).  
Higher scores were reported from the insomnia group as 
compared to other groups. Those with worse sleep status scored 
higher on the APSQ.   
The between group effect sizes for the 10 items ranged from 0.18 
and 0.35, for the total scale 0.39, and for the two factors 0.33 and 
0.41. 
Convergent validity: 
The APSQ and its two factors were significantly correlated with: 
- Pre-Sleep Arousal Scale-Cognitive: r =0.45 –0.52 
- DBAS-10: r = 0.50 – 0.61 
- HADS17 Scale –Anxiety at fair level: r = 0.38 –0.49 
- HADS17 –Depression at a fair level: r = 0.34 –0.40 
 
 
Internal consistency: 
Tang & Harvey, 2004  
Cronbach’s alpha for 
total scale= 0.92  
 
Jansson-Fröjmark et al., 
2011 
Cronbach’s alpha 
coefficients were: 
For total APSQ scale 
=0.93  
For first factor= 0.91  
For the second factor = 
0.86  
NR 
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Table 3. Cont. Studies testing the psychometric properties of extracted instruments   
Author, year Instrument 
 
Sample Psychometric properties 
Validity Reliability  Responsiveness and 
Interpretability 
 Anxiety and 
Preoccupation 
about Sleep 
Questionnaire 
(APSQ) 
 
Continued.  
 ASPQ with daytime parameters: 
APSQ and its two subscales were moderately associated with: 
-  Sleep-onset latency: r =0.28 –0.34 
- WASO32: r =0.32 –0.37, TST31: r = 0.26 – 0.31 
-  Early morning awakening: r = 0.27 –0.30 
-  The APSQ and the two subscales were correlated with 
sleep quality (r = 0.40 –0.48). 
 
ASPQ with daytime impairment: 
-APSQ and its two factors were significantly correlated with 
daytime impairment (r = 0.41 –0.56) 
-Correlations after removal of daytime impairment from the 
composite score:  
APSQ, r = 0.53; first subscale, r = 0.53; second subscale, r = 
0.38. 
  
Ellis et al., 
2007 
Sleep 
preoccupation 
scale (SPS) 
Validity study: 
University students and 
community sample 
Criterion/ concurrent validity: 
- SPS with the Sleep Associated Monitoring Index 
(SAMI): 
- Good correlation between total scores of SPS and 
SAMI; Poor (r= 0.67, p< 0.001), average (r =0.58, p< 
0.001) and good (r =0.62, p< 0.001) sleepers. 
Construct/convergent validity: 
SPS subscales with Global PSQI-score: p< 0.001 
CBC35 subscale: r =0.37 
AC subscale36: r =0.55 
 
Discriminant validity: 
[F (2, 721) =57.27, p<0.001], poor sleeper reported higher 
levels of preoccupation scores than average and good 
sleepers. 
The tool significantly differentiated between Poor sleepers 
and good sleepers (as identified through the PSQI 
questionnaire); as poor sleepers reported more preoccupation 
than normal sleepers. [t (454) =8.78, p<0.001)] 
Internal consistency: 
α= 0.91 (overall) 
For subscales: 
CBC35=0.93 and AC36=0.89 
 
 
NR 
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Table 3. Cont. Studies testing the psychometric properties of extracted instruments   
Author, year Instrument 
 
Sample Psychometric properties 
Validity Reliability  Responsiveness and 
Interpretability 
Tan et al., 2016 Catastrophic 
thoughts about 
insomnia scale 
(CTIS) 
 
University students Content validity: 
Expert panel reviewed the scale. 
Face validity (n=523): The tool was given to participants to 
complete. 
 
Criterion validity: 
1) Catastrophic thoughts about insomnia (CTIS 
scores) was significantly associated with sleep 
quality (PSQI scores), r (137) = 0.643, p< 0.001 
 
2) Catastrophic thoughts about insomnia (CTIS score) 
was significantly associated with insomnia severity 
(ISI scores), r (137) = 0.703, p< 0.001 
 
Predictive validity: 
- CTIS along with DBAS16, IDWS, nBFI37, and CESD-103, 
age, gender, and length of education predicted only 51% of 
the variance in PSQI score F (8, 128) = 17.07, p< 0.001, R2 
= 0.51. CTIS, CESD-103, and gender significantly predicted 
changes in the PSQ scores. 
 
- CTIS, DBAS-16, IDWS, nBFI37, and CESD-103 and age, 
gender, and level of education predicted around two-thirds 
of the changes seen in ISIS scores F (8, 128) = 32.07, p< 
0.001, R2 =0.67.Each of the three instruments  CTIS, the 
CESD-103, and the IDWS independently predicted the 
changes in ISI scores.  
 
Construct/convergent validity: 
CTIS scores were significantly associated with DBAS-16 
scores, r (137) = 0.722, p< 0.001, and IDWS scores, r (137) 
= 0.753, p< 0.001.  
 
Internal consistent: (a = 0.94) 
 
Subscales: 
Helplessness: a = 0.84 
Rumination: a = 0.88 
 NR 
 
 
  
53 
 
Table 3. Cont. Studies testing the psychometric properties of extracted instruments   
Author, year Instrument 
 
Sample Psychometric properties 
Validity  Reliability  Responsiveness and 
Interpretability 
Blake & 
Gomez, 1998 
Sleep Hygiene 
Self-test. (SHS) 
Male war-zone 
veterans  
Criterion validity: 
Sleep Hygiene self-test was significantly correlated with Combat exposure 
scale and Mississippi scale (r =0.20 and 0.10 respectively). 
Internal consistency: 
Overall: 0.54 
 
 
 
 
Responsiveness: 
After 5 sessions of 
education on sleep 
disturbance management 
(1 hour/ week), a 
significant change of 7.6 
points scores was detected 
Mastin et al., 
2006 
Sleep Hygiene 
Index (SHI) 
Psychology 
students (in the 
United States) 
Criterion:  
The SHI was positively correlated (p< 0.01) with the inadequate sleep 
hygiene criteria identified by the American Sleep Disorders Association, 
1990. (r values = 0.371 to 0.458). 
 
Construct:  
A positive association was identified between SHI score and both ESS and 
PSQI scores r (599) = 0.244 and r (269) = 0.481 respectively with p< 0.01  
 
The SHI scores were significantly correlated with PSQI components scores  
 (p≤ 0.05).  
Internal consistency:  
α = 0.66 
 
Test–retest reliability 
(repeated over 4-5 
weeks) 
 r (139) = 0.71, p< 0.01 
NR 
Brown et al., 
2002 
Sleep Hygiene 
Awareness and 
Practice Scale 
(SHAPS) 
 
University 
students in 
united states 
(n=124) 
Construct:  
Correlation with sleep quality (as rated by the PSQI): 
- Sleep hygiene awareness with PSQI rating; (r =0.21) 
- Sleep hygiene practice with PSQI rating: (r =0.49, p< 0.012) 
- Sleep hygiene practice with sleep hygiene awareness (r =0.30, p< 
0.012). 
- Variable sleep length, noise disturbance, going to bed thirsty, and 
worrying about the ability to fall asleep at bedtime were identified as 
significant predictors of  sleep quality predictors (R2 = 0.24, adjusted 
R2 = 0.22, F (1, 118) = 5.30, p= 0.023).  
 
  
Internal consistency: 
Cronbach’s a = 0.78 
The caffeine knowledge 
and sleep-hygiene 
practice subscales: 
Cronbach’s a = 0.55 and 
a = 0.47, respectively. 
 
Test retest (4 weeks 
apart): 
The sleep-hygiene 
awareness activities and 
sleep-hygiene practice: (r 
= 0.76, p< 0.001 and r = 
0.74, p< 0.001, 
respectively).  
The caffeine knowledge 
subsection had poor test-
retest reliability (r = 0.50, 
p< 0.001).  
NR 
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Table 3. Cont. Studies testing the psychometric properties of extracted instruments   
Author, year Instrument 
 
 
Sample 
 
Psychometric properties 
Validity Reliability  Responsiveness and 
Interpretability 
Grandner et al., 
2014 
Sleep 
Practices 
and Attitudes 
Questionnaire 
(SPAQ) 
 
  Face validity: evaluated through group conversations (e.g. focus 
group) between individuals from the community and research 
participants. The participants provided their feedback on the content of 
the instrument and discussed some specific items.  
 
Content validity: questions derived from theoretical framework were 
discussed by a group of professionals in sleep medicine and 
community members to ensure the comprehensiveness and 
representativeness of items.  
 
Concurrent/criterion validity: 
- A significant correlation was identified between PSQI sleep duration 
and average sleep duration (r =0.53, p< 0.001). 
- Sleepiness with the ESS (rs = 0.39, p< 0.001). 
- Coping with acute insomnia correlation with the SHI was moderate 
(r= 0.29, p< 0.001). 
- Activities in bed subscale with the SHI (r = 0.53, p< 0.001). 
- Sleep environment with SHI (r = - 0.34, p< 0.001). 
- Impact of external factors on sleep scores on this subscale 
significantly differed between good and poor sleepers on the PSQI 
(p= 0.004). 
- Sleep quality and global PSQI score: (r = 0.36, p< 0.001)  
 
Construct validity: 
SPAQ with DBAS: DBAS was significantly correlated with subscales 
2 (r = 0.18, p< 0.05), 3 (r =0.28, p< 0.01), 4 (r =0.31, p< 0.001), 8 (r 
=0.23, p< 0.05), 12 (r =0.30, p< 0.001), 13 (r =0.45, p< 0.001), 15 (r 
=0.30, p<0.001), and 16 (r =0.26, p< 0.01).  
Internal consistency: 
Cronbach’s alpha range: 
0.251- 0.864 
(for the different subscales) 
 
 
NR 
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Legend: Abbreviations in Table 1: 
1. MOS: Medical Outcomes Study 
2. GHQ-12: General Health Questionnaire-12, 
3. CES-D Scale: Centre for Epidemiologic Studies Depression 
4. FSS: Fatigue Severity Scale 
5. SWLS: Satisfaction with Life Scale 
6. DIMS: Disorders of Initiating and Maintaining Sleep 
7. DOES: Disorders of Excessive Somnolence 
8. SOL: Sleep Onset Latency 
9. SF-12, SF-36: Short Form 12 
10. POMS:  Profile of Mood States 
11. NPV: Negative Predictive Value   
12. PPV: Positive Predictive Value 
13. BNSQ:  Basic Nordic Sleep Questionnaire  
14. ICC: Inter-Correlation Coefficient  
15. SD: Standard Deviation 
16. CBT-I: Cognitive Behavioral Therapy for insomnia 
17. HADS: Hospital Anxiety and Depression Scale 
18. GBSS+: Great British Sleep Survey extended 
19. A-D schedule:  this consists of the State-Trait Anxiety Inventory (STAI-X1) and the Depression Questionnaire (DQ) 
20. OSAS: Obstructive Sleep Apnea Syndrome 
21. INS: Insomnia  
22. BSD:  Behavioral Sleep Disorders 
23. OSA: obstructive sleep apnea  
24. CPAP: Continuous Positive Airway Pressure  
25. MSLT: Multiple Sleep Latency Test 
26. VAS: Visual Analogue Scale 
27. EEG:  Electroencephalogram 
28. EOG: Electro-Oculogram 
29. SIP: Sickness Impact Profile 
30. SF-36: Short Form 36 
31. TST: Total Sleep Time  
32. WASO: Wake After Sleep Onset  
33. WPAI–GH: Work Productivity and Activity Impairment–General Health Questionnaire 
34. BAI: Beck Anxiety Inventory 
35. CBC: cognitive/ behavioral consequences 
36. AC: Affective Consequences 
37. nBFI: Neuroticism Subscale of the Big Five Inventory 
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Table 4. Characteristics of sleep assessment instruments (n=31)  
Instruments Measurement model Burden (1) Response format 
(2) 
Cultural 
and 
language 
adaptation 
Population in 
which the tool 
was validated 
Number 
of Qs 
Scale Scoring Recall 
period 
The Bergen insomnia 
scale (BIS) 
6  8-points scale representing the 
frequency (number of 
days/week) ranging from 0 to 7  
Total= 0 to 42 Last month  NR Self- report  English NR 
The Insomnia 
Screening Scale (ISS) 
26  
  
NR  Insomnia symptoms: 0-50 
Daytime function: 0-35 
Sleep environment: 0-25 
Sleep opportunity 0-20 
NR NR  Self- report  NR -Community 
sample: (6-72) 
years  
- Primary 
insomnia  
Sleep Quality 
Questionnaire (SQQ) 
10  
 
5-point Likert-type scale (0-4)  
(0= strongly disagree, 4 = 
strongly agree). 
Total: 0-40  Last month  20 minutes  Self-report  Japanese  
 
 
Japanese adults  
Women’s Health 
Initiative Insomnia 
Rating Scale 
(WHIIRS) 
5  5-points Likert scale (except 1 
question 6 points Likert scale)  
Total: 0-20  last month NR Self-report  English  Postmenopausal 
women  
Restorative sleep 
questionnaire (RSQ)  
RSQ-
daily: 11 
items  
RSQ-
weekly: 9 
items  
Likert scale 1-5, in which 1 
corresponds with “not at all” and 
5 with “completely”.  
Total score: 
The average of the 
questionnaire items then 
converted to 0-100 scale.  
A minimum of 5 items must be 
completed.  
RSQ-D: 
One day  
 
RSQ-W: 
Past week  
NR Self-report  English  NR 
The Jenkins Sleep 
Scale (JSS) 
4 items  6-point Likert scale, reflecting 
the frequency of having 
symptoms in the past month: 
(Not at all = 0; 1–3 days = 1, 4–
7 days = 2; 8–14 days = 3; 15–
21 days = 4; 22–28 days = 5). 
Total: 0-20  
(Higher scores reflect worse 
sleep quality).  
Score >4: indicative of a sleep 
problem.  
Previous 1 
month 
NR Self- report  English  
Turkish  
Portuguese 
 
-Post cardiac 
surgery  
-Air traffic 
controllers  
- Patients with 
arthritis 
- Patients with 
ankylosing 
spondylitis 
- Shift workers  
-Patients with 
chest pain 
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Table 4. Cont. Characteristics of sleep assessment instruments (n=31)  
Instruments Measurement model Burden (1) Response 
format (2) 
Cultural 
and 
language 
adaptation 
Population in which 
the tool was validated Number of 
Qs 
Scale Scoring Recall 
period 
Pittsburgh sleep 
quality index (PSQI) 
19 items (+ 
5 questions 
for bed 
partner 
(optional) 
 
First 4 items (open ended),  
PSQI incorporate varying 
answer categories including open 
ending questions (e.g. regular 
bedtime, wakeup time, sleep 
duration and sleep latency) as well 
as forced-choice four-point Likert 
scale different options relating to 
the frequency of engaging in these 
behaviors during the previous 
month.  
 
  
Global PSQI score =0- 21  
Question score= 
0 to 3  
Past month  5-10 minutes  Self-report  English 
French  
India  
Japanese  
Chinese  
Spanish  
Hungarian  
Persian  
Sebarian  
Thai  
Czech 
Korean  
Arabic  
Hebrew  
Brazilian 
Portuguese 
Portuguese 
Sinhala    
Italian 
Malay 
-U.S. College students 
-Pregnant women  
-Lower back pain  
-University students  
-Psychiatric disordered 
people  
- Cancer patients 
-Breast cancer  
-Fibromyalgia (the 
Spanish version 
validated) 
- Older adults with 
Generalized anxiety 
disorders 
-Community dwelling 
Ethiopian adults  
Insomnia severity 
index (ISI) 
7 items 5-point Likert scale  Total: 0 to 28 
 
Last 2 
weeks  
<5 minutes  Self-report  
 
Clinician  
 
Significant 
others 
(usually 
spouse).  
German  
English  
French  
Spanish  
Chinese 
Italian  
Turkish  
Persian  
Arabic  
Korean  
Danish 
-Veterans with 
traumatic brain injury  
-Lower back pain 
-Cancer patients  
-Community-dwelling 
older people  
Athens Insomnia 
scale (AIS) 
AIS-8: 8 
items 
 
AIS-5: 5 
items  
Each item is scored on a scale 0-3 
with 0 indicating “no problem” 
and 3 indicating a “very serious 
problem”. An item is rated positive 
if the described problem’s 
frequency was ≥ 3 times/week  
Total score range: 
AIS-8= 0-24  
AIS-5= 0-15  
Flexible 
based on 
the study 
purpose 
(mostly 1 
month) 
NR Self-report  
  
Administered 
through an 
interviewer  
English  
Greek  
Spanish  
Japanese 
(simplified) 
-Psychiatric patients  
-Individuals with 
primary insomnia  
-Chronic pain patients 
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Table 4. Cont. Characteristics of sleep assessment instruments (n=31)  
Instruments Measurement model Burden (1) Response 
format (2) 
Cultural 
and 
language 
adaptation 
Population in 
which the tool 
was validated 
Number of 
Qs 
Scale Scoring Recall 
period 
Minimal insomnia 
Symptoms Scale 
(MISS) 
3 items  5-point Likert scale (0= no, 4= 
very severe problems) 
Total= 0-12  
 
NR NR  Self-report  English  -Elderly  
Dysfunctional Beliefs 
and Attitudes about 
Sleep Scale (DBAS) 
 
-DBAS: 30 
or 31 items  
-DBAS-16: 
16 items  
-DBAS 10: 
10 items  
Place a mark on a 10 cm long 
line within poles marking 
“strongly agree” and “strongly 
disagree”.  
DBAS full and DBAS 10: 
Average score across the items  
Not 
applicable 
NR Self-report  Chinese  
Taiwanese  
German 
(DBAS-16)  
NR 
Sleep Condition 
Indicator (SCI) 
8 items  5-point scale (0–4) Total score: 0 to 32 
-SCI total score could be 
converted to 0–10 range if the 
original total was divided by 
3.2, or by using an online 
version of the instrument with 
built-in score calculator.  
Typical 
night in the 
last month  
NR Self-report  English  
French  
Swedish 
Community 
dwelling adults 
(French 
population)  
General Sleep 
Disturbance Scale 
(GSDS) 
21 items  8-point Likert scale. Items 
response options range between 
never (0) to everyday (7); 
higher scores indicate more 
severely disturbed sleep.  
0-147 Previous 
week 
5 minutes or 
less  
Self-report  English  
Chinese 
Korean 
Italian   
-Female nurses  
-Parents of infants 
admitted to ICU  
Daily Cognitive 
Communication and 
Sleep Profile 
(DCCASP) 
7 items  7-point Likert scale (1=worst 
function and 7=best function) 
Total:  7-49 Daily  NR  -Self- report  
- Therapist  
-Significant 
others  
English  
French  
NR 
Arabic Scale of 
Insomnia (ASI) 
12 items 5-point Likert scale (0= No, 
4=very much) 
Total: 0-48  Last month  NR Self-reported  English  
Arabic  
NR 
Maugeri Sleep 
Quality and Distress 
Inventory 
(MaSQuDI-17) 
17  3-points Likert scale  
(1=Never, 2= sometimes and 
3= frequently)  
Total: 17 to 51 NR NR  Self-report  NR NR 
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Table 4. Cont. Characteristics of sleep assessment instruments (n=31)  
Instruments Measurement model Burden (1) Response 
format (2) 
Cultural and 
language 
adaptation 
Population in 
which the tool was 
validated 
Number of 
Qs 
Scale Scoring Recall period 
Epworth 
sleepiness 
scale (ESS) 
8  Measured on 4-point Likert scale (0-3, 
corresponding to never dose off and high 
chance of dosing respectively) 
 
Total score (0-24).  
 
Recent times  NR -Self-report  
 
-Completed 
by roommate  
Arabic 
English 
Ethiopian 
German  
Greek  
Chinese 
(Eastern 
China) 
Italian  
Turkish  
Spanish  
-Patients with sleep 
disorders 
-Patients with 
neurological 
disorders 
-Patients with 
psychiatric 
disorders  
-Workers (truck 
drivers) 
-Obstructive sleep 
apnea patients  
-African American 
population 
-Truck drivers  
Karolinska 
sleepiness 
scale (KSS) 
1 item  10 points Likert scale  
1 (extremely alert) to 9 (extremely 
sleepy, fighting sleep) 
Total score:7–9  
 
5 minutes 
before 
answering 
the question  
NR NR Japanese  Registered 
nurses(142)  
Functional 
outcomes of 
sleep 
questionnaire 
(FOSQ) 
FOSQ-30: 30 
items  
 
FOSQ-10: 10 
items  
FOSQ-30: Six-point Likert scale (how 
frequently an activity is performed, 0 = 
never did it, 5 = three or more times a 
week)  
Subscale score calculation: 
A response score of 0 = a N/A or 
missing response. Thus, the potential 
range of scores for any item is 1-4.  
 
Calculate the mean of the answered 
items with responses equal to or greater 
than 1 for each subscale. This is the 
weighted mean item total or subscale 
score. 
Global score:  
FOSQ-30: 
The mean of the subscale 
scores and multiply that by 
the number of subscales 
for which there is a score. 
- Scores range:  5-20 
 
FOSQ-10: 
Total: the mean of the 
subscale scores multiplied 
by 5. 
Subscale score: 1–3.  
Performance 
on a typical 
day (or 
generally 
how the 
person feels 
during the 
day).  
FOSQ-30: 
 15 minutes  
 
FOSQ-10: NR 
Self-
administered 
paper-and-
pencil 
questionnaire 
at a fifth-
grade reading 
level.  
FOSQ-30:  
Thai  
Norwegian  
Swedish  
 
 
 
FOSQ-10:   
Persian  
Mandarin 
Chinese  
Spanish  
FOSQ-30: 
-Obstructive sleep 
apnea patients  
-Veterans with type 
2 diabetes 
-Women with 
breast cancer 
(stages I-III)  
 
-Pregnant women  
 
FOSQ-10: 
Family members of 
critically ill infants  
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Table 4. Cont. Characteristics of sleep assessment instruments (n=31)  
Instruments Measurement model Burden (1) Response 
format (2) 
Cultural 
and 
language 
adaptation 
Population in 
which the tool 
was validated 
Number of 
Qs 
Scale Scoring Recall period 
Occupational 
impact of sleep 
questionnaire 
(OISQ) 
24 items  5-point Likert scale. Scores on 
each question range from 0 
(“never/not applicable to 4 “all 
of the time”). 
Total: 0-96 Last month  NR NR Dutch  
Persian  
NR  
The Sleep 
Functional Impact 
Scale (SFIS) 
26 items 
 
5-points Likert scale Total: 26-130  
≥13 items must be completed 
7 days NR Self-report NR NR 
Sleep disturbance 
questionnaire (SDQ) 
12 items  5-point Likert scale  
 Ranging from “never true,” “to 
“very often true”). 
NR Typical night 
with poor 
sleep  
NR NR NR NR 
Hyperarousal Scale 
(H-scale) 
26   
 
Measured on a 4-point Likert 
scale. (Including the following: 
0 ‘not at all,’ 1 ‘a little,’ 2 
‘quite a bit’ and 3 
‘Extremely’). 
The scale measures the 
summation score (HSUM); 
with 3 scores per item.  
NR NR  Self-report  English  
Swedish  
Insomniacs 
Patients with 
hypersomnia  
Insomnia daytime 
worry scale (IDWS) 
11 items 5-point Likert scale. NR Last week  NR Self-report  NR NR 
Anxiety and 
Preoccupation about 
Sleep Questionnaire 
(APSQ) 
10 items  -Original (2004): 10 points 
Likert scale  
(1= Not true to 10=very true) 
 
-Modified (2011): 5-point 
Likert scale. (1 = strongly 
disagree, 5= strongly agree)].  
Total:  
Original:10-100 
 
Modified: 10 to 50  
Original: past 
3 days  
 
Modified: last 
month  
NR Self-report  NR NR 
Sleep preoccupation 
scale (SPS) 
22 items  7-point Likert scale (0= never 
to 6= all of the time) 
Total: 0-132 NR NR Self-report  NR NR 
Catastrophic 
thoughts about 
insomnia scale 
(CTIS) 
18 items  7-points Likert scale  
Ranges from 0=strongly 
disagree to 6= strongly agree 
and 3= neutral  
Total: 0-108  NR NR  Self-report English  NR 
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Table 4. Cont. Characteristics of sleep assessment instruments (n=31)  
Instruments Measurement model Burden (1) Response 
format (2) 
Cultural 
and 
language 
adaptation 
Population in 
which the tool 
was validated 
Number 
of Qs 
Scale Scoring Recall period 
Sleep hygiene-self 
test (SHS) 
30 
items  
Dichotomous response (yes or No) Total score  
(Yes = 1 point and 
No.=0 point). Every 
fifth item is scored in 
the reverse direction  
Previous month  NR Self-report  NR NR 
Sleep hygiene index 
(SHI)  
13-item 5-point scale ranging from 0 (never) to 
4 (always). 
 Total score: 0-52 or 
13-65 (higher score 
indicates worse sleep 
hygiene)  
NR NR Self-report  -English  
-Persian  
-Turkish 
-Korean 
-Individuals with 
chronic pain 
-Elderly 
-University 
students  
Sleep Hygiene 
Awareness and 
Practice Scale 
(SHAPS)  
 
 
 
 
50 
items  
  
-Subsection 1: behavior is rated on a 
scale from “behavior is very beneficial 
to sleep” (1) to” behavior is very 
harmful to sleep” (7). A rating of 4= 
behavior has no effect (1 point for each 
correct answer, 2 points for omitted 
answers and 3 points for wrong 
answers) (original developers lack et 
al, 1987). 
 
-Subsection 2: Respondents are asked 
to write y if the substance contains 
caffeine, n if it does not, and x if they 
have never heard of it. Score range: 0-7 
(brown et al., 2002).  
Awareness:  
Subsection 1: 
Total:  13 to 39 
Subsection 2: 
Score: 0 to 100. 
 
Practice: 
The total: scores can 
range from 0 to 133; 
higher scores suggests 
behaviors associated 
with poor sleep 
hygiene are common).  
 
NR  
  
NR  Self-report  NR Insomniacs  
Good sleepers  
University 
students  
Sleep Practices 
and Attitudes 
Questionnaire 
(SPAQ) 
151 
items 
Sleep duration subscale and sleep 
debt subscale (measure of the 
difference between the needed and the 
actual sleep duration): score < 0 
indicate that more than needed sleep is 
obtained while a score > 0 indicate that 
the sleep obtained is less than needed.  
-All other subscales scores range from 
 0 to 1. 
NR NR 10 minutes  Self-report  English  NR 
NR, Not reported 
(1) Administration time 
(2) Individuals who need to complete the questionnaire 
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As presented in Table 3 and Table 4, most of the sleep assessment instruments 
identified contain less than 20 items. The longest of these instruments is the Sleep 
Practices and Attitudes Questionnaire (SPAQ), which contains 151 questions divided 
into 16 domains (143). On the other hand, the Karolinska Sleepiness Scale (KSS), the 
Minimal Insomnia Symptoms Scale (MISS), and the Jenkins Sleep Scale (JSS) are the 
shortest instruments identified, consisting of one, three, and four questions, respectively 
(144–146). Some of the instruments have multiple versions, each consisting of a 
different number of questions [e.g., the Functional Outcomes of Sleep Questionnaire 
(FOSQ)-30 and the FOSQ-10 have 30 and 10 questions, respectively] (147,148). Most 
of the instruments use Likert-type scales as response options to generate scores. The 
time needed to complete an instrument was not reported in most of the studies reviewed. 
However, the response burden, wherever reported, did not exceed 10 minutes. The 
recall period for the majority of the instruments was one month, except for the Insomnia 
Severity Index (ISI) and the Sleep Functional Impact Scale (SFIS) which had a recall 
period of 2 weeks and 1 week, respectively (149–151).  
The instruments were classified into four categories based on the outcomes that 
were assessed in the 107 studies, as follows: (1) instruments screening for insomnia 
symptoms (n=15); (2) instruments assessing consequences of poor sleep (n=8); (3) 
instruments assessing preoccupation with sleep (n=4) and; (4) instruments evaluating 
sleep hygiene (n=4). A detailed description of the psychometric properties for the four 
categories of instruments is provided in Table 5. 
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Table 5. Evaluation of the psychometric properties of the instruments (n=31) * 
Questionnaire Reliability Validity Responsiveness b Interpretability b 
Internal 
Consistency a 
Test-
retest b 
Content b Construct b Criterion b 
Instruments screening for insomnia symptoms 
BIS + + N/A + N/A N/A N/A 
ISS + N/A N/A N/A +/- N/A + 
SQQ + + + + N/A N/A N/A 
WHIIRS + + + - N/A N/A N/A 
RSQ + + + + N/A N/A N/A 
PSQI + + N/A + + N/A + 
ISI + N/A + + + + + 
JSS + - N/A - N/A N/A N/A 
AIS + + N/A N/A N/A N/A + 
MISS + + N/A N/A + + + 
DBAS + N/A N/A + ? + N/A 
SCI + N/A + + + N/A + 
 GSDS + N/A N/A N/A - N/A N/A 
DCCASP + + N/A N/A - N/A N/A 
ASI + + + + ? N/A N/A 
Instruments evaluating consequences of poor sleep 
MaSQuDI-17 + N/A N/A +/- N/A N/A N/A 
ESS + + N/A N/A + + N/A 
KSS N/A N/A N/A N/A + N/A N/A 
FOSQ + + + + + + N/A 
OISQ + + N/A N/A + N/A N/A 
 SFIS + N/A + + N/A N/A N/A 
 SDQ + N/A N/A N/A N/A N/A N/A 
H-scale N/A N/A N/A N/A - N/A N/A 
Instruments evaluating preoccupation about insomnia 
IDWS + N/A N/A N/A + N/A N/A 
APSQ + N/A N/A - N/A N/A N/A 
SPS + N/A N/A - - N/A N/A 
CTIS + N/A + + + N/A N/A 
Instruments measuring sleep hygiene 
 SHS - N/A N/A N/A - + N/A 
SHI - + N/A - - N/A N/A 
SHAPS + + N/A - N/A N/A N/A 
SPAQ - N/A + - - N/A N/A 
Legend: 
*: Following the Terwee et al. quality criteria  
a: Cronbach’s alpha: + if 0.7-0.95; - if (< 0.7 or >0.95) 
b: Pearson’s correlation coefficient (r): + if r≥0.70; - if r<0.70 
c: content validity: +; reported  
 N/A, no information available to establish rating; +/-, conflicting results in studies or inconsistent results across subscales; ?, questionable/not rated 
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2.2.1. Instruments screening for insomnia symptoms 
From the 15 instruments screening for insomnia symptoms, two [the Women’s 
Health Initiative Insomnia Rating Scale (WHIIRS) and the Restorative Sleep 
Questionnaire (RSQ)] were dimension-specific and focused on evaluating the sleep 
quality through assessing problems with initiation and maintenance of sleep (152–154). 
The remaining 13 instruments were multidimensional, assessing sleep quality and 
consequences of poor sleep. Some of the identified instruments also measure other 
specific dimensions such as satisfaction with sleep in the Bergen Insomnia Scale (BIS) 
and sleep environment in the Insomnia Screening Scale (ISS) (155,156). The 
Dysfunctional Beliefs and Attitudes about Sleep Scale (DBAS) explores perceptions 
regarding insomnia.(157–159). On the other hand, the Daily Cognitive-Communication 
and Sleep Profile (DCCASP) measures the daily fluctuation in sleep quality and 
assesses the effects of these fluctuations on the cognitive functioning and 
communication, while the General Sleep Disturbance Scale (GSDS) assesses sleeping 
patterns and the use of sleep aids during the past month (160,161). 
 
2.2.2. Instruments assessing consequences of poor sleep 
These instruments measure the impact of insomnia on individual’s functioning 
and daytime performance. Two of these instruments [the Epworth Sleepiness Scale 
(ESS) and the KSS] focus on assessing sleepiness only, whereas the Hyperarousal Scale 
(H-Scale) also assesses daytime alertness (144,162–164). Three instruments, the 
FOSQ, Occupational Impact of Sleep Questionnaire (OISQ), and the Sleep Functional 
Impact Scale (SFIS), evaluate the effects of insomnia on overall functioning 
(147,148,151,165). Conversely, the Sleep Disturbance Questionnaire (SDQ) evaluates 
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factors which contribute to poor sleep, while the Maugeri Sleep Quality and Distress 
Inventory (MaSQuDI-17) measures the emotional burden of insomnia (157,166). 
 
2.2.3. Instruments assessing preoccupation with sleep 
Three of these instruments [Insomnia Daytime Worry Scale (IDWS), Anxiety 
and Preoccupation about Sleep Questionnaire (APSQ), and Sleep Preoccupation Scale 
(SPS)] evaluate the extent of worry about insomnia symptoms (167–170). Whereas the 
fourth instrument; the Catastrophic Thoughts about Insomnia Scale (CTIS) assesses 
exaggerated thinking about insomnia and its consequences (171).  
 
2.2.4. Instruments assessing sleep hygiene 
Out of the four instruments included under this category [Sleep Hygiene Index 
(SHI), Sleep Hygiene Awareness and Practice Scale (SHAPS), Sleep Hygiene Self-test 
(SHS) and the SPAQ], SPAQ was the only comprehensive instrument which assessed 
sleep quality, quantity, consequences of poor sleep, and sleep hygiene (143,172–174). 
The SHS also evaluates the effects of interventions which are expected to improve sleep 
hygiene and it is the only sleep-hygiene instrument which has been validated for 
responsiveness. The SHAPS measures knowledge about sleep hygiene in addition to 
behaviors surrounding sleep. 
 
2.2.5. Other characteristics of the identified instruments 
Some of the sleep instruments which were validated in the 107 articles included 
in this review, such as the BIS, Sleep Condition Indicator (SCI), ISS, Athens Insomnia 
Scale (AIS) and Sleep Hygiene Index (SHI) were developed in accordance with  
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international diagnostic criteria for insomnia such as the International Classification of 
Sleep Disorders 2nd edition (ICSD-II), International Classification of Diseases 10th 
edition (ICD-10), and various editions of the Diagnostic and Statistical Manual of 
Mental Disorders (DSM) (155,172,175–177). Most of these instruments were validated 
among university students and in primary insomniacs. 
Many of the identified sleep instruments have been translated and culturally 
adapted in a variety of languages, such as the Pittsburgh Sleep Quality Index (PSQI), 
ISI, and ESS which are available in at least 18, 10, and 6 languages, respectively(178–
182). Only four instruments were identified in Arabic, three of which (PSQI, ISI, and 
ESS) were originally developed in English, but translated and validated in Arabic-
speaking populations(183). While the Arabic Scale of Insomnia (ASI) was the only 
identified instrument which was originally developed in Arabic (184). 
 
2.2.6. Quality assessment 
The majority of the instruments used in the 107 studies included in this review 
did not meet all of the eight criteria set by the SAC-MOT (139). However, the 
conceptual and measurement models were described for all instruments. Additionally, 
the reliability of sleep measures was usually reported in the validation studies, 
particularly the internal consistency was reported for all instruments, except for the H-
scale and the KSS. Overall, the reported internal consistency values for the sleep and 
sleep hygiene instruments across the different studies included in this systematic review 
ranged between 0.53 and 0.97. This indicates that these instruments were different as 
some (Cronbach’s alpha ≥0.7) were measuring only one construct while those with 
lower Cronbach’s alpha values were probably measuring more than one construct.    
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 As outlined in Table 5, the test-retest reliability was only reported for 15 of the 
31 instruments. Validity measures were reported for almost all the instruments 
identified (29 out of 31), of which criterion validity was the most reported and content 
validity the least reported validity measure. The generalizability of the psychometric 
properties was examined for three instruments (ISS, ISI and AIS) in community 
samples and among primary insomniacs. On the other hand, six instruments 
(MaSQuDI-17, ESS, FOSQ, DBAS, APSQ, SPS) provided evidence of discriminating 
capacity between healthy individuals and poor sleepers. As summarized in Table 3, 
some of the sleep instruments were tested for other validity measures such as 
incremental validity, diagnostic validity, and external validity (156,175–178,185,186). 
Additionally, the SHS was the only instrument that was assessed for responsiveness to 
change in sleep hygiene after interventions (174).  With the exception of SHAPS, all of 
the sleep hygiene instruments had low internal consistency (α < 0.7) and only the SHI 
and the SHAPS were evaluated for their reproducibility (143,172–174).  
The improvement in scientists understanding of insomnia pathophysiology 
hasbeen associated with a parallel increase in the development of instruments that 
measure different aspects of sleep problems. In fact, around 17 of the 31 instruments 
identified in this systematic review were developed after 2005, indicating that the 
development of sleep related subjective measures has been extremely active in the last 
decade. The instruments available today assess different aspects of sleep dysfunction 
including the night-time symptoms, daytime consequences in addition to cognitive and 
behavioral aspects that affect sleep.  
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In the validation studies reviewed, the sleep instruments identified were mostly 
tested for their reliability. These studies reported primarily the internal consistency of 
the questionnaires. Additionally, instruments’ precision was mostly assessed through 
the test-retest reliability method, which compares between the responses to the 
instrument’s questions answered by the same individuals at two different time points 
(187). However, the time frame in between the two measurements in the validation 
studies assessing reproducibility was highly variable, ranging between 2 days and 6 
months (146,180).  
Overall, three main validity measures were reported in the studies included in 
this review: content, criterion and construct validity. Content validity is often one of 
the first properties tested when an instrument is developed (140). Criterion validity was 
the most commonly reported validity measure in the studies included in this review. Of 
which concurrent validity was evaluated for 18 out of the 31 sleep instruments 
identified, whereas the predictive validity was assessed only for 5 instruments. 
However, the choice of the instrument to be used as a comparator or a “gold standard” 
in the assessment of the criterion validity was rarely justified. In situations where a gold 
standard measure is not available, construct validity could be tested (188).  
On the other hand, the diagnostic validity was reported for only five of the 
instruments identified in this review (specifically the PSQI, ISI, AIS, MISS and the 
SCI). In fact, the diagnostic validity is an important measure as it examines the extent 
to which the instrument can accurately differentiate between healthy individuals and 
insomniacs at a specific score (189). Additionally, incremental validity which describes 
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the ability of an instrument to predict sleep parameters beyond what is possible by other 
existing instruments was only tested for the Sleep Quality Questionnaire (SQQ) (185). 
Nevertheless, an inconsistency in the way of reporting validity measures was identified 
in the validation studies reviewed, this particularly introduced a difficulty in 
distinguishing between criterion and construct validity. 
Furthermore, responsiveness and interpretability were the least reported 
psychometric properties in the studies review. In fact, responsiveness is an important 
psychometric property which could  provide useful information regarding the 
instrument’s ability to detect clinically meaningful changes in sleep parameters (141). 
Additionally, interpretability which reflects the degree to which the scores of an 
instrument could be translated into a clinically meaningful classification, could be 
useful in assessing the effectiveness of treatments or interventions. 
The psychometric properties for the four instruments that evaluate 
preoccupation with sleep were not adequately reported. Although all of these 
instruments demonstrated good internal consistency, their reproducibility was not 
assessed, and their validity measures were often associated with low correlation 
coefficients. Among the sleep hygiene assessing instruments, SHI was the only 
instrument available in languages other than English. This could be related to the 
simplicity of this instrument in terms of its language and the number of items included. 
Additionally, this instrument has good quality as it was developed according to ICSD-
II criteria for inadequate sleep hygiene and has been shown to have good psychometric 
properties(172).  The findings of this review have shown that ISI, FOSQ and MISS 
were the only instruments evaluated for all four psychometric properties (145,147–
149,186,190).  
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This search concluded that only three subjective sleep instruments were 
translated and culturally adapted in an Arabic context: the PSQI, ESS and ISI. 
Additionally, through this search the Arabic Scale of Insomnia (ASI), an instrument 
that was developed in the Arabic language and tested among university students in 
Kuwait, was identified (184).  Notably, none of the instruments assessing preoccupation 
about insomnia or sleep hygiene identified in this review were available in Arabic. 
 
 
2.3. Insomnia management in primary healthcare settings 
Insomnia is a common problem at primary healthcare settings and studies are 
suggesting that up to two third of patients could present with at least one of the insomnia 
symptoms (48–57). However, the prevalence of insomnia might be underestimated 
because screening for this condition is not part of the routine practice in most primary 
care centers (191). Patients may also contribute to the under detection of insomnia by 
not reporting their sleeping problem due to their underestimation of the importance of 
insomnia in comparison with their other health concerns when presenting to primary 
care (192). Furthermore, observations from practice suggest that insomnia is not 
receiving enough medical attention and is still underestimated as a condition and 
therefore undertreated (193). Results from a Canadian study indicated that 29.9 % of 
the adults studied complained of at least one of the insomnia symptoms, however, only 
13% of those affected consulted a healthcare provider for insomnia management (15). 
Similarly, in another study only 11.1% of the insomniacs studied visited a doctor at a 
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PHCC to manage insomnia (193).  However, a study that assessed help seeking 
behavior among adults at PHCCs found that 52% of patients with probable insomnia 
reported discussing their sleeping problem with a physician (48). Interestingly, in this 
study, patients who consulted physicians for insomnia were often those with comorbid 
conditions, and reported poor sleep quality, less total sleep per night, and poor daytime 
performance due to sleep impairment.  
Patients with primary insomnia often avoid seeking medical help as many of 
them perceive the condition to be benign and trivial and believe that sleeping problems 
could be self-managed not requiring medical intervention (193). Additionally, in this 
study some individuals were not even aware of the treatment options available for 
insomnia. Furthermore, there appears to be stigma associated with insomnia and its 
possible link to mental disorders, which might discourage some individuals from 
seeking professional help (193).    
Unlike other medical conditions, individuals experiencing insomnia often 
attempt to treat themselves through using over the counter (OTC) products or non- 
pharmacological strategies (15). Only after self-treatment shows to be ineffective, 
patients seek professional help and meet their general practitioners to diagnose their 
problem and get a more effective therapy (194). A variety of treatment approaches are 
available for the management of insomnia including behavioral interventions and 
pharmacological therapies (195). Despite that, insomnia treatments including 
behavioral therapies such as CBT-I and hypnotics are underutilized in practice (196). 
A study which assessed the management of insomnia at PHCCs reported that the 
patterns of benzodiazepine use was lower than the prevalence of insomnia and found 
that around 46% of the insomniac patients were treated with antidepressants despite not 
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having a mental disorder (58). However, antidepressants are not indicated for the 
management of insomnia in the absence of a mood disorder, and there is inconclusive  
evidence of their effectiveness for this indication (197). Studies also suggest that 
patients with other chronic diseases and those with greater disability are the ones most 
likely to be treated for insomnia (58).  
Failure to manage insomnia effectively may have serious consequences not only 
on the patients’ health but also on the country’s economy and development. Studies 
have shown that insomnia increases healthcare utilization and resource consumption, 
as insomniacs at PHCCs are twice more likely to be admitted to a hospital as compared 
to non-insomniacs (49). Insomnia also increases the need for medical attention 
represented in general practitioner’s visits, laboratory tests and other services. 
Moreover, patients who suffer from insomnia associated with impaired daytime 
performance have lower quality of life and they usually complain of excessive daytime 
sleepiness, loss of concentration at work and memory problems (49,51). These 
problems put the person at risk of dozing off while driving which in turn increases the 
risk of road accidents (40). Furthermore, patients with insomnia symptoms were 
reported to have around 13 clinical consultations per year as compared to 5 
consultations per year for other types of patients (49). 
Several studies have explored physicians’ perspectives on insomnia and their 
approaches for diagnosis and management of the condition. Studies done at PHCCs 
have reported that general practitioners often do not prioritize the management of 
sleeping problems and perceive insomnia as a symptom of an underlying condition 
(192,198,199). One of the studies which assessed the perceptions of prescribers and 
patients on insomnia evaluation and treatment showed that physicians focus on the 
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causes and precipitants of insomnia and provide treatment accordingly, whereas 
patients were frustrated about the neglect of their insomnia complaints by physicians 
and often felt the need to convince their general practitioners about the seriousness of 
their sleeping problem (59). Additionally, patients presenting with insomnia symptoms 
were confused when a medication for a different indication such as depression or 
anxiety was given to treat their insomnia complain (195).  The cause of this 
misunderstanding between physicians and patients could be related to the differences 
in their perspective of insomnia, as physicians viewed it as a symptom of a different 
problem whereas patients perceived insomnia as their main complaint and focused on 
its effects on their daily life. 
When it comes to treatment approaches, general practitioners at PHCCs 
described a stepped approach starting with psychological assessment followed by sleep 
hygiene and lastly medications (198). Although physicians provide sleep hygiene 
related advice, most physicians expect that patients will not be satisfied with any 
nonpharmacological therapy (192). On the other hand, some patients perceived 
physician’s advice on sleep hygiene as too simple and questioned its effectiveness 
(195). Hypnotics are also one of the options for insomnia management, however, 
physicians at PHCCs use medications as the last resort when other options are shown  
to be ineffective (192). Additionally, prescribers at PHCCs have demonstrated a good 
understanding of the health consequences associated with the administration of 
hypnotic medications and hence these were only prescribed to patients with chronic 
insomnia and in cases where other therapies were ineffective (198). Moreover, studies 
have indicated that physicians often view these medications as a quick solution which 
should be used for short duration. 
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Disparity has also been found between what is recommended in clinical 
guidelines and what is prescribed by clinicians in actual practice. For example, although 
all the recent sleep related guidelines recommend CBT-I as the first line treatment, 
studies have shown that prescribers at PHCCs do not routinely recommend it for 
insomniacs (60,61,199,200). In fact, physicians at PHCCs have expressed their doubts 
about the effectiveness of CBT-I (195). Studies have also shown that patients and most 
of the pharmacists lacked awareness about CBT as a treatment for insomnia, despite 
available evidence that the introduction of CBT-I programs at PHCCs is effective for  
the management of chronic insomnia (198,200). In one study, insomnia symptoms 
resolved in 88% of chronic insomnia patients who completed 6 sessions of CBT-I (72). 
Additionally, it was shown in this study that patients who completed the CBT-I had a 
significant improvement in sleep and mood related measures. Also, the use of sleeping 
aids in these patients, including both prescribed medicine and over the counter products, 
was significantly lower after the therapy.  
Some general practitioners have related the lack of implementation of 
guidelines’ recommendations in their practice to their working environment and the 
workload (199). The disparity between guidelines and practice could also be related to 
the pressure exerted by patients who want a rapid solution for their problem on 
prescribers. Often these patients want medications to solve their sleeping problems and 
are not interested in time consuming non-pharmacological therapies (199). In their 
study Sake and colleagues reported that a lack of a clear treatment guideline for use at 
PHCCs is one of the barriers to accurate diagnose and manage of insomnia (191). The 
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authors also suggested that the provision of a simple routine sleep assessment 
questionnaire would help in identifying patients with sleeping problems. In addition, 
recent studies have indicated that physicians at PHCCs need training and education on 
insomnia and its management (198). 
The information available about the prevalence of insomnia at PHCCs in the 
Middle East is limited, but the few studies available suggest a high prevalence. Two 
recently published studies conducted in KSA found that between 60 and 76% of 
PHCCs’ attendees report insomnia symptoms (50,55). Additionally, around 57% of 
patients with insomnia also had accompanying daytime dysfunction (50). However, 
none of the patients with insomnia in these studies discussed their sleeping problem 
with a physician at PHCC and as a result they were not diagnosed with insomnia nor 
they received a treatment for it. A study done in Qatar found that sleep disturbances 
and excessive daytime sleepiness were common among diabetic Arab patients at 
PHCCs (68). Other than the above, no other published studies have been found in 
relation to the management approaches of insomnia at PHCC’s in Arab countries. In 
addition, perspectives of HCPs about insomnia and its management at PHCCs is these 
countries is largely unknown. 
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CHAPTER 3: METHODOLOGY  
The main aim of this study was to explore the prevalence of insomnia among university 
students and to describe the approaches for its management among HCPs at PHCCs in 
Qatar. To achieve these primary objectives, two different and yet interconnected study 
phases were undertaken using quantitative and qualitative methods. Below is a detailed 
description of the methods utilized in each of the two phases of the study. 
 
3.1. Phase 1: Exploring sleep patterns, behaviors and the use of sleep medicines 
among university students in Qatar 
3.1.1. Study design 
This was a quantitative, cross-sectional survey of students enrolled at QU in the 
fall semester of the 2018 academic year. An online, self-administered questionnaire 
was utilized in order to provide the respondents with the opportunity to report their 
sleeping patterns and habits over the past month.  
 
 
3.1.2. Study population 
The number of students at QU, the only government-owned university in Qatar, 
is the largest in the country. Around 20,000 undergraduate and graduate students were 
distributed across 9 different colleges when this study was conducted (201).  
Inclusion and exclusion criteria 
Participants were included in this study if they were: 
▪ Enrolled as QU students at the time of recruitment  
▪ Residing in Qatar 
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▪ Able to read and write in either Arabic or English languages 
Participants who did not meet the inclusion criteria specified above were 
excluded from the study.  
 
 
3.1.3. Sample size determination 
The sample size required for this phase was calculated using the Cochrane formula as 
described below (202): 
 
n = (1.96) ^2 x (0.3) (0.7)/ (0.05^2) =323 persons  
n = Sample size  
d = sampling error / level of precision  
Z2 = the abscissa of the normal curve that cuts off an area α at the tails (1 – α equals the 
desired confidence level, e.g., 95%) 
P = Probability 
Accumulating evidence from literature suggested that the prevalence of insomnia 
among university students centers around 30% (34,101,108). Therefore, according to 
the sample size calculation, the minimum sample size required for this study was 325 
participants. 
Considering a response rate of 15%, the sample size required was 2,167 students which 
was rounded up to 2, 200 students.  
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3.1.4. Sampling technique 
 The initial sampling plan was to select the 2,200 students using proportionate, 
stratified simple random sampling technique, such that students were to be stratified 
into different clusters according to their college of study. When this method was 
applied, the minimum sample size specified for this study was not achieved despite 
sending three reminders over a period of 5 weeks. Therefore, the questionnaires were 
then sent to all QU students (19,738) with the aim of achieving the minimum sample 
size required. Whole population sampling method was used in which the questionnaire 
which was sent to all undergraduate QU students.  
 
 
3.1.5. Recruitment and data collection process  
Students were recruited for participation in the study through e-mails. The 
questionnaire was built in an online platform using SurveyMonkey®. Students were 
provided with a link to access the online questionnaires. Students were given the option 
to answer in either English or Arabic as links to questionnaires of both languages were 
provided. The survey link was opened from the 7th of January to the 7th of March 2019. 
The survey was completely anonymous and no identifying information were collected. 
Data were then exported from the online SurveyMonkey® platform to SPSS® statistical 
software for analysis.  
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3.1.6. Study instruments 
After the extensive literature review of sleep instruments summarized in Chapter 
2, section 2.2, two of these instruments were selected to be use in this study: (1) the 
Pittsburgh Sleep Quality Index and (2) the Sleep Hygiene Index. These instruments 
investigate factors contributing to poor sleep and the consequences of sleep 
disturbances from the students’ perspective. The questionnaires also measure sleep 
hygiene practices and the utilization of sleep aids including both pharmacological and 
non-pharmacological options. Details about the two questionnaires used and their 
adaptation process are provided below. 
Pittsburgh Sleep Quality Index (PSQI) 
The PSQI is a validated instrument available in English and Arabic languages 
(178,181). This instrument explores sleep pattern, daytime consequences of impaired 
sleep and the use of sleeping aids during the past month. It consists of 19 self-rated 
questions and additional five questions to be completed by a roommate or a bed partner. 
Considering that this questionnaire was completed by students who were attending 
routine classes at the university, the last five questions meant to be filled by a roommate 
were excluded.  Removing these questions will not have bearing on the results because 
as per the developer guidelines, they are not included in the calculation of the total 
PSQI score. The 19 questions of the PSQI are categorized into seven different 
components which are required for the calculation of the PSQI’s global score which 
ranges between 0 and 21. A score of 5 has been reported as the cut-off  to distinguish 
sleep quality; such that a score higher than 5 indicates poor sleep quality (178). This 
cut-off score is associated with a sensitivity of 89.6% and specificity of 86.5% to detect 
poor sleepers (178). The PSQI has been previously translated into Arabic and validated 
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among university students (181). The Arabic version of the PSQI questionnaire has 
shown a marginally acceptable internal consistency reliability for the global score 
(Cronbach’s alpha = 0.65). In the present study, the PSQI global score was calculated 
if all the 7 components for calculation were available. Therefore, respondents who 
missed some questions or provided invalid responses were excluded from the global 
score computation. 
 Sleep Hygiene Index (SHI) 
SHI is an instrument that assesses the presence of behaviors and environmental 
conditions which may compromise the individual’s sleep hygiene (or healthy sleep 
practices). The SHI consists of 13 self-rated questions with a response option in a 5-
point Likert-type scale, ranging between “Never” and “Always”. The SHI scores on the 
SHI range from 0 to 52, with higher scores indicating poor sleep hygiene (172). A study 
done among university students identified the cut-off score of 16 with a sensitivity of 
(77%) and specificity of (47.5%) for identification of sleep quality (203). This indicates 
that the SHI is a good instrument for detecting individuals with poor sleep hygiene, but 
it might not be effective in identifying individuals with good sleep hygiene. The SHI is 
available in English, Persian and Turkish languages (172,204,205). To be consistent 
with the questionnaire, respondents were asked to provide responses on their sleep 
hygiene practices in the previous month. At the time when the SHI was selected to use 
in this study, it had not yet been translated into Arabic or validated in an Arabic-
speaking population. Considering that many of the programs at QU are taught in Arabic 
only and that most of the students speak Arabic language, translating the SHI to Arabic 
was necessary. Translating the instrument was also important to reach all of the 
intended sample and to avoid selection bias. Before starting the translation, the 
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developer of the tool (Dr. David Mastin) was contacted and permission was obtained 
to conduct the translation.  More information about the linguistic validation and cultural 
adaptation of the SHI is provided in the next section. 
 
 
3.1.7. Translation of the sleep hygiene index and validation process  
The SHI was translated to Arabic language following the forward-backward 
translation method recommended by the International Society for Pharmacoeconomics 
and Outcomes Research (ISPOR) guidelines (206).  
3.1.7.1.Forward translation 
The SHI was translated from English to Arabic by three independent translators 
who were native Arabic speakers, one of whom was a professional translator with 
experience in translating materials from English to Arabic in different specialties. The 
second was a HCP (clinical pharmacist) with experience in mental health, and the third 
was an individual with years of experience in translation at the College of Pharmacy, 
QU. 
3.1.7.2.Reconciliation 
A fourth individual who is a healthcare professional (pharmacist) reconciled the 
three translations and produced the first reconciled Arabic translation of the SHI. 
3.1.7.3. Backward translation and review 
Two individuals with background in healthcare, independently translated the 
first reconciled SHI from Arabic back to English. A meeting was arranged for the 
backward translation review, which was attended by the backward translators, research 
team and the translator who developed the first reconciled Arabic version of the 
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instrument. In this meeting, the two backward translations were compared to the 
original English version of the SHI and when any discrepancy was identified, the 
Arabic version of the instrument was reviewed and edited. At the end of the meeting, 
the second reconciled Arabic version of the instrument was developed.  
3.1.7.4.Cognitive debriefing  
The cognitive debriefing was done to assess the clarity and appropriateness of 
the content of the questionnaire in a sample of Arabic-speaking population living in 
Qatar. Nine native Arabic language speakers were interviewed for the cognitive 
debriefing step. The participants selected reflected different age groups, gender, 
nationalities and occupations. The variability in the participants’ demographic 
background was important to ensure that the items of the questionnaire were understood 
by Arabic speakers coming from different countries and with different educational 
backgrounds. This step was done to ensure the comprehension, time burden and 
acceptability of Arabic version of the SHI.  In addition, the Arabic translation of the 
SHI was also validated for its reliability after administration to QU students.  
 
 
3.1.8. Data analysis  
Quantitative data obtained from surveys were analyzed using SPSS software 
versions 25 and 26 (IBM SPSS® Statistics for Windows; IBM Corp, Armonk, New 
York, USA). Questions not answered on either PSQI or SHI were considered as missing 
values and surveys with missing responses were excluded from the calculation of the 
total score for each of the instruments. Descriptive statistics including frequencies and 
percentages were computed for demographic characteristics, sleep patterns and sleep 
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habits reported by the participants. The total scores for both PSQI and SHI were 
computed as per developers’ guidelines. While the difference in PSQI and SHI scores 
for different colleges and sociodemographic variables was calculated using Mann-
Whitney U and Kruskal-Wallis tests. Additionally, the association between different 
demographic characteristics and the components of the PSQI with the overall scores of 
the two instruments were analyzed using Spearman’s Rank correlation test. The 
Pearson’s correlation test was also used to explore the association between continuous 
variables (i.e. PSQI and SHI scores), whereas the Spearman’s correlation was used for 
categorical variables (e.g. college and PSQI score). Binary logistic regression (a.k.a. 
univariate regression) was also used to assess the cause-effect relationship between 
different demographic variables and sleep quality or sleep hygiene practices. While 
multiple logistic regression was conducted to explore the effects of different variables 
including sleep hygiene on sleep quality.  A p-value <0.2 was used as a cut-off point to 
determine variables which proceeded to the multiple logistic regression. This p-value 
was selected as recommended in previous studies to enhance the univariate model’s 
ability to identify all  truly important variables (207,208).  
 
 
3.1.9. Ethical considerations 
The participants completed consent forms before participating in the study. All 
responses were anonymous. This study was approved by QU’s Institutional Review 
Board (IRB) and was given reference number of: QU-IRB 977-EA/18.  
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3.2.  Phase 2: Healthcare providers’ perspective and experiences on the 
management of insomnia at primary healthcare centers in Qatar 
3.2.1. Study design 
This phase utilized a qualitative phenomenological design for enquiry to 
describe the views and experiences of HCPs at PHCCs regarding insomnia and its 
management.  This study also used the social constructivist framework described by 
Creswell to interpret the resultant data from the interviews (209). The interviews were 
conducted at PHCCs in patients’ counselling room, physician’s office or the pharmacy 
according to the participant’s preference. The interview’s duration ranged between 20 
and 40 minutes.   
 
 
3.2.2. Setting and study population  
Face-to-face interviews were conducted with HCPs working at several different 
PHCCs in Qatar. The interviews were conducted within PHCCs in suitable private 
rooms, such as those used for counselling patients within the pharmacy or at physician’s 
offices. The interview’s duration ranged between 20 and 40 minutes.   
Inclusion and exclusion criteria 
HCPs were eligible for participating in this phase of the study if they were:  
▪ Physicians and pharmacists who have been practicing at PHCCs in Qatar for a 
minimum of one year.  
▪ HCPs who are involved in providing direct care to patients on daily basis. 
HCPs that were not eligible for participating in the study if:  
▪ They were not pharmacists or physicians.  
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▪ They were working for less than a year at PHCCs.  
▪ They were in administrative or managerial positions and were not involved in 
providing direct patient care on daily basis. 
 
 
3.2.3. Sample size determination  
Pharmacists and physicians were interviewed until saturation was achieved (no 
new themes emerging). In this study saturation was achieved after interviewing 10 
physicians and 8 pharmacists from PHCCs. In addition, one psychiatrist who is 
responsible for one of the mental health clinics was interviewed for his expert opinion.  
 
 
3.2.4. Sampling 
PHCCs to be included in the study were selected from the 26 currently operating 
healthcare centers. Healthcare centers included in this study were selected from various 
geographical regions of Qatar including the Northern (N), Central (C) and Western (W) 
regions. From each region, PHCCs were selected through purposive sampling of 
different locations and regions to ensure maximum variation of participants’ 
characteristics based on the geographical region, different cultural factors, and 
nationalities. However, centers which were operating for less than one year were 
excluded. PHCCs selected for participation in this study included: Madinat Khalifa (N), 
Al-Khor (N), Lebaib (N), Airport (C), West Bay (C), Al-Rayyan (W), Abu-Baker 
Siddiq (W), and Mesaimeer (W). HCPs who were approached at each center were also 
selected purposively. Consent forms were obtained from physicians and pharmacists 
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who agreed to participate in the study.  
 
 
3.2.5. Data collection tools 
Semi-structure topic guides were used during the interviews to explore 
healthcare professionals’ experiences and practice in assessing and managing insomnia. 
Two topic guides were developed, one to conduct the interviews for physicians (31 
items) and another one to conduct the interviews for pharmacists (21 items) (Appendix 
B). The topic guides were used to direct the interview, however, deviations from the 
topic guide were allowed as long as it remained within the scope of the study. The 
interviews were conducted in either Arabic or English based on the participant’s 
preference. 
Most of the interviews were tape-recorded. However, if the participants 
objected to the tape recording, the answers of the participant were documented 
immediately by the researcher conducting the interview. The recorded interviews were 
then transcribed, and the transcripts were sent to the participant to ensure the accuracy 
of the information transcribed. The data collection was continued until saturation was 
achieved and no new themes were generated.  
 
 
3.2.6. Data analysis  
The information transcripts obtained from the interviews were thematically 
analyzed, following the six steps recommended by Braun and Clarke, to generate 
themes and codes (210). Initially, the transcripts were read repeatedly to ensure 
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adequate understanding of the data, followed by the generation of the initial codes. All 
initial codes and individual quotes were reviewed by two researchers (RA and MZ) and 
modifications were done as agreed by the researchers. NVivo 12 software was used to 
aid in the coding process. The codes were then grouped into categories which were 
further divided into themes. The themes generated and the categories forming them 
were then thoroughly reviewed with the research team and modifications were made 
based on the feedback obtained. While reviewing the themes and codes, the research 
question was kept into consideration to ensure that the generated themes answered the 
research questions. The deductive approach was followed in generating the final 
themes.   
 
 
3.2.7. Ethical considerations 
This study received approval from the PHCC’s research committee (reference 
number: PHCC/RC/18/12/004) and QU IRB (reference number: QU-IRB 1097-
EA/19). Participants were given an informed consent to read and sign before 
participating in the study. The personal identifiers of the interviewees (i.e. name) were 
removed to ensure the anonymity of the responses. The participants were also given the 
chance to read the transcripts to remove phrases or sentences which they would prefer 
not to include in the data analysis. 
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CHAPTER 4: RESULTS 
In this chapter, the results of this study will be presented. As in the methodology, the 
results of the two phases will be presented separately starting with Phase 1 which 
describes the results obtained from the questionnaires administered to QU students 
followed by Phase 2 which represents the qualitative findings obtained from the 
interviews with healthcare professionals in primary care.  
 
 
4.1. Phase 1: Exploring sleep patterns, behaviors and the use of sleep medicines 
among university students in Qatar 
4.1.1. Sociodemographic characteristics of the study participants  
A total of 2,062 students responded to the survey resulting in a response rate of 
10.45%. Most of the respondents were females (85%), Qatari nationals (63%) and 
mostly in their late teens or early twenties (70% in the age category between 18-23) as 
shown in Table 6. Some of the key demographic variables of the participants in this 
study are representative of the characteristics of the student population enrolled in QU 
for 2018 fall semester of which 65.6% were Qatari citizens and 77.3% were female 
students (201). The demographic profile of the QU students enrolled in the 2018 Fall 
semester is summarized in Table 7.   
The majority of respondents were from the Colleges of Arts and Sciences 
(33.3%), Business and Economics (19.3%), and Engineering (15.7%).This corresponds 
with the data reported in the university census as most of the registered students for this 
semester were in  the colleges of Arts and Sciences (32%), Business and Economics 
(22%) and Engineering (15%) as shown in Table 7.  
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Table 6. Sociodemographic characteristics of Qatar University students’ respondents (N=2062*) 
Variable n (%) 
Gender** 
Male  303 (14.7) 
Female  1753 (85.3) 
Nationality** 
Qatari 1302 (63.3) 
Non-Qatari 756 (36.7) 
Age category** 
≤ 23 years 1439 (70) 
>23 years 616 (30) 
Marital status** 
Single  1616 (78.6) 
Married 439 (21.4) 
 College**                             
College of Arts and Sciences 683 (33.3) 
College of Business and Economics 397 (19.3) 
College of Engineering 322 (15.7) 
College of Education  221 (10.8) 
College of Law 157 (7.6) 
College of sharia and Islamic studies 123 (6) 
College of Health Sciences  78 (3.8) 
College of Medicine  36 (1.8) 
College of Pharmacy  36 (1.8) 
Previous use of sleep aids (open time frame) ** 
Herbal  137 (6.6) 
Non-prescription medicine (OTC) 370 (17.6) 
Prescription medicine  84 (4.1) 
None 1560 (75.7) 
Use of multiple medications 
Prescription and herbal  9 (11.4) 
Non-prescription and herbal 50 (63.3) 
Prescription and non-prescription products  20 (25.3) 
*Total number of valid students who responded to the survey questions 
**Missing data  
 
  
90 
 
Table 7. Characteristics of Qatar University students registered for Fall 2018 (N=19,738)  
Variable   n (%)  
College* 
 
Arts and Sciences  6,250 (32) 
Business and Economics  4,328 (22) 
Engineering  2,964 (15) 
Education  2,182 (11) 
Law 1,642 (8) 
Sharia and Islamic studies 1,107 (6) 
Health Sciences 579 (3) 
Medicine  314 (2) 
Pharmacy  237 (1) 
Nationality  
Qatari  12,957 (65.6) 
Non-Qatari  6,781 (34.4) 
Gender   
Male 4461 (22.6) 
Female 15,277 (77.4) 
*N=19,603; the remaining students are either in the foundation program or not yet specialized 
 
 
4.1.2. Sleep quality and sleep hygiene  
The PSQI scores were calculated for 1,549 participants who have provided valid 
answers for all of the questions required for score calculation. The findings revealed 
that around 69.7% of the respondents had PSQI scores higher than 5, indicating poor 
sleep quality (mean ±SD 7.57±3.03) (Table 8).  
One third of the students reported having less than 6 hours of sleep at night in 
the previous month. Additionally, 60% of the respondents indicated that they had 
trouble falling asleep within 30 minutes of going to bed at least once a week within the 
previous month, while 63% of them indicated that they woke up in the middle of the 
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night or early morning (Table 9). Some respondents have also reported that their sleep 
was interrupted because they needed to use the bathroom, could not breath comfortably 
or felt it was too hot. The respondents also provided additional reasons outside the list 
provided in the questionnaire for not being able to sleep well. These responses were 
thematically analyzed, and the findings are reported later in this section. 
 
 
Table 8. Pittsburgh sleep quality index scores of responding Qatar University student (N= 1549*) 
Mean± SD 7.57±3.03 
Minimum score 0 
Maximum score 20 
PSQI global score n (%) 
Less than or equal to 5 (good sleep quality) 
 
470 (30.3) 
More than 5 (worse sleep quality) 
 
1079 (69.7) 
*Number of students for whom the PSQI global score was computed 
 
 
In their response on the PSQI questionnaire, more than two-thirds of the 
respondents perceived their sleep quality as good (Table 9). Around 64% of the 
university students experienced excessive daytime sleepiness while doing important 
tasks such as driving or engaging in social activities. Only a minority of the students 
indicated that they had a problem with keeping up their enthusiasm for doing their work 
within the previous month. Around one-quarter of the participating students (25%) have 
used sleep aids previously, while 15.6% reported using these sleep aids during the past 
month (Tables 1 and 9). The most commonly used sleep aids among QU students were 
non-prescription medicines, while prescription medicines were not commonly used.  
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* Total number of valid students who responded to the survey questions
Table 9. Qatar University students’ perceptions of their sleep quality (N=2062*) 
Question n (%) 
 Sleep latency (duration of time required to fall asleep) 
 ≤ 15 minutes  16-30 minutes 31-60 Minutes > 60 minutes 
631 (35.4) 620 (34.8) 313 (17.6) 218 (12.2) 
Actual duration of sleep during the past month (as reported by the participants) 
 ≥ 7 hours ≥ 6 hours up to < 7 
hours  
≥ 5 hours up to < 
6 hours 
< 5 hours  
792 (44.3) 414 (23.2) 330 (18.5) 250 (14.0) 
Habitual sleep efficiency as calculated from questions 1 (usual bedtime) and question 3 (Usual wake up time) 
 ≥ 85% 75% to < 85% 65% to < 75%  < 65% 
1194 (70.2) 276 (16.2) 145 (8.5) 86 (5.1) 
During the past month how often have you had trouble sleeping because you… 
 Not during the 
past month  
Less than once a 
week  
Once or twice a 
week  
Three or 
more times a 
week 
a) Cannot get to sleep within 30 minutes  387 (21.2) 342 (18.7) 446 (24.4) 650 (35.6) 
b) Wake up in the middle of the night or early 
morning  
365 (20) 321 (17.6) 440 (24.1) 697 (38.2) 
c) Have to get up to use the bathroom  639 (35.0) 486 (26.6) 405 (22.2) 294 (16.1) 
d) Cannot breathe comfortably  1134 (62.4) 307 (16.9) 233 (12.8) 143 (7.9) 
e) Cough or snore loudly  1360 (75.2) 245 (13.5) 117 (6.5) 87 (4.8) 
f) Feel too cold  587 (32.2) 441 (24.2) 465 (25.5) 331 (18.1) 
g) Feel too hot  707 (39.0) 456 (25.1) 444 (24.5) 208 (11.5) 
h) Had bad dreams  735 (40.4) 614 (33.7) 329 (18.1) 143 (7.9) 
i) Have pain 908 (49.9) 433 (23.8) 287 (15.8) 190 (10.5) 
j) Other reasons 898 (54.1) 268 (16.1) 262 (15.8) 232 (14.0) 
During the past month, how would you rate your sleep quality overall? 
 Very good Fairly good Fairly bad Very bad  
315 (17.3) 938 (51.5) 378 (20.7) 191 (10.5) 
During the past month, how often have you taken medicine (prescribed or "Over the counter") to help your sleep? 
 Not during the 
past month 
Less than once a 
week 
Once or twice a 
week 
Three or 
more times a 
week 
1532 (84.3) 128 (7.0) 88 (4.8) 69 (3.8) 
During the past month, how often have you had trouble staying awake while driving, eating meals, or engaging in social activity? 
 
 
  
Not during the 
past month  
Less than once a 
week  
Once or twice a 
week  
Three or 
more times a 
week  
653 (35.9) 484 (26.6) 448 (24.6) 233 (12.8) 
During the past month, how much of a problem has it been for you to keep up enthusiasm to get things done? 
 No problem at all  Only a very slight 
problem 
Somewhat of a 
problem  
A very big 
problem  
353 (19.3) 619 (33.9) 617 (33.8) 237 (13.0) 
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Furthermore, the respondents’ answers to the questionnaire items have shown 
that almost all students with good sleep quality – identified by PSQI scores - were able 
to correctly predict their sleep quality as good (Table 10). On the other hand, only 43% 
of the students who had bad sleep quality were able to correctly classify their sleep 
quality as bad. Additionally, around 70% of the students were found to have a sleep 
efficiency of 85% or higher in the previous month, indicating that most students have 
short sleep latency and spend the majority of their time in bed asleep.  
 
 
 
 
Similarly, the SHI-related findings have also indicated that poor sleep hygiene 
is common among QU students as the majority (78.8%) of them had SHI scores higher 
than 16 with a mean score of 21.79±6.69 as shown in Tables 11 and 12. The most 
commonly reported negative sleep habits by the responding students included engaging 
in activities that may keep them awake before sleeping time (64.7%) and using bed for 
things other than sleep such as watching television and studying (46.4%) as reported in 
Table 13.  
 
 
Table 10. Subjective and objective sleep quality as perceived by Qatar University students (N=1549*) 
Calculated sleep quality n (%) 
Perceived sleep quality n (%) 
Good sleep quality Poor sleep quality 
PSQI score ≤5 (Good sleep quality) 462 (98.0) 8 (2.0) 
PSQI score >5 (Poor sleep quality) 614 (56.9) 465 (43.1) 
*Number of students for whom the PSQI score was calculated  
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Table 11. Sleep hygiene index score distribution among Qatar University students (N= 1690*) 
Mean+/- SD 21.79+/- 6.69 
Minimum score  0 
Maximum score 43 
*Number of students for whom the SHI total score was computed 
* Minimum attainable score is 0 and maximum possible score is 52 
 
 
Table 12. Qatar University student respondents’ sleep hygiene index scores (N=1690*) 
SHI score category n (%) 
0-16** 359 (21.1) 
17-52*** 1331 (78.8) 
*Number of students for whom the SHI total score was computed 
**This score category indicates a good sleep hygiene  
***This score category indicates worse sleep hygiene 
 
 
The test of difference for the mean in PSQI scores and SHI scores across 
different sociodemographic characteristics was performed and the results are presented 
in Tables 14 and 15. A statistically significant difference in the mean of PSQI scores 
was found between different colleges and gender categories (Table 14). Students from 
the College of Law had the highest PSQI median scores (worst sleep quality), while 
students from the College of Medicine had the lowest scores (best sleep quality). A 
post-hoc pairwise comparison of sleep quality between colleges revealed that the 
statistical significance in the Kruskal-Wallis test was driven by the significant 
differences between the following colleges: Medicine and Law (p=0.035), Pharmacy 
and Law (p=0.037), Education and Business & Economics (p=0.044), Education and 
Arts & Sciences (p=0.013), Education and Law (p=0.001) Health Sciences and Law 
(p=0.032), Sharia & Islamic Studies and Law (p=0.018).  
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Table 13: Frequency of different sleep hygiene practices among Qatar University students (N= 1726*) 
 Questions Never 
n (%) 
Rarely 
n (%) 
Sometimes 
n (%) 
Frequently  
n (%) 
Always 
n (%) 
1) I take daytime naps lasting 2 or more 
hours  
403 (23.3) 503 (29.1) 386 (22.4) 258 (14.9) 176 (10.2) 
2) Going to bed at various times from day 
to day.  
120 (7.0) 362 (21.0) 546 (31.6) 429 (24.9) 269 (15.6) 
3) Getting out of bed at various times 
from day to day.   
153 (8.9) 476 (27.7) 544 (31.7) 362 (21.1) 182 (10.6) 
4) I exercise to the point of sweating 
within 1 hour of going to bed. 
1245 (72.1) 288 (16.7) 125 (7.2) 51 (3.0) 17 (1.0) 
5) I stay in bed longer than I should (after 
waking up) two or three times a week.  
243 (14.1) 422 (24.5) 470 (27.3) 353 (20.5) 236 (13.7) 
6) I use tobacco or caffeine (for example: 
coffee or tea) within 4hrs of going to 
bed or after going to bed  
695 (40.4) 320 (18.6) 360 (20.9) 199 (11.6) 147 (8.5) 
7) I do something that may wake me up 
before bedtime (for example: play 
video games, use the internet, or 
clean).  
125 (7.3) 146 (8.5) 336 (19.5) 464 (27.0) 649 (37.7) 
8) I go to bed feeling stressed, angry, 
upset, or nervous.  
272 (15.8) 463 (26.9) 572 (33.2) 282 (16.4) 132 (7.7) 
9)  I use my bed for things other than 
sleeping or marital intimacy (for 
example: watch television, read, eat, or 
study). 
283 (16.5) 252 (14.7) 388 (22.6) 343 (20.0) 453 (26.4) 
10) I sleep on an uncomfortable bed (for 
example: poor mattress or pillow, too 
much or not enough blankets). 
1162 (67.6) 294 (17.1) 169 (9.8) 60 (3.5) 34 (2.0) 
11)  I sleep in an uncomfortable bedroom 
(for example: too bright, too stuffy, too 
hot, too cold, or too noisy). 
1103 (64.2) 319 (18.6) 181 (10.5) 74 (4.3) 42 (2.4) 
12)  I do important work before bedtime 
(for example: pay bills, schedule, or 
study). 
261 (15.2) 325 (18.9) 528 (30.8) 364 (21.2) 239 (13.9) 
13) I think, plan, or worry when I am in 
bed. 
140 (8.1) 280 (16.3) 520 (30.2) 365 (21.2) 415 (24.1) 
*Number of participants who have answered at least one of the SHI questions. 
 
 
Similarly, a significant difference in SHI scores was found between different 
students’ colleges and age categories with p values of 0.024 and <0.001, respectively 
(Table 15). It was noted from the analysis that students from the colleges of Education 
and Sharia & Islamic studies had the lowest median of SHI scores, indicating that they 
had better sleep habits than other colleges.  
  
96 
 
 
 
Table 14: Difference in sleep quality scores between different sociodemographic variables  
Variable PSQI score 
Mean (SD) 
PSQI score 
Median (IQR) 
p value* 
Gender    0.014 
Male  7.1 (2.9) 7 (4)  
Female  7.7 (3.3) 7 (5)  
Age category    0.463  
≤ 23 7.6 (3.2) 7 (5)  
>23 7.7 (3.4) 7 (5)   
Country of origin   0.110 
Qatar 7.7 (3.4) 7 (5)  
Other countries  7.4 (3.1) 7 (4)  
Marital Status    0.138 
Single  7.7 (3.3) 7 (5)  
Married  7.3 (3.3) 7 (5)  
College    0.034** 
Arts and Sciences  7.9 (3.4) 7 (5)  
Business and Economics  7.6 (3.1) 7 (4)  
Education  7.1 (3.5) 7 (4)  
Engineering  7.6 (3.3) 7 (5)  
Health sciences  6.9 (2.8) 7 (4)  
law  8.2 (3.1) 8 (4)  
Medicine  6.7 (2.9) 6.5 (4)   
Pharmacy  6.8 (3.1) 7 (6)  
Sharia and Islamic studies 7.4 (3.3) 7 (6)  
*p value was computed using Mann-Whitney U test 
**p value calculated using the Kruskal-Wallis test 
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A positive association was identified between the sleep quality and sleep 
hygiene scores through linear regression analysis with a correlation coefficient of 0.394 
(p<0.001). The assessment of the correlation between sleep quality and different 
sociodemographic variables revealed that gender was the only variable significantly 
associated with sleep quality (p=0.014) as shown in Table 16. In addition, the use of a 
Table 15. Difference in sleep hygiene scores between sociodemographic variables  
Variable  SHI scores  
Mean (SD)  
SHI scores  
Median (IQR) 
p value*  
Gender    0.101 
Male  20.9 (7.1) 21 (9)  
Female  21.8 (6.5) 22 (9)  
Nationality    0.097 
Qatari 21.8 (6.6) 22 (9)  
Non-Qatari  21.4 (6.6) 22 (9)  
Age category    <0.001 
≤ 23 22.1 (6.4) 22 (8)  
>23 20.7 (6.9) 21 (10)  
Marital Status    0.138 
Single  22.1 (6.5) 22 (8)  
Married  20.0 (6.7) 20 (8)  
College    0.024** 
Arts and Sciences  21.8 (6.5) 22.0 (9.0)  
Business and Economics  22.0 (6.5) 22.0 (8.0)  
Education  19.9 (6.3) 20.0 (9.0)  
Engineering  22.2 (6.6) 22.0 (9.0)  
Health sciences  21.8 (7.5) 21.0 (11.0)  
law  22.5 (6.9) 22.0 (9.0)  
Medicine  22.1 (5.6) 21.0 (6.0)  
Pharmacy  21.5 (6.3) 21.5 (9.0)  
Sharia and Islamic studies 20.2 (6.7) 20.0 (9)  
*p value was computed using Mann-Whitney U test 
**p value calculated using the Kruskal-Wallis test  
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sleep aid was significantly correlated with the PSQI score. On the other hand, the SHI 
score was significantly associated with students’ age and marital status (p<0.001 for 
both) as described in Table 17. Moreover, the use of OTC products and prescription 
medicine was significantly associated with SHI scores, indicating that a correlation 
exists between the use of some sleep aids and sleep hygiene. The findings have also 
confirmed that all of the sleep parameters including sleep latency and sleep efficiency 
which were used in the calculation of the PSQI scores were significantly correlated with 
the PSQI and the SHI scores (p< 0.001) as shown in Tables 18 and 19. 
 
 
Table 16. Association between students’ sleep quality and sociodemographic variables   
Variable Correlation with PSQI global scores 
R p-value* 
College  -0.027  0.291 
Gender  0.062 0.014 
Age  0.019 0.464 
Marital status -0.038 0.138 
Country of origin  -0.041  0.110 
Use of herbal products  0.155 < 0.001 
Use of OTC products ** 0.260 < 0.001 
Use of Prescription medicine  0.120 < 0.001 
*p value was calculated using Spearman Rank test   
**Over the counter products  
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Table 17. Association between students’ sleep hygiene and sociodemographic variables   
Variable Correlation with SHI scores 
R p-value* 
College  -0.012 0.614 
Gender  0.040 0.101 
Age  -0.098 < 0.001 
Marital status -0.137 < 0.001 
Country of origin  -0.040 0.097 
Use of herbal products  0.021 0.383 
Use of OTC products ** 0.153 < 0.001 
Use of Prescription medicine  0.061 0.012 
*p value was calculated using Spearman Rank test   
**Over the counter products  
 
 
 
Table 18. Correlations between different sleep parameters and sleep quality among students 
Variable Correlation with PSQI global scores 
R p-value* 
Sleep latency (minutes)  0.504 < 0.001 
Duration of sleep (hours) 0.621 < 0.001 
Sleep efficiency  0.501 < 0.001 
Subjective sleep quality  0.682 < 0.001 
Use of sleep aids (during past month)  0.363 < 0.001 
Excessive daytime sleepiness  0.435 < 0.001 
*p value was calculated using Spearman Rank test   
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The results of the simple logistic regression analysis are presented in Table 20. 
The findings indicate that “College” as an independent variable has significant effects 
on students’ sleep quality (p=0.031). To understand this relationship, the PSQI score 
for each college was compared to PSQI scores of the College of Arts & Sciences which 
was used as the reference category. According to the results of this analysis, a 
significant difference was found between College of Arts & Sciences and  the College 
of Education as it was shown that students from College of Arts & Sciences are 59% 
less likely to have good sleep quality as compared to students from the College of 
Education (OR=0.594; 95% CI=0.41-0.861, p=0.006). Additionally, there was a 
statistically significant difference between sleep quality of students in College of Arts 
& Sciences and those in the colleges of Law and Sharia & Islamic Studies. The findings 
indicate that students from College of Arts & Sciences are more likely to have good 
sleep quality by 1.4 folds as compared to students in the College of Law (OR=1.415, 
95% CI=0.884-2.264, p=0.148). On the other hand, students from College of Arts & 
Sciences are around 73% less likely to have good sleep quality when compared to 
students from the College of Sharia & Islamic Studies (OR=0.733, 95% CI=0.461- 
1.164, p=0.188). Overall, college as an independent variable has contributed to only 
Table 19: Correlations between different sleep parameters and sleep hygiene among students 
Variable Correlation with SHI scores 
R p-value* 
Sleep latency (minutes)  0.222 < 0.001 
Duration of sleep (hours) 0.150 < 0.001 
Sleep efficiency  0.103 < 0.001 
Subjective sleep quality  0.315 < 0.001 
Use of sleep aids (during past month)  0.124  < 0.001 
Excessive daytime sleepiness  0.234 < 0.001 
*p value was calculated using Spearman Rank test   
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1% of the variance seen in sleep quality.  
Additionally, the students marital status was found to have a significant effect 
on the sleep quality; single students were reported to be 74% less likely to have good 
sleep quality as compared to married students (OR=0.738, 95% CI= 0.571-0.953, 
p=0.02). However, the contribution of this variable to the variance seen in sleep quality 
was less than 1%. Gender had also a significant influence on sleep quality, as it was 
shown that male students were 1.3 times more likely to have good sleep quality 
compared to female students (OR=1.31, 95% CI=0.965-1.78, p=0.083).  
On the other hand, sleep hygiene contributed to around 7% of the variance 
observed in sleep quality such that individuals with sleep hygiene scores less than or 
equal to 16 were four times more likely to have good sleep quality as compared to their 
counterparts who scored higher than 16 on the SHI (OR=3.825, 95% CI=0.965-1.78, 
p<0.001). This indicates that students who adopt healthy sleep habits were more likely 
to have better sleep quality.  
 The combined effects of different sociodemographic variables, sleep hygiene, 
and the college designation can explain around 8% of the change observed in sleep 
quality (Table 21). However, sleep hygiene was the only variable that showed a 
significant effect on sleep quality such that students with better sleep hygiene practices 
(SHI score ≤16) were four times more likely to have good sleep quality (OR= 3.66, 
95% CI= 2.8-4.8 , p < 0.001). 
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Table 20: Simple regression analysis on the association between students’ sociodemographic characteristics 
and sleep hygiene with sleep quality* 
Variable B S.E. Wald P** Exp(B) 
College *** R2=1.1% 
College  
  16.896 0.031  
Business and Economics  
0.133 0.163 0.661 0.416 1.142 
Education  -0.521 0.189 7.579 0.006 0.594 
Engineering  0.010 0.169 0.004 0.953 1.010 
Health sciences  -0.137 0.289 0.225 0.635 0.872 
Law 0.347 0.240 2.094 0.148 1.415 
Medicine  -.186 0.420 0.196 0.658 0.831 
Pharmacy  -0.444 0.399 1.235 0.267 0.642 
Sharia and Islamic studies -0.311 0.236 1.735 0.188 0.733 
Gender  R2= 0.2% 
Female 0.270 0.156 2.998 0.083 1.31 
Age R2= 0.1% 
More than 23 years old  -0.125 0.119 1.112 0.292 0.882 
Marital status  R2= 0.3% 
Married  -0.304 0.131 5.420 0.020 0.738 
Nationality R2 < 0.001% 
Non-Qatari  -0.061 0.115 0.282 0.595 0.941 
Sleep Hygiene  R2 = 6.7% 
SHI scores > 16 1.342 0.134 100.381 <0.001 3.825 
*Simple analysis was conducted using binary logistic regression to assess the effects of each variable on sleep quality.  
**Significant if P value <0.2 
***College of Arts and sciences used as the reference 
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Table 21. Multiple regression analysis on the association between students’ sociodemographic characteristics and sleep 
hygiene with sleep quality. * 
Variable  B  S.E. Wald P** Exp (B) 
R2=7.5% 
College    8.830 0.357  
Business and economics  0.101 0.178 0.321 0.571 0.781 
Education -0.370 0.207 3.177 0.075 0.691 
Engineering  -0.031 0.187 0.027 0.869 0.969 
Health sciences  -0.156 0.308 0.256 0.613 0.855 
Law 0.213 0.254 0.700 0.403 1.237 
Medicine  -0.482 0.435 1.228 0.268 0.617 
Pharmacy  -0.550 0.416 1.754 0.185 0.577 
Sharia and Islamic studies  -0.177 0.258 0.473 0.492 0.837 
Gender  0.244 0.177 1.910 0.167 1.276 
Marital status  -0.198 0.146 1.831 0.176 0.821 
Sleep hygiene*** 1.298 0.137 90.022 <0.001 3.661 
*Multiple logistic regression conducted to assesses the effect of each variable when other variables are kept constant.  
** Significant if P value< 0.05 
***Measured by SHI scores  
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4.1.3. Students’ perceptions of other factors influencing sleep quality 
(open-ended responses) 
Some of the responding students provided additional reasons for their inability 
to sleep well in the past month. Content analysis of the students’ responses generated 
11 main themes summarized in Table 22. The most frequently reported issue among 
the participants was related to the theme “symptoms of physical illness” as many of the 
students have indicated that they could not sleep due to chronic illnesses such as 
‘diabetes’, ‘acid reflux’ or ‘sinusitis associated with headache and pain’. Some 
respondents highlighted that incidents of acute medical conditions as a reason for 
inability to sleep within the past month. One student reported that ‘pain associated with 
urinary tract infections’ as the cause of sleep disturbance. Others have related their 
inability to sleep to ‘food poisoning’ and ‘cold’, as an example.  
 
 
Table 22: Additional reasons for students’ inability to sleep * 
Themes  Number of quotes  
Symptoms of disease   63 
Psychological problems 48 
Children waking up 43 
Overthinking  43 
Sleeping habits  42 
Sleep disturbances 35 
Academic pressure  32 
Family problems  11 
External noise  10 
Medication related  5 
Other reasons  13 
*These themes were extracted from the participants’ responses on question 5 J  
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The second most reported theme was “psychological problems” which included 
factors such as anxiety, depression and panic. For example, some of the respondents 
indicated that they could not sleep because of ‘anxiety and fear’, ‘anxiety that affects 
the colon and causes difficulty breathing’, ‘fear of the future’ and ‘depression’. 
Additionally, overthinking which is triggered by worries about academic performance 
or life problems was a predominantly reported reason for lack of sleep. In this regard 
one student said: ‘Marital problems and the psychological pressure of the university 
affects me’. 
Students also indicated that their engagement in negative sleep hygiene 
practices including daytime naps, consumption of stimulants (e.g. caffeine) and 
excessive use of electronic devices especially before sleep affected their sleep quality. 
Some of the students suggested that their sleep was often interrupted during the 
previous month due to noises from different sources including children waking up.  The 
following were examples of the statements reported by students: ‘The loud noises that 
come from the street’, ‘The reasons are that I can’t sleep rapidly when I go to bed, it 
sometimes takes me around 3 hours’.  
A significant number of the responding students indicated that they had a sleep 
problem including “insomnia”, “interrupted sleep”, which prevented them from 
enjoying a good night sleep in the previous month. Some of the students related their 
sleeping problem to the use of some medications which prevented them from sleep, 
while others indicated that they were unable to sleep without taking sleep aids.  
 
 
 
  
106 
 
4.1.4.   Arabic sleep hygiene index reliability assessment  
Overall, the participants found the Arabic version of the SHI to be simple, clear 
and brief. However, several changes were necessary to ensure the cultural adaptability 
of the instrument. These changes included removing the word “alcohol” in question 
number 6 (I use alcohol, tobacco, or caffeine within 4 hr of going to bed or after going 
to bed). Also, the word “sex” in question number 9 (I use my bed for things other than 
sleeping or sex) was replaced with “marital intimacy”. After these changes were 
implemented, the Arabic SHI was administered to the study population. The SHI score 
was calculated for 1588 students who have provided answers for all of the Arabic SHI 
questions. The findings have shown that the Arabic version of the SHI has an acceptable 
internal consistency reliability with an overall Cronbach’s alpha of 0.589. Deleting 
items from the scale was not associated with a large change in the Cronbach’s alpha 
value. However, the deletion of either item 1 or item 5 was associated with an increase 
in the Cronbach alpha value to 0.603 and 0.604, respectively (Table 23). Indicating that 
removing these items improves the internal consistency of the Arabic SHI. 
Interestingly, deleting item 2 “I go to bed at different times from day to day” did not 
change Cronbach’s alpha value. Whereas deleting any of the other remaining items was 
associated with a lowering in the Cronbach alpha value, indicative that the removal of 
these items decreases the internal consistency of the Arabic SHI.  
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Table 23: Changes in reliability measure when deleting selected items in the Arabic sleep hygiene instrument (N=1588) 
Item Scale 
mean if 
item is 
deleted* 
Scale 
variance If 
item is 
deleted 
Cronbach’s 
alpha if item 
is deleted 
1. I take daytime naps lasting two or more hours. 19.4 36.6 0.603 
2. I go to bed at different times from day to day. 19.2 32.7 0.589 
3. I get out of bed at different times from day to day. 18.6 30.4 0.540 
4. I exercise to the point of sweating within 1hr of going to bed  18.8 31.0 0.550 
5. I stay in bed longer than I should (after waking up) two or three times a week  20. 35.8 0.604 
6. I use tobacco or caffeine (for example coffee or tea) within 4 hrs of going to be or 
after going to bed.  
18.8 30.2 0.545 
7. I do something that may wake me up before bedtime (for example: play video 
games, use the internet, or clean).  
19.5 31.3 0.571 
8. I go to bed feeling stressed, angry, upset, or nervous.  17.9 30.7 0.551 
9. I use my bed for things other than sleeping or marital intimacy (for example: watch 
television, read, eat, or study).  
19.1 31.1 0.552 
10. I sleep on an uncomfortable bed (for example: poor mattress or pillow, too much 
or not enough blankets). 
18.5 30.3 0.563 
11. I sleep in an uncomfortable bedroom (for example: too bright, too stuffy, too hot, 
too cold or too noisy).  
20.2 33.6 0.579 
12 I do important work before bedtime (for example: pay bills, schedule, or study).  20.2 32.7 0.568 
13. I think, plan or worry when I am in bed.  18.8 31.8 0.572 
*The scale for each item ranges between 0 (never) and 4 (always), while the total scale ranges between 0 and 52 
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4.2. Phase 2: Healthcare providers’ perspective and experiences with insomnia 
management at primary healthcare centers in Qatar 
4.2.1. Participants’ characteristics 
A total of 19 HCPs from 5 different PHCCs in Qatar were interviewed in the 
period between June and December 2019. Participating HCPs included 11 physicians 
(MDs) of whom 10 were general practitioners and one psychiatrist working at a mental 
health clinic at PHCC, and 8 pharmacists (PHs). Out of the 19 participants, 11 were 
males and 8 were females. Participants’ characteristics are summarized in Table 24.  
 
 
 
MD: Medical Doctor, PH: Pharmacist, *: Psychiatrist at mental health clinic in PHCC. 
 
 
 
 
 
Table 24. Characteristics of healthcare providers interviewed 
Participant’s code  Gender  Insomnia training  
MD 1 Male  No 
MD 2 Female No 
MD 3 Male  No 
MD 4 Female  No, but received mental health training.  
MD 5 Female  No 
MD 6 Male  No 
MD 7 Male  No 
MD 8 Female No, but received mental health training.  
MD 9 Male No 
MD 10 Male  No 
MD 11* Male A licensed psychiatrist.  
PH 1 Female No 
PH 2 Female No 
PH 3 Male  No 
PH 4 Female No 
PH 5 Female  No 
PH 6 Male  No 
PH 7 Male  No 
PH 8 Male No 
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4.2.2. Themes generated from the one-to-one interviews 
Five major themes emerged from the interviews including: general perspectives 
on insomnia, views on primary healthcare as the setting for insomnia diagnosis and 
management, current practices of insomnia management at PHCCs, HCPs perceptions 
on their role regarding insomnia management, and challenges with insomnia 
management in primary care. The themes and subthemes are summarized in Table 25. 
 
 
Table 25. Themes and subthemes relating to healthcare providers’ perspectives and experiences with insomnia  
Theme 1: General perspectives on insomnia 
Insomnia prevalence and clinical presentations (MDs, PHs) 
Impact of insomnia (MDs, PHs) 
Insomnia as a symptom (MDs, PHs) 
Importance of addressing insomnia (MDs, PHs) 
 
Theme 2: Primary healthcare as the setting for insomnia diagnosis and management  
Priority for the management of underlying medical conditions (MDs, PHs) 
Primary healthcare most appropriate for insomnia management (MDs, PHs) 
Recognition of the need to refer complex cases (MDs, PHs) 
Routine mental health screening at primary healthcare centres (MDs) 
The need for diagnostic tools and tests to help physicians in diagnosing insomnia (MDs) 
 
Theme 3: Current practices of insomnia management at primary healthcare centers  
 Pharmacological management of insomnia (MDs, PHs) 
Non-Pharmacological insomnia therapies (MDs, PHs) 
Knowledge of HCPs regarding the management of insomnia (MDs, PHs) 
 
Theme 4: Healthcare professionals’ role perception regarding insomnia management  
Physicians’ specific roles (MDs, PHs) 
Pharmacists’ specific roles (PHs) 
 
Theme 5: Challenges for insomnia management in primary care (MDs, PHs) 
Time constrain (MDs, PHs) 
Lack of insomnia guidelines (MDs, PHs) 
Patient related factors (MDs, PHs) 
Lack of privacy for consultation (PHs) 
Insufficient patient education (PHs) 
Physicians’ reaction to pharmacists’ interventions (PH) 
Need for HCPs training (MDs, PHs) 
Need for specialized sleep clinic and PHCCs (MDs, PHs) 
MDs: Theme or subtheme emerged from the physicians’ interviews  
PHs: Theme or subtheme emerged from the pharmacists’ interviews  
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4.2.2.1 Theme 1: General perspectives on insomnia 
This was a predominant theme that emerged from the HCPs interviews 
regarding issues related to their perception of insomnia as a disease or a condition 
affecting health. Several subthemes were identified under this theme, including 
insomnia prevalence and clinical presentations, impact of insomnia, understanding 
insomnia as a symptom and the importance of addressing insomnia.  
 
Insomnia prevalence and clinical presentation 
Physicians indicated that insomnia is a problem that affects around 10-20% of 
their patients, some have also suggested that it is a problem which they see on a daily 
basis. However, pharmacists perceived insomnia as being uncommon at PHCCs and 
suggested that only around 4 patients present with insomnia complaints weekly. 
Overall, the HCPs interviewed perceived insomnia as particularly being common 
among individuals with mental illnesses, those who have chronic diseases and patients 
on multiple medications. 
 
‘So, you find that the group that takes a medication or multi-medications for chronic 
diseases are above 45 or 50, he is taking more than one medication for diabetes, 
hypertension, dyslipidemia. So, these are critical groups, as we call them, they 
complain a lot of insomnia.’ (MD10) 
 
 There was agreement between HCPs that most people presenting with insomnia 
were elderly individuals and young patients, particularly adolescents and high school 
students who were going through a transitional period in their lives. Some have also 
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suggested that elderly patients were more prone to insomnia due to their living 
circumstances as they mostly live alone and are often not involved in social activities. 
There was also the suggestion that women going through their menopause and 
experiencing life changing events such as separation from children after marriage could 
result in sleeping problems.  
 
 ‘We see for example...from what we have seen, I mean, I have seen elderly patients 
complaining from it [referring to insomnia]. She could be a menopausal woman, older 
than 70, older than 60 and so.’ (MD5) 
 
‘Insomnia, sleep disturbance we see it…mostly in two groups or among students who 
are in middle school or high school and elderly patients, these are the age groups that 
complains mostly from sleep disorders.’ (MD 9) 
 
HCPs also suggested that some social factors including living circumstances, 
going through life changing events or having problems either at work or home could 
result in the development of insomnia. Also, lack of family support especially for 
adolescents who are going through an important phase of their lives could contribute to 
worsening their sleep quality.  
Themes that emerged primarily from MDs have reported that insomnia patients 
often present with complaints of tiredness, fatigue, headache, dizziness, lack of 
concentration, nervousness and muscle ache. Other patient complaints mentioned by 
participants were more aligned with the classical insomnia symptoms including 
difficulty falling asleep, interrupted sleep and consequences of disrupted sleep such as 
affecting daytime performance especially at work. Participating PHs perceived that 
most patients do not disclose insomnia symptoms to them. Thus, PHs discover the 
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patient may be suffering from insomnia when reviewing the patient’s medications, or 
occasionally this may be brought up during a medication counseling session.  
HCPs interviewed thought that patients often seek professional help for 
insomnia when they fail to manage their sleep problem on their own. Some suggested 
that the patients’ desperate need for sleep coupled with the daytime consequences of 
sleep deprivation forces patients to see a physician. MDs believed that seeking the help 
of a healthcare professional is best especially if there is an underlying problem, either 
physical or psychological. Interestingly, some suggested that patients seek help at 
PHCCs because they believe that MDs at these settings are more likely to prescribe 
medications on their request, unlike in secondary care where more assessments are 
often needed before resorting to the use of medicines. Table 26 provides a summary of 
the insomnia prevalence and related patient characteristics when they present at PHCC 
as perceived by the HCPs interviewed. 
 
Impact of insomnia  
HCPs in this study demonstrated awareness about the health complications 
associated with insomnia and its effects on patients’ health and quality of life. They 
indicated that lack of sleep affects the individuals’ mood and worsens pre-existing or 
underlying mental illnesses such as depression and anxiety. Individuals with sleep 
deprivation also tend to be impulsive and can easily get aggressive against others. HCPs 
also indicated that insomnia is often associated with physical complications such as 
tiredness, headache and lower concentration. They also highlighted that lack of sleep 
has significant effects on individuals’ performance during the day, especially at work, 
resulting in lower productivity, more absenteeism, and increased risk of committing 
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mistakes which may have serious consequences, especially for individuals working at 
high risk jobs where mistakes cost lives. 
 
 
 
 
Insomnia as a symptom  
HCPs in this study indicated that insomnia is often not considered as an 
independent health problem; rather, they perceived it to be a symptom of an underlying 
disease. It was perceived that primary insomnia was a rare presentation at PHCCs, and 
that for most patients the symptoms are associated with secondary insomnia. HCPs 
identified psychiatric illnesses and chronic medical conditions as the main causes of 
insomnia symptoms in patients presenting at primary care settings. Specifically, 
depression and anxiety were highlighted as the most common psychiatric illnesses 
among insomnia patients. Additionally, other factors such as stress and family problems 
 
Table 26. Insomnia presentations’ profile  
Prevalence  Affected populations Common complaints             Reasons for seeking help 
Around 10-20% 
of patients 
attending 
PHCCs present 
with insomnia 
complaint.  
 
Elderly individuals  
 
Teenagers and high 
school students  
 
Women at menopause 
-Difficulty falling 
asleep 
 
-Interrupted sleep 
 
-Tiredness  
 
- Headache and 
dizziness  
 
- Lack of 
concentration  
 
-Nervousness  
 
- Muscle aches   
Failed to manage their insomnia at 
home.  
 
Insomnia affecting patients’ 
daytime performance.  
 
Patients want to take a medication 
to help them sleep.  
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were reported to contribute to the development of insomnia. 
 
‘Around 70% of the cases are secondary insomnia while 20-30% of the cases are 
primary insomnia.’ (MD 11) 
 
‘Insomnia is often considered to be part of a system and not an independent disease. 
They consider that insomnia accompanies anxiety, insomnia accompanies depression, 
or it could be the other way around; because depression comes with one of the two 
either too much sleep or lack of sleep.’ (MD10) 
 
‘Most of the patients who present with depression or anxiety have insomnia.’ (MD 11) 
 
Moreover, HCPs believed that certain chronic diseases such as diabetes and 
hypertension, which are prevalent among patients attending PHCCs, were also linked 
with the development of insomnia. In addition, both physicians and pharmacists 
acknowledged that insomnia could be caused by some medications.  
 
 ‘…it could be a symptom of a disease or a side effect of a medication because these 
individuals have polypharmacy and it could be due to social circumstances.’ (MD 6) 
  
‘…even for people who have gastritis, they will experience esophageal reflux, which 
will be problematic. They cannot sleep, they will not be able to sleep because of this 
problem.’ (PH 5) 
 
It was perceived that poor sleep hygiene practices were also linked to the 
incidence of insomnia among patients attending PHCCs in Qatar. HCPs indicated that 
some sleep-related behaviors and habits, such as staying up late and napping were 
culturally acceptable. Additionally, consuming stimulants, engaging in activities which 
might keep them awake late at night and using bedrooms for activities other than sleep 
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were perceived as common habits among the general population in Qatar. Moreover, it 
was suggested that unusual work routines, which involves staying awake at night for 
work and napping cause sleep disturbances.  
 
‘I think there's a cultural thing where people find it acceptable to sleep for hours during 
the day and you know maybe struggle at night to sleep and I don't know why. So, there's 
basic medical, lack of medical education basically.’ (MD7)  
 
‘Because some people are living in their bedroom, they eat, drink, sleep and watch TV 
in their bedrooms. How would they be able to sleep? How would the sleep induction 
even happen?’ (MD6)  
 
‘…people seem to think “oh, let me have a cup of coffee” or tea or even hot chocolate, 
I mean that’s going to make you go to the toilet, it might wake you up... and even if they 
do wake up [to go to the] toilet, I would say even water perhaps… and some people 
think: “oh, reading a book is good”, but actually you are stimulating. So, some people 
think: “oh, let me watch some TV”, some people go to sleep…watching TV or watching 
a film, but actually you are stimulating your brain, aren’t you? So, that is actually poor 
practice to do.’ (MD 8) 
 
‘That he is doing something wrong. That there is something, for example, in his lifestyle 
wrong, and this is causing insomnia. What is the mistake? It could be psychological, or 
it could be routine related like the [unhealthy] sleeping habits or psychological like 
work pressure or pressure at home…’ (PH 7) 
 
Importance of addressing insomnia  
Overall, most HCPs recognized insomnia as an important health problem which 
needs to be managed and not to be left for patients to manage it on their own. However, 
some believed that there are a few patients who may be able to self-manage their 
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sleeping problems.  They also indicated that sleeping problems need to be treated early 
on by HCPs before it becomes more complicated and affect the patient’s life. There 
was also an overall perception that insomnia is not currently receiving the needed 
attention at PHCCs and that it is not taken seriously by HCPs.   
 
‘…it is a problem, and a very important one. It affects patient’s life.  Anything affecting 
patient’s life is an important issue regardless of how simple it is.’ (PH 5) 
 
‘…like when a patient is complaining of something, [HCPs] should take him seriously 
not ignore him. Even when they take his concern into consideration, they should take 
the problem seriously and they should diagnose it and treat it correctly.’ (PH 2) 
 
 
4.2.2.2 Theme 2: Primary healthcare as the setting for insomnia diagnosis and 
management 
Primary healthcare is most appropriate for insomnia management  
A recurrent theme that emerged from the HCPs interviews was related to their 
perception that PHCCs are the best places for the management of insomnia in Qatar. 
HCPs indicated that sleep problems should be managed by HCPs and that patients 
should seek the help of MDs instead of relying on un-trusted sources for health 
information (e.g. internet, relatives…etc.). HCPs strongly believed that PHCCs are 
easily accessible by patients in Qatar, which supports being the most appropriate 
settings for insomnia management.  There were also limitations to this role voiced by 
some of the respondents, stating that PHCCs were qualified to manage only mild forms 
of insomnia, leaving the more severe forms to be managed at specialized hospitals. 
However, there was a unified believe that insomnia treatment should be initiated at 
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PHCCs.  
 
‘These are our [referring to PHCC] cases; these are our cases. But this is something, 
you know, we call it psychosocial, this is ours, I mean they [insomnia cases] belong to 
family physician…’ (MD 9) 
 
‘It is possible for some cases, but other cases may need different medications. Some 
cases need other medications which are not available here [referring to PHCC].’ (PH 
3).  
 
Recognition of the need to refer complex cases  
A common view amongst the HCPs in this study was that patients with severe 
insomnia and those not responding to the treatment provided by MDs at PHCCs should 
be sent for consultations with specialists. Predominant reasons that were given included 
beliefs that that psychiatrists have the authority to prescribe specialized insomnia 
medications (such as benzodiazepines and z-drugs) and they can monitor response to 
therapy. Another reason was the belief that PHCCs are not equipped to deal with 
complex insomnia cases; therefore, patients who have more complicated cases are often 
referred to mental health hospitals for further assessment and management.  
 
‘If initially the patient was treated well here, he would not need to go to secondary 
care. As we are here primary care, the hospital is secondary care. But, if you waited 
and left the patient without care, and nobody is listening to him, of course his condition 
will deteriorate, and eventually you will refer him to the hospital.’ (PH 1) 
‘So, I think for the very small minority of patients who need them I'd refer them to 
psychiatry.’ (MD 7) 
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‘…we work within our own limits. First of all, we continue trying to treat the patient 
until a specific point at which we need to refer [the patient] to the specialist. But of 
course, we must have a role, because it is not possible for us to refer all the cases, first 
of all this will lead to patient crowding at the other institutions.’ (MD 5) 
 
 Some of the MDs in this study also indicated that they refer patients to the 
mental health clinics at primary care to receive psychological therapies such as CBT. 
Likewise, some pharmacists suggested that they could refer some patients back to the 
physician if they noticed that they had a significant sleeping problem which was not 
detected or addressed by the physician. Surprisingly, some of the HCPs interviewed 
seemed to be unaware about the availability of mental health services at PHCCs in 
which psychotherapies such as CBT are offered.  Some of the HCPs believed that 
referral to the mental health clinics available at some of the PHCCs across Qatar is 
advantageous as it helps in combating patients’ resistance against receiving treatment 
at mental health hospitals whether it was due to their fear of the social stigma or because 
some perception of insomnia as an insignificant health problem. 
 
 ‘…but we sometimes refer them to…psychological, behavioral treatment in our health 
centers [specialized in the provision of mental health services] for behavioral therapy, 
not…pharmacological therapy.’ (MD6) 
 
 There were mixed opinions between MDs in relation to the waiting time 
required before referral to secondary institutions as some indicated that it was usually 
a quick process that required around one month while others said that it often takes 
longer than a month for patients to be seen once they are referred. Some MDs suggested 
that they attempt to manage insomnia during this waiting period with non-
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pharmacological therapies and herbal products. 
 
‘We can try to treat the simple cases which doesn't need medications, there is no need 
to refer these to the specialist. We can try using the simple natural ways first, then we 
could refer to the doctor. I don't like referring patients to the psychiatrist immediately. 
I like to make use of my chance with the patient and to give the patient her chance and 
time with me. Then if I couldn't know the cause and reached a dead end then we ask 
help from the consultant.’ (MD 5) 
 
 ‘I mean, if he was taking the medications but there was no improvement, of course, we 
refer him to a specialist or consultant, secondary care or tertiary care to discover why 
his symptoms are not improving [despite already on pharmacotherapy].’ (MD 3) 
 
Prioritizing management of underlying medical conditions 
Overall, HCPs believed that the management of the underlying causes of 
insomnia was often prioritized over the insomnia treatment. Some HCPs also indicated 
that providing treatment for insomnia without managing the underlying cause would be 
ineffective and would not resolve the sleep problem. It was also stressed that assessing 
and managing sleep problems at the same time of managing the underlying cause of 
insomnia was important.   
 
 ‘Certainly, we need to solve the problem first and then we should monitor to see if the 
results of this treatment influence insomnia.’ (MD 5) 
 
 ‘So often when I'm doing a care [plan] the first thing is sleep while I'm doing everything 
else like investigating other problems…’ (MD 7) 
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Routine mental health screening at PHCCs  
 The physician respondents emphasized that at PHCCs routine screening for 
mental illnesses has been introduced and is regularly undertaken during the patient 
assessment, more specifically screening for depression and anxiety. It was reported that 
this assessment is initially done by the nurse and if the patient was found to have 
symptoms associated with mental illness, the physician would be informed to so that it 
could be addressed or managed as deemed appropriate.  
 
‘Mental health assessment is usually done by the nurse; it usually involves screening 
any patient who is 18 years or older. Patients are asked 4 questions; 2 of them are 
about anxiety and the remaining 2 questions are related to depression. If this 
[screening] test showed that the patient has a problem, we continue the assessment and 
we ask the remaining questions which include some questions related to sleep.’ (MD 
4) 
 There was an overall perception that MDs at PHCCs were prepared to deal with 
mental illnesses and that some had received adequate training on the management of 
psychiatric illnesses. Additionally, MDs indicated that they have regular lectures as part 
of their continued medical education (CME) program in which different topics and 
health problems are discussed. Some suggested that training on insomnia management 
could also be provided as part of these CME programs 
 
 ‘The same way we were given courses for anxiety and depression and we started 
treating patients here, of course [referring to] mild cases, it was definitely very useful.’ 
(MD 3)  
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The need for diagnostic tools and tests for insomnia  
Although MDs at PHCCs indicated their readiness to manage patients with 
mental illness, the need for tools including validated questionnaires to help with the 
diagnosis of insomnia was highlighted.  
 
‘But we need a questionnaire which could be given...the doctors could be encouraged 
to include the sleep questionnaire to be given at each patient’s visit. It could increase 
the number of patients diagnosed [referring to insomnia] ...’ (MD 2) 
 
 
4.2.2.3 Theme 3: Current practices of insomnia management at primary healthcare 
centers 
Pharmacological management of insomnia  
There was an overall awareness that at PHCCs in Qatar, there is limited 
insomnia specific treatments available, although other classes of medications such as 
antihistamines, anxiolytics, anti-psychotics and antidepressants were available and 
often used for the management of insomnia. The physician respondents indicated that 
they prescribe medications only for transient insomnia linked to jet lag, bereavement or 
if the patient came with a complaint of lack of sleep lasting for few days. On the other 
hand, HCPs suggested that no treatments were available for the management of chronic 
insomnia.  
 
‘…we don’t have benzodiazepines in our health center, so we don’t use these 
[controlled medications] it’s forbidden. They are not available in our clinic.’ (MD 6) 
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 The medications often prescribed at PHCCs were described to be mainly 
antihistamines or antidepressants. MDs had mixed opinions about prescribing 
antihistamines for insomnia as some were against their use because they have not been 
approved to be used as hypnotics, believe they are not effective for treating insomnia, 
or because their sedative effects vary from one patient to another. Physicians also 
indicated that they prescribe them for short relief of insomnia symptoms, and for a 
maximum duration of one week. Prescribing antidepressants or anxiolytics with 
sedative properties to help with sleep was perceived as mostly indicated for individuals 
with other comorbid psychiatric problems, although occasionally these might be used 
for individuals with only insomnia. There was an agreement between HCPs that 
insomnia medications are often prescribed for short course of therapy to manage acute 
insomnia cases. Additionally, participating pharmacists indicated that they are not 
allowed to dispense more than one-month supply of antihistamines. 
 
 ‘… [if] the physician feels that they [referring to patients with insomnia] need to be 
started on some sort of a medication, we do have a [number of] formulary [medications, 
such as] anti-depressants and anti-anxiolytics [that] we can prescribe.’ (MD 8) 
 
‘…we do not have for example short acting [benzodiazepine], this is surely not 
available. Mostly we have…for insomnia alone promethazine, chlorpheniramine or 
antihistamine medications which causes drowsiness. Other than that, not directly for 
insomnia but for anxiety or depression.’ (PH 3) 
 
There was however an overall perception that this limited availability of 
medications to treat insomnia, more specifically regarding hypnotic medications, was 
appropriate. HCPs believed that prescribing hypnotics should be left only for specialists 
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who have enough knowledge and experience in dealing with these medications. Also, 
some highlighted the fact that these medications require close follow up and monitoring 
by a specialist which is often not possible at PHCCs. Additionally, the interviewed 
HCPs perceived that the need for hypnotics at PHCCs is low and does not justify adding 
these medications to the formulary. There were also concerns voiced by HCPs about 
possible abuse of hypnotics by patients if these medications were more readily available 
at PHCCs. 
 
‘No, I am telling you, as long as we don't have a specialized clinic, we must not have 
medications...specialized for this problem, and these medications are of course costly 
and must be saved for special clinics, therefore it is normal that it is not available at 
the centre.’ (PH 7) 
 
 However, there were a few who suggested that the unavailability of insomnia 
medications at PHCCs was inconvenient for some patients, as they have to wait longer 
to be seen by a specialist and be prescribed a medication which is not available at 
PHCC. HCPs emphasized that adding hypnotics to the PHCC formulary would require 
enforcing a strict control over these medications, while others suggested that hypnotic 
refills could be safely dispensed at PHCCs although the initial prescribing authority 
should continue to be limited to psychiatrists. This was specifically recommended to 
reduce the workload on hospitals and to enhance accessibility of certain medications.  
 
 ‘Not having these medications [in the PHCC] makes it more difficult for the patient to 
receive these medications. He would find it hard to go get an appointment and…’ (PH 
2) 
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‘It could be useful. But I don’t support adding them, honestly, not everyone is trained 
on these medications.’ (MD 4) 
 
‘I think if they were added it would be a disaster because the kind of patients, we have 
are very demanding and they don't take no for [an answer] and if they knew it [referring 
to a hypnotic medication] was there they would want it to be prescribed. I can see it 
easily being abused, so I don't think it's a good idea at all.’ (MD 7) 
 
 There was a sense of reluctance among HCPs interviewed in this study towards 
the use of medications for insomnia management. Predominantly, participants believed 
that medications should be the last resort for insomnia management and that it should 
be reserved for resistant symptoms that significantly impacts the patient’s health and 
safety. These views were supported by HCPs believes that providing medications 
would discourage patients from putting effort in changing their unhealthy lifestyle to 
manage their sleep problem. Additionally, both MDs and PHs considered medications 
as a quick fix which would control the symptoms of insomnia in the short term but will 
not likely solve the problem. In addition, HCPs expressed their concerns about the 
safety of hypnotics and were specifically worried about the risks of dependence and 
tolerance associated with these medications. The interviewees were also worried that 
these medications could be misused and that physicians could be pressured by patients 
to prescribe. 
 
 ‘I don't want the patient to become dependent on it [referring to hypnotic medication] 
and use it for life. I want the patient's insomnia to get better, because if the person got 
used to a medication for insomnia, they will have to use it for life.’ (MD 5) 
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‘… a person has to [try] as hard as he can by himself without medications. If his 
condition became really bad, then he can try antihistamine. But I do not prefer going 
to medications directly especially antipsychotic medications, I do not like them.’ (PH 
1) 
 
‘Well, if it was used for long term of course it has well known side effects, first of all 
the patient will become addicted to these medication, it could also affect the memory of 
course it [worsen] Alzheimer’s [symptoms].’ (PH 7) 
 
HCPs highlighted on the importance of following up with patients once 
treatment is initiated. Physicians indicated that they usually have regular follow ups 
with their patients to monitor their improvement with therapy. However, some of the 
HCPs suggested that it was often difficult to follow up with patients especially after 
referral to other institutions, as patients hardly return to meet the same physician at 
PHCC. Similarly, PHs noted that patients are usually looking for a quick solution for 
their sleep problem and if the treatment provided by one physician was not effective, 
they would go to a different physician. Some of the MDs proposed that monitoring 
insomnia patients should be done at secondary care in which more resources are 
available for insomnia management. While others argued that primary care is suitable 
for monitoring insomnia patients especially with the introduction of the new family 
physician module in which each patient is assigned to one physician.  
 
‘We always have to follow up with all the patients. We don't only treat them as acute 
cases, we tell the patient to come back if she didn't improve… [they are asked to] come 
back again in one week or one month depending...’ (MD 5) 
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‘…we don't really get the patients coming back to see us that often either. Once you've 
referred them, they just don’t seem to come back, and they just disengage.’ (MD 7) 
 
‘…but if we want to add a medication then they must, the problem is that if you advise 
him (to take a medication) he could take the medication and leave.  But you need him 
to come back, so that he could follow-up with you.’ (PH 3) 
 
Non-pharmacological insomnia therapies  
A variety of perspectives regarding the use of non-pharmacological therapies 
emerged from the interviews, with some participants voicing doubts on the efficacy of 
these therapies especially if the cause of insomnia was not treated first, while others 
suggested that these therapies could be useful. Those questioning the use of non-
pharmacological products have related that to the lack of evidence to support the 
efficacy and safety of these products. Despite that there was an overall sense that these 
products are safe as they are not associated with side effects and risks of dependence or 
abuse. HCPs who suggested that non-pharmacological treatments could be useful have 
indicated that the efficacy of such therapies is subjective and depends on the patients’ 
personal beliefs and expectations. Some have also indicated that their opinion on the 
efficacy was based on personal experiences.  
Overall, non-pharmacological therapies appeared to be favored by HCPs over 
pharmacological treatment options for insomnia management. HCPs indicated that they 
frequently provided sleep hygiene advice to patients complaining from sleeping 
problems. This practice was related to HCPs perception of sleep hygiene as important 
for achieving sleep quality. However, physicians perceived that unhealthy sleep habits 
and practices are deeply rooted in Qatar’s culture. Furthermore, some of the PHs 
indicated that they encourage patients to enhance their spirituality through improving 
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their relationship with god and reading Quran as a way to help in improving their sleep. 
Likewise, others have suggested that positive thinking or doing some relaxing activities 
such as yoga could help insomnia patients. 
 
‘…part of the problem is the culture which makes it OK to sleep during the day and 
stay awake at night. Therefore, more needs to be done in terms of psychoeducation.’ 
(MD 11) 
 
‘We try to help him, we…tackle the sleep pattern and sleep hygiene, sometimes we need 
to educate the patient about the sleep hygiene. There are wrong habits we try to avoid 
them, the atmosphere of the house; hot, cold, too hot, too cold. dark, illuminated, not 
alone.’ (MD 6) 
 
‘No medication needed. Just like the easy kind of for most people easy kind of advice 
on how to change their sleeping habits with profound results so far beyond any drugs 
or anything else I can do for them. So, that's time well spent.’ (MD 7) 
 
‘You get some things … that can help. Such as essential oils, I mean these things people 
seem to think it doesn’t really help, but it does, it can help, …things like we mentioned 
warm bath, things like that, that can help. I mean we do it for babies and they instantly 
go to sleep. So, and there has been evidence that show it has, .... changing your sleeping 
habits or having good sleep habits will help, … to keep away from coffee, tea and things 
like that, and just stressing on the importance.’ (MD 8) 
 
‘For me personally, according to my opinion there are some specific things like 
avoiding drinks that contains sugar or stimulating drinks like tea and other stimulants. 
For example, to have a warm shower, having dim light, read a book and read Quran 
so these are the general advices…’ (PH 8) 
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‘Non-pharmacological...the first thing would be to change his lifestyle; this is the first 
treatment he must follow. Such as to sleep early, to prepare himself for sleep, avoid for 
example consuming a lot of stimulants, avoid too much thinking about the subject 
(maybe referring to insomnia), these are the treatments, drink for example milk, 
roselle...I mean herbal things which could help him to relax.’ (PH 7) 
 
‘This is my personal opinion; it needs psychological intervention. This condition does 
not require medications; it needs someone to listen, talk and understand them.’ (PH 1) 
 
Overall, there was a general perception among physicians that CBT was an 
effective treatment for insomnia. However, concerns were voiced by some of the HCPs 
in regard to its efficacy if the cause of the sleep problem was not managed first. Some 
indicated that they had no previous experience with CBT and thus preferred not to 
comment about its efficacy. There were differing views regarding the provision of CBT 
at PHCC, some MDs believed they were prepared to provide this service to their 
patients, others were more inclined to refer their patients to specialists, and some 
recommended training some of the HCPs at PHCCs to offer this service. Most of the 
PHs interviewed were not aware about the availability of CBT at PHCCs.   
 
‘I have heard about the cognitive thing but...ahhh... I haven't really tried it with my 
patients, I try only the first one [probably referring to the sleep hygiene].’ (MD 5) 
 
‘The best thing is to do CBT or that you talk with him before the CBT, you reach to the 
point of making a connection with the patient and that there are things which we need 
to think about them logically but not deeply. You can talk… the importance of the CBT 
is that it builds the patients self-confidence.’ (MD 10) 
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‘So, CBT doesn't work well for something that is a physical physiological problem. So, 
if someone is just working a shift pattern, how is a CBT going to help? But CBT could 
help if they're stressed out and they're having trouble switching off. So, you can you 
know as a kind of rumination thing that can use CBT, you can use CBT to kind of 
address some of those things. So yeah it depends on what the cause is, root causes is...’  
(MD 7)  
 
Knowledge about insomnia management approaches  
HCPs at PHCCs perceived that their knowledge about insomnia treatments was 
insufficient and therefore suggested that prescribing and managing patients requiring 
pharmacological treatments should be the role of psychiatrists. 
 
‘Because of the side effects [referring to hypnotic medications] and the data of all of 
that, because they have more side effects, because I see many cases that receive 
psychiatric therapy and sometimes the patients receive medications which I might not 
even know. So, when I log into the system, I see a number of medications; so, is this 
side effect caused by the medication? It's preferable for these medications to be 
prescribed by psychiatrist not us’ (MD 1) 
 
‘… honestly, not everyone is trained on these medications. Physicians shouldn’t be 
allowed to treat insomnia on their own.’ (MD 4)  
 
Some of the PHs indicated that they had prior knowledge about CBT, and some 
indicated that they got that knowledge through personal reading. Also, among PHs, 
some indicated not being familiar with the term “sleep hygiene”; however, all were 
aware of practices and behaviors associated with sleep hygiene and reported to be 
providing advice to patients on these on a regular basis.  
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‘I have heard about the cognitive behavioral therapy, ok, CBT, yes, but, ahh, I think 
they made a clinic or something like this in primary healthcare…but CBT is for 
everything is not insomnia only’ (PH 6)   
 
A summary of the current practices for insomnia management at PHCCs in Qatar is 
provided in Table 27. 
 
 
Table 27: Current practices for insomnia management at primary care in Qatar 
Subtheme  Categories  Summary 
Pharmacological 
management of insomnia  
1a. Limited pharmacological 
options for insomnia management 
 
1b. Duration of therapy 
 
1c.  Hesitancy about 
pharmacological insomnia 
management 
 
1d. Continuity of care 
 
 
Overall, HCPs interviewed acknowledged the 
lack of insomnia medications at PHCCs in Qatar. 
However, there was a general agreement that this 
was appropriate because these medications were 
perceived to be advanced and requiring a 
specialist’s care. Additionally, it was suggested 
that the treatments currently available at PHCCs 
including antihistamines, antidepressants and 
anti-psychotic medications were enough for 
primary care settings.  
Moreover, HCPs expressed their hesitancy 
towards prescribing and dispensing medications 
for insomnia management. This hesitancy was 
mainly derived by concerns about the safety of 
these medications including issues related to 
medication dependence. Furthermore, regular 
follow ups with patients were deemed to be 
important to monitor patient’s improvement.  
Non-pharmacological 
treatments  
2a. Non-pharmacological 
therapies are the preferred 
treatment options 
 
2b. Perceptions on the safety and 
efficacy of non-pharmacological 
therapies 
There was an overall preference for the use of 
non-pharmacological treatments for insomnia 
management. HCPs viewed non-pharmacological 
therapies including some OTC products as safe 
but expressed some doubts about the efficacy of 
these therapies. 
Knowledge about 
insomnia management 
approaches  
 
 
 
There was an overall sense among HCPs that 
their knowledge about insomnia treatments and 
management approaches was insufficient. 
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4.2.2.4 Theme 4: Healthcare providers’ perspectives on their role in insomnia 
management  
Physicians’ role in insomnia management 
A prominent view among the HCPs interviewed was that the assessment and 
management of insomnia was mainly the role of physicians. MDs highlighted the 
importance of history taking during insomnia assessment and diagnosis. According to 
MDs, the assessment of insomnia often includes asking about sleep routine, sleep 
environment and daily routine including work related issues. Despite the perceived 
importance of asking about sleep; some MDs admitted that assessment of sleep is not 
part of the routine patient assessment at PHCCs. Also, it was suggested that questions 
about sleep problems are often quick and superficial.  
In their talk about the assessment of sleep problems, MDs stressed on the 
importance of building a rapport with patients before asking further questions and doing 
a thorough assessment. MDs suggested that through history taking they often determine 
the cause of insomnia which could be physical, mental or medication related which is 
then confirmed through further testing. Additionally, MDs indicated that as part of the 
diagnosis they classify insomnia as either acute or chronic depending on the duration 
of the complaint and as primary or secondary based on the cause. The classification 
then guides the insomnia management.  
 
‘At the beginning [referring to the initial assessment of insomnia]…I try to see if there 
is a psychological component or if it was really a medical condition that is related to 
age, menopause and things like that or is it something that needs treatment, medications 
I mean.’ (MD 5)  
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 ‘…it is just a side question [referring to the assessment of insomnia]; I ask him for 
example: “ do you sleep well?”, “ do you eat well, how is you eating?”, “ you sleep 
for how many hours?”, you see how. And the number of sleep hours are not an 
indication of…sleep 8 hours doesn’t mean he is sleeping well. So, of course, I have to 
ask.’ (MD 9) 
 
‘…it’s all in the history, I mean 70% of our work. People think “is it a blood test, is 
it…”, no it’s history. So, 75%, you know, you could…get some idea of diagnosis just by 
history taking.’ (MD 8) 
 
Physicians indicated that their approach to patient care involves treating the 
patient as a one unit and taking all different aspects of the patients’ life into 
consideration while managing insomnia. MDs felt that some factors including patients’ 
lifestyle, living circumstances, social aspects and nature of their work were important 
and should be accounted for when managing sleep problems. Additionally, some MDs 
believe that all the patient’s health problems and concerns should be addressed at the 
same time instead of managing each problem in isolation. Moreover, some physicians 
highlighted the importance of patients’ engagement in decision making to ensure that 
patients’ needs, and preferences are considered.  
 
 ‘…the patient is treated as a whole; we don't take the patient only as a person who has 
diabetes and say, " just take the pill in the morning and at night". This is the secret 
behind the success of the chronic diseases clinic, that we spend more time with the 
patient and talk to him more, and as I told, there are aspects which might be missed 
when we are dealing with the patient…’ (MD 1) 
 
‘So, we try to do something…sleep hygiene, the social economy, food, type of foods, 
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when to sleep, the drinks, the medicines, … the stimulation, it causes bad sleep or 
insomnia… we tackle all these aspects: the disease, the pain, the fear, the anxiety, the 
depression, the polypharmacy we will tackle everything.’ (MD 6) 
 
Additionally, physicians indicated that they often counseled their patients about 
medications prescribed. MDs said that they often educate their patients about 
antidepressants or antipsychotics prescribed by telling them that these medicines are 
not hypnotics and that they do not cause addiction. MDs have also suggested that they 
provide information related to the expected onset of action and side effects of 
medications prescribed. On the other hand, the psychiatrist indicated that when 
hypnotics are prescribed patients are always warned about the addictive potential of 
these medications and are informed that these medications are for short term use only.  
 
‘To deal with the patient and warn him regarding the medication side effects and 
instruct him on how to take the medication, because they have many side effects,’(MD1) 
 
Furthermore, some MDs indicated that they usually attempt to enhance patients’ 
knowledge about normal sleep, sleep problems and treatment approaches for insomnia. 
However, some MDs recognized the need for enhancing patients’ awareness about 
sleep hygiene and engaging in educational campaigns targeting patients attending 
PHCCs.  
 
‘…sometimes patients come with their relatives, elderly who have chronic diseases, as 
part of health education we need to tell him about the number of hours of sleep, and it 
must not be less than 8 hours… This is part of the health education ...’ (MD 1).  
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‘But top of the list would be actually hanging a big poster in the waiting room in places 
like this saying like “Are you tired, how much sleep are you getting?”’ (MD 7) 
 
Pharmacists’ roles in insomnia management   
PHs perceived that they had an important role in providing patient counselling 
while dispensing medications. Some PHs indicated that they usually counsel patients 
about the best time for medication intake to avoid sleep disturbance, if insomnia was 
caused by a medication. They also noted that they educate their patients about possible 
drug-drug interactions and advise them on possible alternatives to medications that 
might be causing insomnia. Furthermore, PHs highlighted their role in clarifying 
misunderstandings about medications and encouraging patients to get information from 
trusted sources. However, some PHs indicated that counselling provision was not 
always feasible in the pharmacy due to time constrains associated with workload in the 
dispensary, or due to patient-related attitudes who do not appear to be interested in the 
education provided by PHs. 
 
 ‘… [referring to PHs providing counseling to patient with insomnia] when to take the 
medication, whether he should eat or not when taking the medication, and if there was 
any specific side effect to this, like for example… If there was a drug-drug interaction, 
avoid those drugs and avoid them for at least 2 hours…things like these.’ (PH 1). 
 
On the other hand, PHs indicated that their role in insomnia assessment and 
management is often limited to informing MDs if they identified untreated sleep 
problems while performing some PHs-related duties such as medication reconciliation 
or when reviewing patient medication profiles.  
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‘This is not the duty of the pharmacists [referring to patient assessment for insomnia], 
pharmacists don’t provide these treatments because this is a primary care setting and 
the pharmacist here is not a clinical pharmacist, therefore, pharmacists are not 
involved much in this…’ (PH 1). 
 
‘The patient will not come directly [to the pharmacist] to tell you that “I have 
insomnia”, he comes to you after he has already seen the physician and got the 
prescription’ (PH 3). 
 
‘It [referring to the pharmacist’s role in insomnia management] is limited, except in the 
“intensive medication reconciliation”. The pharmacist would notify the physician [if 
he noticed a sleeping problem] and he will deal with the patient based on the severity 
of insomnia.’ (PH 5). 
 
Some PHs perceived that they had other specific roles in insomnia management 
at PHCCs; one of which is responding to consultations from other HCPs.  PHs reported 
that they are often contacted with questions relating to medication availability, side 
effects, efficacy, onset of action, safety, the recommended duration of therapy or issues 
surrounding the choice of treatment in specific cases. PHs highlighted that the questions 
received were often in the context of acute insomnia as chronic insomnia cases are not 
managed in primary care. Overall, PHs perceived that consultations coming from other 
HCPs about sleep problems were not very common. Some PHs believe that this was 
related to the fact that PHCCs are not specialized to manage sleep problems. While 
others perceived that overall, insomnia is not a very common problem at PHCCs to 
begin with. 
  
 ‘…no physician has ever called me and said could this medication be the cause of 
[insomnia] and so on…’ (PH 6). 
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‘…they [referring to physicians at PHCC] also ask about our opinion in regard to the 
side effects of the medication, the duration of use and the extent to which these 
medication could result in an effect, this is our area, that is why doctors always ask us 
about them.’ (PH 1). 
 
PHs also identified other opportunities for insomnia management during their 
interaction with patients while dispensing medications, such as identifying patients who 
may be experiencing sleeping problems as a result of medication-related issues due to 
duplicate therapy, drug-drug interactions or simply untreated sleep problems. PHs 
believed that there is an opportunity for their involvement particularly when patients 
request clarification or education on complicated therapeutic regimens, or when 
addressing patients concerns about specific medication side effects, risk of addiction 
and withdrawal symptoms upon discontinuation. PHs suggested that they could use this 
chance to ask about sleep-related problems, provide more education on sleep hygiene 
and overall enhance patients’ understanding on the available treatments or adherence 
issues. Some PHs also stated that if treatment modification was required, they could 
intervene and contact the patient’s physician. PHs anticipated that they had more 
chance of identifying sleeping problems when dealing with patients on chronic 
medications. However, they suggested that it is sometimes difficult for them to use 
these opportunities effectively to identify sleep problems especially when they do not 
have complete medication information.  
 
‘If I believe that the drug is the problem, I will contact the doctor and ask the patient 
to go back to the physician to give him an alternative medication, something that helps 
in reducing the problem’ (PH 5) 
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It was highlighted that PHs play an important role in reassuring patients on the 
choice and efficacy of insomnia treatments. Considering that PHs are the last HCPs that 
the patients interact with before leaving PHCCs, they are in a suitable position to 
provide patients with emotional and psychological support to ensure adherence. It was 
suggested that this would in turn reduce any apprehensive behaviors surrounding 
medications and treatments, which could help in calming them down and probably 
minimize the effect of stress on their sleep. Some perceived that for the most part 
patients feel comfortable discussing their sleep problems with PHs; which gives the PH 
opportunities for being part of the assessment process.  
 
‘There is none except if the patient said something from his side, he says for example: 
" I..I can't sleep, I can't rest and so, the doctor prescribed some medications, so would 
these medicines really help me to sleep or not ?"’ (PH 7) 
 
‘…and another thing that they commonly say is “If I took this medication for a while 
would I become addicted it?”’ (PH 1) 
 
 
4.2.2.5 Theme 5: Challenges with insomnia management in primary care        
HCPs identified several barriers and challenges which limits their ability to 
assess and manage sleep problems at PHCCs (Figure 2). Both MDs and PHs 
complained of time constraints as they have indicated that the time spent with each 
patient is often not enough for doing adequate patient assessment and management of 
insomnia. MDs suggested that with the high patient load at PHCCs it might not be 
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possible to devote more than 15 minutes to each patient. Similarly, PHs highlighted that 
it is often difficult for them to ask patients questions and retrieve their medication 
history from the computer in a short time.  
 
 
 
 
 
 
 
 
 
 
 
 
Pharmacists
1. Responding  to 
consultations from other 
HCPs.
2. Answering patients’ drug 
related questions.
3. Opportunities for insomnia 
assessment (e.g. medication 
dispensing). 
4. Comforting patients   
Physicians 
1.  Insomnia assessment , 
diagnosis  and managment 
2. History taking
Challenges:  
1. Lack of privacy 
2. Physicians’ response to 
pharmacists’ 
interventions 
Patient 
counselling 
and 
education  
Challenges: 
1. Time  
2. Lack of insomnia guidelines  
3. Patients related issues (stigma, hiding 
insomnia complaint) 
4. Insufficient knowledge & training  
5. Need for sleep clinics  
Figure 2. Healthcare providers’ roles in primary care and barriers to insomnia management 
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Despite the limited time available, PHs indicated that most of them are 
committed to provide quick sleep hygiene advice to patients complaining from 
insomnia. However, PHs recognized that more time is necessary for patients who are 
referred for intensive medication reconciliation. 
 
‘… [regarding the difficulties that doctors face] one of them is actually time constraint, 
that we cannot give patients time and ask more questions because these questions 
specifically require more...time from the patient and doctor.’ (MD 2) 
 
‘At least 30 minutes. Of course, in 15 minutes...we can know [if the patient has 
insomnia] ... but treating it will definitely take more time and it [referring to the 
appointment] might extend to the time of the next patient's appointment.’ (MD 5) 
 
There were mixed views among PHs about the availability of insomnia 
guidelines at PHCCs in Qatar. Predominantly it was perceived as a challenge to 
adequately addressing insomnia. Some MDs indicated that they often refer to 
international guidelines or medical databases available on the PHCCs’ website when 
dealing with insomnia cases.   
 
‘I haven’t seen guidelines related to insomnia on our website. There are no guidelines 
specific for insomnia on the PHCCs’ website. But we usually visit Up-to-date or NICE 
guidelines’ (MD 4) 
 
‘Honestly, I haven't read any guidelines on insomnia. I have only read about the 
treatment approaches from websites, but I haven't seen any specific guideline.’ (MD 5) 
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‘We don’t have any guidelines for the diagnosis and assessment of insomnia. But I refer 
to the oxford handbook, it has a section on insomnia, it is really good. There is a great 
need to have a guideline even for physical problems which might be causing insomnia.’  
(MD 11) 
 
‘…they definitely have it on the system. I haven’t seen it myself, but physicians should 
know about it. If I got a patient, I have a guideline to follow. I do not go back to 
guidelines unless I have an unfamiliar [diagnosis] or to check the diagnosis and 
treatments prescribed by the physician... to check if it is correct…Other than that, I do 
not really check … or when I receive email assign for a guideline or for general 
knowledge if I would like to read on a particular topic. But they are obligated to follow 
the guidelines more [referring to physician].’ (PH 2) 
 
HCPs also suggested that patients’ beliefs and attitudes could act as an obstacle 
to proper identification and management of insomnia.  One of these main challenges 
highlighted by both MDs and PHs was the lack of disclosure of sleep problems by 
patients. It was suggested that patients rarely come with insomnia as the main 
complaint, instead, insomnia is often mentioned as a side problem during conversations. 
HCPs related this observation to patients’ discomfort with discussing sleep problems 
which are often linked to mental illnesses. Additionally, they suggested that patients 
may not be taking insomnia seriously enough or that they might be denying the 
existence of a problem to begin with. One interviewee related the inadequate patients’ 
reporting of sleep problems to the counselling provided at PHCCs, as patients are often 
told to expect insomnia as a common side effect of many medications.  Nevertheless, 
it was suggested that a subgroup of patients, especially elderly and some individuals 
with mental illnesses, are often more engaging and open to discuss their problems more 
openly.  
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‘Insomnia is not the main complaint. Usually patients bring it up when they are talking 
about their other problems.’ (MD 4) 
 
‘… this [referring to insomnia] is a hidden complaint, you know, he will not come to 
you saying: “I can’t sleep”, this is usually rare, you know, this kind of patients are 
rare…’ (MD 9) 
 
‘…because the patient does not present with insomnia as a main problem. He comes 
with other medical problems and he will mention insomnia while talking. It is rare to 
see a patient coming with insomnia as their main complain.’ (PH 2) 
 
‘Some patients have more tendency to talk, especially elderly people. He wants to talk, 
and he is comfortable with this pharmacist. So, he will start telling you that, for 
example, “I have this problem these days and I cannot sleep at night”.’ (PH 5) 
 
Another important challenge which was mentioned by some MDs was related 
to the lack of transparency in the part of the patient in reporting more specifics on their 
health-related problems or regarding their medications. Contributing factors to this 
challenge was suggested to be related to the patient’s personality (for example being 
shy) or simply related to discomfort most patients experience when sharing 
information, they might feel is more personal and not related to their physical 
presentation. 
 
‘ …[the difficulties are related to] the patient herself as a person, some patients have 
difficult personalities and some, for example, are looking for the easiest solution which 
is to directly use medication and she is not willing to make effort and listen to the 
advice. So, this is considered as a difficult patient. Or the patient might not be 
completely honest, she could be hiding something, she might be taking a specific 
medication and she doesn't want to tell about it, or she might have a disease and she is 
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hiding it’ (MD 5) 
 
Patients’ stigma against mental illnesses was identified by HCPs in this study 
as a significant barrier to the management of insomnia in primary care settings. Both 
MDs and PHs working at PHCCs agreed that insomnia is often linked to mental 
illnesses which are viewed negatively by the society. HCPs indicated that this stigma 
influences the treatment seeking behavior among patients; resulting in resistance 
against referral to a mental health hospital for treatment and follow up. HCPs believe 
this is usually linked to the patients’ fear of being labelled as mentally ill by the society. 
The interviewees suggested that these beliefs have serious implications on patients who 
may choose to avoid treating their problem until their condition deteriorates.  
Some of the MDs interviewed felt that the integration of mental health services 
into primary care though the introduction of mental health clinics might encourage 
patients to seek professional help without worrying about being stigmatized. Yet, one 
MD had a different view and suggested that the mental health clinics currently 
operating at PHCCs may not be very helpful in avoiding this stigma, as patients would 
still be drawing attention because they are receiving a special care provided by a 
psychiatrist. 
 
‘A lot of people don’t want to be [referred to mental health services], a lot of resistance, 
they don’t want to be referred, they don’t want to be labelled. They're scared of what 
their friends and family would think, this is a horrible kind of stigma. So, it’s very 
difficult, that's the thing that needs to be tackled, I think.’ (MD 7) 
 
‘…we have a stigma against insomnia, anxiety, stress, depression, these names or terms 
we try to escape from as Arabs. If you try to separate the service and tell the patient to 
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go to mental health hospital, he wouldn’t go. He would never agree to enter there, so 
it is better to provide the same service in a secured place; for example the patient when 
he enters to the physician’s room nobody would know if he is coming for depression, 
anxiety, or just insomnia. But if you separate the service, then the patient will run away 
from you. Because we are not prepared….’ (MD 10) 
 
‘…generally, people are afraid of saying things which might indicate that they 
are…have depression, so people don't disclose information related to this topic…’ (PH 
7) 
 
‘This is the problem, the society’s negative view is there, for me to visit a psychiatrist, 
no, it is difficult, I am not crazy, I don’t have a psychiatric problem or that, for example, 
some people in the society would say that this person was seeing a psychiatrist, it could 
be that he only had insomnia, simple anxiety, just depression, they would say no, he has 
a psychiatric illness and they consider him as crazy.’ (PH 3)  
 
Another challenge that emerged from the HCPs interviews was related to 
patients’ attitudes towards medications. HCPs indicated that they commonly interact 
with two different types of patients, the first of which want medications to manage their 
problems regardless of the cost or probable side effects, while the second type of 
patients do not prefer taking medications and are often worried about the safety. PHs 
indicated that the first group of patients often search for quick solutions and mostly 
come after they have tried some OTC products. In relation to psychotherapies such as 
CBT, one MD suggested that patients’ attitudes towards such therapies are often 
influenced by their previous experiences. There was a predominant perception that 
these types of therapies are not usually favored by patients. 
‘There is a culture here of wanting medications and not giving the patient a medicine 
means you are a bad doctor.’ (MD 11) 
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‘There are patients, for example, when you are counselling him on the medication 
would find that he has a lot of doubts, he is doubting a lot and is reviewing with you 
and, I mean not in an acceptable, but a little too much.’ (PH 3) 
 
‘They are psychologically vulnerable. They have anxiety from everything. So, if he read 
the pamphlet, then he would develop all the side effects listed. It is all psychological.’ 
(PH 5)  
 
PHs have reported some additional factors which they perceived as barriers to 
the management of sleeping problems at PHCC, one of which is the lack of privacy in 
the pharmacy. This might prevent patients from asking questions or discussing their 
sleep problems with PHs. The pharmacy window is a busy area where there is almost 
always a queue of patients waiting to take their medications. However, one PH has 
talked about the availability of a closed consultation room in which patients could have 
some privacy. Additionally, PHs perceived the counselling provided to patients at 
PHCCs as insufficient. Some PHs recommended assessing the patients’ general 
awareness about sleep problems before providing education in relation to insomnia, its 
consequences or the basic non-pharmacological management strategies.  
 
‘There is no privacy on the window, because in front of you is the and there is another 
patient here and another patient there and there and here…so…some patients are not 
shy and would talk, but other patients, no, they would be shy to talk about their 
problems.’ (PH 1) 
 
‘…they [referring to physicians] do not give proper advice. They just…they just give 
the patient what they want.’ (PH 2) 
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Furthermore, PHs indicated that one of the barriers which might prevent them 
from playing an active role in insomnia management was related to physicians’ 
response to their interventions. PHs considered the management of insomnia to be the 
physicians’ duty, therefore they were worried that their attempts to contribute to the 
management of sleep problems might create conflicts with physicians due to role 
overlap. Others suggested that PHs’ interventions and recommendations might be 
perceived by some MDs as an additional workload.  
 
‘In addition, if we intervened in physicians work, some of them take it personally and 
get annoyed.’ (PH 1) 
 
‘As I said, we will not do anything as pharmacists. It is the physicians’ responsibility. 
It has to come from them. If they did not request … if they did not … they would say, 
this is an additional load on us, we already have enough work...’ (PH 2)  
 
HCPs highlighted the need for training courses on the diagnosis and 
management of insomnia at PHCCs. Both MDs and PHs agreed that physicians need to 
be trained since they are more involved in insomnia management. MDs also indicated 
that they could benefit from receiving training sessions or workshops on insomnia 
diagnosis and management (as part of the CME sessions).  Considering that insomnia 
diagnosis and management was not included in the PHs’ job description, some PHs 
suggested that they did not need to receive training. However, PHs indicated that if 
these duties became part of the PHs’ role they should be properly trained.  
The need for specialized clinics to manage sleep problems at PHCCs in Qatar 
was a predominant suggestion by HCPs. They indicated that opening these clinics 
which will be operated by physicians with special training in sleep medicine would help 
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in improving insomnia management. It was also suggested that having these clinics will 
help HCPs in dedicating more time for the management of insomnia unlike the current 
situation in PHCCs in which insomnia is not receiving enough attention. It was 
expected that this will help in minimizing the stigma associated with these conditions 
at PHCCs since that treatment will be provided in regular clinic hours, by MDs. It was 
also suggested to have protected time slots for MDs so that they can provide additional 
time for patients presenting with sleep problems. 
 
‘The main point here is that we really need specialized clinics for these patients here 
at primary care.’ (PH 1). 
 
‘There should be a specialized clinic for this, and it should be treated in specific 
hospitals, I mean they can have their own medications, get special care and so. Like 
this [referring to the current system in PHCC] the patients will mix up, like insomnia 
patients with normal patients with patients with acute problems... all will be mixed up, 
there will be no focus on them, even if we make a specialized clinic for them, due to the 
patient flow in the centre it will be different and not possible to make a special clinic 
for insomnia.’ (PH 7). 
 
‘There is a need for a shared guidance in general for sleep. There is a need for sleep 
clinic where they can do sleep study, assessment and tests. Patients with severe 
insomnia are referred there...’ (MD 11). 
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CHAPTER 5: DISCUSSION 
This chapter provides an in-depth interpretation and analysis of the results presented 
in the previous chapter. The first part of this chapter will discuss the findings obtained 
from university students and will attempt to provide an explanation of these results 
with reference to the existing body of literature. The second part will focus on 
analyzing perceptions about insomnia and its management as viewed through the lens 
of healthcare providers working at PHCCs in Qatar.  
 
5.1. Arabic sleep hygiene index’s reliability  
As part of this study the SHI was translated to Arabic language and the 
translated instrument was used for assessing the sleep hygiene practices in the study 
sample. The Arabic SHI had moderate internal consistency with Cronbach’s alpha of 
0.59 which is lower than the reported Cronbach’s alpha for the English (0.66 and 0.64) 
and Turkish (0.70) versions of the instruments (172,203,205). Assessing other 
psychometric properties of this instrument including reproducibility and validity 
measures was not possible due to time restrictions. 
 
 
5.2. Phase 1: Exploring sleep patterns, behaviors and the use of sleep medicines 
among university students in Qatar 
 For the most part, the results obtained in this phase of the study have 
contributed towards advanced understanding of the prevalence of insomnia and sleep 
hygiene patterns among university students in Arab populations, and add to the limited 
research and published literature currently available in the Arab region. 
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The findings of this study conducted among QU students have shown that more 
than two-thirds had poor sleep quality. Similar results have been reported from other 
Arab countries as it was shown that the prevalence of insomnia among university 
students from KSA, UAE and Jordan ranged between  67 and 85% (105,110,111,114). 
The mean PSQI score found among QU students (7.57) was  similar to those reported 
for students from Kuwait and KSA (around 7), but was slightly lower than the scores 
reported for students from Jordan (8.01) (105,114,211). Studies undertaken in other 
Arab countries such as Palestine, Bahrain and Lebanon reported lower prevalence rates 
of poor sleep quality among university students, ranging between 9.8 and 59% 
(102,106–109,118). These prevalence rates appear to be higher than those reported in 
other adult populations (30%), which confirms previous research findings which 
suggested that young adults, including university students, are at higher risk for 
insufficient sleep and insomnia (16,18,34,78,79,91,119). The prevalence reported 
among QU students is also higher than the 5% insomnia prevalence detected among  
the general population in Qatar (32).  
Sleep fragmentation, which is a common feature of insomnia, was reported by 
60% of the respondents while in a similar study from Bahrain only  40% of the students 
were found to suffer from interrupted sleep  (102). Sleep interruption was often related 
to some physical complaints often caused by symptoms of a chronic disease condition 
such as diabetes or an acute illness. This finding corroborates to the notion that 
individuals with chronic diseases are at higher risk for insomnia (212,213). In 
particular, chronic painful physical conditions such as backache and  joint problems 
were found to worsen insomnia symptoms and result in sever daytime consequences 
(214). 
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Many of the students also complained of psychological problems including 
anxiety, depression and panic, which are most likely related to the tremendous amount 
of stress and academic pressure to which the students are subjected. This finding is 
consistent previous reports from the literature which suggested that stress was the factor 
mediating the association between mental illnesses and insomnia in university students 
(99,100,119). The students’ stress also translates into excessive thinking about their 
academic performance and the tasks awaiting completion (98). As a result, this prevents 
students from falling asleep and if they managed to sleep those worries and thoughts 
often find their way into their dreams and appear as nightmares, preventing them from 
having a peaceful sleep.  
Some of the participants related their inability to sleep to some negative sleeping 
habits including sleeping late, daytime naps and consuming stimulants late at night. 
These habits are known to be common among university students and were associated 
with increased likelihood of poor sleep quality in this population 
(84,85,98,112,115,116,118,122,128).   
Despite the high prevalence of poor sleep quality found among QU students, 
several findings in this study suggest that students are mostly unaware of having a 
sleeping problem and many appear to have developed compensatory mechanisms. This 
is evidenced by the following findings: 
• Only about a third of QU students appeared to be sleep deprived or having 
insufficient sleep (<6 hours). This was consistent with the findings of studies 
conducted among university students in Egypt, China and India in which around 
12-50% of the sample had insufficient sleep (<7 hours) (78,90,106,112,113). The 
discrepancy seen between poor sleep quality and sleep insufficiency among 
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university students suggests that sleep quality is not determined solely by the 
number of hours of sleep. 
• Around 60% of the students found difficulty with falling asleep within 30 minutes 
of going to bed at least once a week, and 30% reported an average sleep latency 
higher than 30 minutes. However, the majority of the students had a sleep efficiency 
of 85% or higher indicating that the time spent in bed before sleep is minimal. These 
findings fall within the range for sleep latency reported in epidemiological studies 
done among university students (78,92,94,107,109,112,118). Similarly, previous 
studies have also shown that university students often report good sleep efficiency 
(>85%) (105,118).  
• Less than 50% of QU students with poor sleep quality (as identified by PSQI score 
>5) perceived their sleep quality to be bad. This was consistent with reports from 
previous studies which have shown that university students are not always capable 
of correctly determining their sleep quality. One study conducted among university 
students in the US found that 62% had poor sleep quality (measured by PSQI); 
nevertheless, only 27% described their sleep quality as poor (90). Similarly, around 
38.4%, 22.2% and 56.8% of students with poor sleep quality from India, Ethiopia 
and Brazil, respectively, were able to correctly rate their sleep quality as poor 
(78,97,99). However, it seems that students with good sleep quality are more likely 
to accurately predict their sleep quality and this was confirmed by a study which 
found that students who have perceived their sleep quality to be good had lower 
mean scores on the insomnia severity index (111).  
Overall, these findings combined indicate that university students tend to overestimate 
the quality of their sleep. This could be attributed to lack of awareness about the 
  
151 
 
characteristics of healthy sleep, which might play a role in shaping their perceptions of 
their sleep quality. Importantly, this indicates that some students who do not complain 
from any sleep problem may indeed be suffering from poor sleep quality or insomnia. 
This observation highlights the importance of using validated instruments for 
identifying sleep quality rather than relying on participants’ self-reports or complaints. 
The use of sleep aids was not a common practice among QU students as only 
one-quarter of the sample admitted to trying sleep aids previously, while only around 
16% indicated that the use was within the previous month. This finding was consistent 
with the results of a study that was conducted among Ethiopian university students, 
which found that 21% of the participants had used sleep aids in the past month (100).  
However, evidence from the published literature suggests that the use of sleep aids is 
even less common among university students as only 1% of Palestinian and Japanese, 
6% of Lithuanian and around 9% of Egyptian, Ethiopian, Brazilian and Saudi Arabian 
university students indicated the use of sleep aids (80,92,97,99,109,116,118). In 
contrast, it was found that around 46% of medical students from Saudi Arabia reported 
a previous use of sleep medicines (117).The use of sleep medicine was significantly 
associated with worse sleep quality in previous studies, suggesting that individuals who 
take sleep medicine at least once a week are 14 times more likely to have poor sleep 
quality compared to those who do not take these remedies (107).  
Poor sleep hygiene practices were found to be common among university 
students in Qatar as around 79% scored higher than the cutoff point of 16 on the SHI 
(203). In particular, students reported engaging in awakening activities before sleep and 
using bed for purposes other than sleep such as for watching television or studying. 
This is consistent with the findings of other studies which indicated that university 
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students commonly engage in negative sleep hygiene practices up to 5 days per week 
(77,89). Practices reported in these studies included engaging in strenuous exercises 
within 2 hours before sleep. Evidence also suggests that some habits including  lack of 
exercise and studying or watching television in bed were associated with poor sleep 
quality (215). Lack of awareness about the impact of such practices on sleep might be 
the reason why students engage in such behaviors (77,89). It was previously shown that 
the majority of university students were not aware that performing active exercise or 
engaging in emotionally upsetting activities around bedtime and using bed for various 
activities could negatively impact their sleep (77). A significant number of university 
students were misinformed on issues related to daytime napping and use of sleep aids 
(77). On the other hand, other studies have argued that knowledge about sleep hygiene 
does not necessarily influence individuals’ behaviors and practice of sleep hygiene 
(216).  
A substantial proportion of the QU students indicated that they go to sleep while 
feeling angry, stressed or nervous. Similarly, thinking, planning and worrying in bed 
were all common habits in around 45% of the sample in this study. Overthinking was 
also one of the prominent themes identified by students for their inability to sleep. 
These findings are not surprising and are expected in this population which is subjected 
to a significant amount of pressure and stress and many studies from various countries 
have consistently shown that stress is common among university students (79,217–
220). Worries about academic performance, passing courses and future plans are the 
most common causes of stress among university students (221). Additionally, studying 
for prolonged periods of time, assessments and time constraints were other documented 
causes of stress in this population (220). Furthermore, it was found that university 
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students frequently worry about their sleep quality and whether they were getting 
enough sleep which might further contribute to their sleeping problem (84,89,221).  
More than 30% of the respondents had inconsistent sleep schedules and reported that 
they stayed in bed longer than needed at least two or three times a week within the 
previous month. Students have also indicated that they sleep late mostly to study or 
complete their assignments. This is consistent with previous reports which identified 
irregular sleeping patterns as a common behavior among university students 
(84,85,98,112). Similarly, going to bed late was considered the most common sleep 
habit among Saudi university student (115). Excessive daytime sleepiness, which is a 
consequence for insufficient sleep, was also found to be prevalent among QU students 
affecting more than 60% of them. This observation was in agreement with the results 
of preceding studies which discovered that between 37% to 57% of Saudi students had 
excessive sleepiness (107,116,117,126). Also, irregular sleeping patterns including 
delayed wake up times and getting out of bed later were shown to be more common 
among students suffering from chronic insomnia  (87).  
The results of this study indicate that at least a quarter of the QU students have 
reported commonly taking daytime naps lasting 2 hours or longer in the previous 
month. This proportion is significantly less than the findings of other studies which 
have shown that between 49% and 86% of university students take daytime naps 
(109,112,116,117). However, the results of this study are similar to that of a Saudi study 
which has shown that around 23% of the students reported taking daily naps. The lower 
prevalence of nap taking behavior observed in this study could be due to limiting the 
question to long naps that lasts for a minimum of 2 hours. In fact, a meta-analysis done 
previously have identified the mean duration of daytime naps in university students as 
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54 minutes (112). Daytime naps can be an effective compensation mechanism in 
individuals suffering from sleep deprivation. Indeed, short daytime naps which does 
not exceed 30 minutes are recommended to maintain alertness and enhance 
performance for the remaining part of the day (222). However, naps lasting for longer 
than 30 minutes have negative effects, resulting in lethargy and disorientation shortly 
after waking up and altering night-time sleep. Midday napping is also a common 
practice in Arab and Muslim societies in general as it is a practice that has been 
recommended in Islam and practiced by the Prophet  (223). Therefore, it is expected 
that the number of university students who commonly take daytime naps, regardless of 
the duration, is probably underestimated in this study since QU is a Muslim-students 
dominated university. Hence, it is recommended in future studies to include an 
additional item on the frequency of taking naps without restricting the duration. 
Another coping mechanism for lack of sleep manifests through the consumption 
of stimulants. Caffeine containing beverages are commonly consumed by individuals 
suffering from insufficient sleep.  However, the consumption of caffeine or tobacco 
within 4 hours of sleep was not a common behavior among QU students as only 20% 
reported engaging in this practice. Also, only very few students reported exercising 
vigorously within one hour of sleep. In contrast, other studies have suggested that 
caffeine intake was highly prevalent among university students in Arab countries with 
regular consumption of caffeine being reported by more than 65% of students 
(116,118,128). Additionally, around 28% of Palestinian university students reported 
late night caffeine intake at least once a week (109). Similarly, around 65% of 
university students from the US indicated that they drink caffeine containing beverages 
within 4 hours of going to bed at least once a week (89).  
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Environmental factors such as noise, light and temperature  were identified in 
other studies as important factors that influence the university students’ sleep quality 
(89,113). Nonetheless, environmental factors were not shown to be a source of 
annoyance for most of QU students; yet those complaining from external factors were 
often individuals who had young children who wake up at night crying and requiring 
attention.  
At least 70% of university students spend more than 3 hours daily on electronic 
devices, with laptops and smart phones being the most used devices (130,224). 
Electronic devices are important for university students as they provide them with easy 
access to educational material, facilitating communication with colleagues, instructors 
and social media, as well as for engaging in extracurricular activities (224,225). 
However, the use of electronic devices, especially around the sleep time, can disturb 
the night-time sleep and alter its quality. In the present study, some students indicated 
that using electronic devices and playing video games prevented them from falling 
asleep. Studies are suggesting that mobile phones’ dependency is common among 
university students (226). Addiction to mobile phones was associated with sleep 
disturbance and use of sleep medication.  
A statistically significant correlation between sleep hygiene practices and sleep 
quality was identified among QU students; suggesting that students with better sleep 
hygiene are more likely to have good sleep quality. The association between sleep 
hygiene and sleep quality among university students has been frequently reported in the 
literature (77,83,203,215). In particular, one study found that a one unit increase in 
sleep hygiene practice score is associated with a corresponding decrease in PSQI score 
by 0.08 (77). It was even suggested that some sleep hygiene practices could predict 
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insomnia severity among university students both concurrently and up to 2 months later 
(83). The main sleep hygiene practices predicting sleep quality were improper sleep 
scheduling, engaging in arousing behaviors near bedtime and sleeping in uncomfortable 
environment (83). It is worth noting that the first two of these habits were also the most 
common sleep related behaviors among QU students.  
The effects of different sociodemographic characteristics of the participants on 
sleep quality and sleep hygiene were also investigated in this study. The results from 
the regression analysis have shown that students from the colleges of Education and 
Sharia & Islamic studies had better sleep quality than students from the College of Arts 
& Sciences. Interestingly, the test of difference has also revealed that students from 
these two colleges had better sleep hygiene practices. These findings provide an 
additional confirmation about the correlation between sleep hygiene and sleep quality 
in QU students.  
The findings have suggested that sleep quality differed significantly between 
different colleges and genders. Notably, students from the college of Law were shown 
to have the worst sleep quality (mean PSQI score of 8.2) while students from the college 
of Medicine had the best sleep quality (mean PSQI score of 6.7). Nevertheless, this 
result is different from the observations in other studies which indicated that medical 
students usually have worse sleep quality than students from other colleges. 
Specifically, several studies have found that Medical students tend to have worse sleep 
quality than Law students (92,227,228). It was shown that both Medical and Law 
students spend longer time studying and have less free time. Studies have also 
suggested that Medical students often get less sleep and have worse daytime 
dysfunction. Yet, daytime sleepiness was found to be more common among Law 
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students (227). Although the reasons for this observation cannot be certainly 
determined, the variance in sleep hygiene patterns across different colleges could 
provide some explanation, as students from the college of Law were shown to have 
worse sleep hygiene than Medical students in the current study. This is coherent with 
the findings of the regression analysis which has shown that sleep hygiene was the main 
factor influencing sleep quality in QU students. Previous studies which included Law 
students noted that this population is often stressed due to the competitive nature of the 
Law school, and these students were also more prone to depression and anxiety 
(229,230).  
The findings have also identified a significant correlation between sleep quality 
and gender with female students having worse sleep quality (mean PSQI score of 7.7). 
It is well known that females are more vulnerable to sleep problems, and a large body 
of evidence today suggests that female university students have worse sleep quality 
than their male colleagues (78,84,85,87,90,96,122). Likewise, meta-analysis of 31 
epidemiological studies proved that females were at higher risk for having insomnia  
with a risk ratio of 1.41 (231). This finding was confirmed again in a study that was 
conducted in Egypt, which found that females scored higher on the insomnia scale 
(232). 
Furthermore, marital status was found to be a significant predictor of sleep 
quality in this study, as married students were more likely to have better sleep quality.  
The marital status was also significantly associated with the sleep hygiene scores. This 
finding is indeed interesting and was unexpected, especially that many individuals have 
reported inability to sleep due to children waking up. Therefore, it was expected that 
married students would have worse sleep quality than single students. Due to the small 
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number of students who identified themselves as divorced or widowed (n= 51), they 
were considered as single students and therefore some of the single students could have 
children preventing them from sleeping. However, considering the size of this group it 
is unlikely that it had a significant influence on the results. In addition, there is mixed 
evidence in the literature in regards to the effects of marital status on sleep quality; as 
some studies were in line with the findings of this study and reported that single 
students were more likely to have poor sleep quality while others failed to find an 
association between the two variables (82,98,118,215,233–235). Another study that 
was conducted among Kuwaiti university students has suggested that married students 
have better awareness about sleep hygiene (211). In this study awareness of sleep 
hygiene was not assessed, however, married students appeared to have better sleep 
hygiene practices, yet the difference between the SHI scores was not statistically 
significant. Furthermore, the effect of marital status on sleep quality disappeared after 
accounting for other variables in the multiple logistic regression analysis.  
In the current study age was identified as an important factor which significantly 
predicted sleep hygiene, such that older university students (> 23 years) were more 
likely to have better sleep hygiene. This is comparable with the findings of previous 
research which indicated that younger individuals have less awareness about sleep 
hygiene and often tend to adopt  unhealthy sleep habits (236,237).  However, like in 
previous studies, this study also failed to find a significant correlation between sleep 
quality and age (90,118). In contrast, a study that was conducted among medical 
students identified age as a significant predictor of sleep quality and indicated that  the 
probability of poor sleep quality increases with age (215). Therefore, the effects of age 
on sleep quality remains to be a controversial issue.  
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No significant difference in sleep quality scores was identified for nationality 
and marital status variables. Likewise, sleep hygiene scores for different nationalities, 
marital status and gender categories were not found to be significantly different. The 
effects of college and sociodemographic variables on sleep quality were all diminished 
after accounting for other variables in the multiple logistic regression. After putting all 
other factors into consideration, sleep hygiene was the only variable that continued to 
have a significant effect on sleep quality. The findings indicated that each of the 
different sociodemographic variables including college contributed to less than 2% of 
the variance seen in sleep quality. In contrast, sleep hygiene alone was responsible for 
around 7% of the change seen in sleep quality with odds ratio of 3.82; suggesting that 
individuals with good sleep hygiene are approximately 4 times more likely to have good 
sleep quality.  
 
 
5.2.1. Strengths and limitations 
Up to our knowledge, this study is the first in Qatar exploring sleep hygiene 
practices of university students. The findings helped in clarifying some of the 
unknowns about the prevalence of poor sleep quality among university students in an 
Arab country and described some of the most common sleep habits in this population. 
This study found that poor sleep quality was highly prevalent and affected more than 
two-thirds of the university students. Similarly, poor sleep hygiene practices were 
common among these students. Importantly, sleep hygiene was identified as the single 
most important factor that influences sleep quality. 
Nevertheless, this study has some limitations which includes not assessing 
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students’ knowledge and beliefs about sleep and sleep hygiene which could influence 
their behaviors and habits. The second limitation is related to missing to stratify 
students according to the year of study which was not done because there is little 
evidence in the research about the effects of the year of study on sleep quality. 
Additionally, using proportionate sampling technique was not feasible in this study, 
however, using the universal sampling technique the resulting proportion of students 
per college in the sample studied was found to be comparable to the proportion of 
students per college registered for that academic semester. Moreover, due to time limits 
it was not possible to assess other reliability and validity measures for the newly 
translated sleep hygiene instrument, yet this could be done in future projects. This tool 
is available to be used in other Arabic speaking populations.  
 
 
5.2.2.  Recommendations for future research 
There is a need to spread awareness among university students on sleep 
problems and their consequences. Therefore, it is recommended to launch awareness 
campaigns focused on educating students on sleep, sleep hygiene and optimal lifestyle 
habits which would help in improving sleep quality. This intervention needs to be 
provided to all QU students and should be reinforced every year with the entry of new 
students to the university. A meta-analysis has previously shown that sleep hygiene 
education improves different sleep parameters including sleep onset latency (by 5 
minutes) and total sleep time (by 25 minutes). This intervention was also found to 
significantly improve sleep quality and insomnia severity as it reduced PSQI score by 
3 points and the ISI Score by 2 points (65).  The implementation of this campaign 
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should be followed by conducting further research to explore the impact of this 
intervention on students’ knowledge about different aspects of sleep and their practice 
of healthy sleeping habits. Furthermore, ways for managing students’ sleeping 
problems through the provision of psychological services by professionals in university 
should be explored. Such services could be provided by the Student Counselling Center 
in QU which currently provides psychological and emotional support for students.  
 
 
5.2.3. Conclusion  
In conclusion, insomnia and poor sleep quality affects the majority of QU 
students and is associated with excessive daytime sleepiness. Most of QU students also 
have inadequate sleep hygiene practices. College, marital status, gender and sleep 
hygiene significantly influenced the sleep quality. After controlling for other variables, 
sleep hygiene effects remained significant and students with good sleep hygiene 
practice were 4 times more likely to have good sleep quality.  
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5.3. Phase 2: Healthcare providers’ perspective and experiences with insomnia 
management at primary healthcare centers in Qatar 
This phase of the study has helped in shedding the light on HCPs perspectives 
and experiences with insomnia at PHCCs in Qatar. This is the first study in Qatar 
exploring the diagnostic and management approaches for insomnia, in an effort to 
identify important gaps in the provision of insomnia care to patients accessing primary 
care services.  
Overall, HCPs viewed insomnia as a relatively common problem which they 
deal with on daily basis in their practice. Insomnia presentations appear to be 
particularly common among elderly patients, teenagers and individuals with chronic 
diseases or mental illnesses. It is well known that elderly people are often more  
susceptible for insomnia which often coexists with other of chronic illnesses such as 
physical disabilities, respiratory problems and depressive symptoms (38,238). Since 
primary healthcare corporation is the main provider of care for the management of 
chronic diseases in Qatar, insomnia related to chronic illnesses is expected to be 
common among PHCCs’ attendants (239). This finding is consistent with the 
characteristics of insomnia patients reported previously from PHCCs in other countries, 
which confirms that this is a universal problem which is not likely to be affected by 
culture (191,198). Additionally, the observed prevalence of insomnia among 
adolescents and high school students is specifically linked to the physiological changes 
and psychological problems which are common in this age group (240,241). The 
academic workload coupled with the psychological stress associated with transition to 
adulthood and early school schedules compromises sleep quality and quantity in this 
population (240,242).  
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The emerging themes from the HCPs interviews highlighted the importance of 
insomnia as a health problem which requires management at primary care. Overall, it 
was evident that HCPs recognized the detrimental consequences of sleep deprivation 
including its effects on daytime performance and productivity. It was suggested that 
patients often seek out medical attention when they feel that their sleep problem is 
affecting their lives or when their attempts to manage the problem on their own fails. 
This was also shown in previous studies which suggested that patients consult their 
HCPs about insomnia when its effects on their lives become evident (195,199). These 
findings highlight the need for enhancing public awareness about the importance of 
sleep and the key indicators of sleep problems for which patients need to seek medical 
attention. Therefore, PHCCs could play an important role in improving public’s 
attitudes towards sleep by providing routine sleep health education.   
However, there was also some a sense of dissatisfaction with the amount of 
attention insomnia complaints were currently getting at PHCCs. Perceptions that both, 
some HCPs as well as some patients, did not take insomnia seriously emerged from 
these interviews.  Similar reports have been observed in other studies, reporting that 
patients were not satisfied with the current approach for insomnia management and 
suggesting that they often felt that their sleep complaints were not taken seriously by 
HCPs (199). From their experience, HCPs suggested that patients usually come with 
complaints of tiredness, headache, dizziness or lack of concentration while other 
complain of their inability to have good sleep. However, it was harder for pharmacists 
to spot insomnia patients probably because they usually do not receive complaints about 
sleep problems from patients. Previous research studies have shown that patients tend 
to hide their sleep concerns and avoid disclosing them even to physicians, thus routine 
  
164 
 
assessments and queries on sleep by HCPs including pharmacists should occur along 
with regular questioning about lifestyle habits which affects health in primary care 
settings (15,48,192,193,243).  
HCPs generally perceived insomnia as a symptom of an underlying problem 
which could be either physical, psychological or medication related. In this study the 
interviewees predominantly linked insomnia to anxiety and depression. It was also 
suggested that depression and anxiety are responsible  for around 50% of the insomnia 
cases seen in practice (53). As a matter of fact, depression and anxiety are known to be 
the two most common mental health problems at PHCCs in Qatar affecting up to 36% 
of Qatari patients (68,244). These findings are also consistent with those derived from 
similar studies which suggested that HCPs at primary care settings usually considered 
insomnia to be  secondary to another problem and often stress on the importance of 
identifying the cause of insomnia (191,195,198,199). As a result, the treatment of the 
perceived cause of insomnia appears to be the priority, while insomnia itself may be 
left without being addressed until later stages in the management process. 
This attitude towards initiating insomnia management  seems to be a common 
practice in primary care settings as studies from other countries (Australia and the UK) 
have also reported that HCPs prefer to treat the perceived cause of insomnia first 
(191,195,198). However, this practice is not supported by evidence from the literature 
as it was shown that traditional  treatments of depression often fail to resolve insomnia 
symptoms in up to 50% of the patients (245). Moreover, baseline insomnia was 
identified as a significant predictor of improvement in psychiatric illnesses after therapy 
while subjective sleep quality predicts the risk of depression recurrence                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
(245,246). The current practice is also against the directions of the latest insomnia 
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guidelines which  abandoned the old primary/secondary classification of insomnia and 
recommended treating insomnia as an independent health problem (10,13). Some 
studies have even suggested that treating insomnia first could be beneficial in preparing 
patients for further treatment of the comorbid psychiatric illness (247). Therefore, this 
indicates that the currently followed treatment approach in PHCCs which depends on 
treating comorbid conditions only is not optimal and opposes the evidence in the 
literature. 
Furthermore, the interviewees indicated that routine mental health assessments 
were performed for all patients attending PHCCs. This suggests that they probably 
perceived that the diagnosis of mental illnesses would facilitate the identification of 
insomnia cases. HCPs also believed that physicians were provided with adequate 
training to deal with mental illnesses but highlighted the need for additional training on 
sleep medicine and insomnia management. This is consistent with the 
recommendations of previous studies which also identified the need for enhancing 
HCPs knowledge and skills in insomnia diagnosis and management (195). It is worth 
mentioning that many of the PHCCs’ staff have received mental health training in 
preparation for the identification of mental illness (75).  
The HCPs interviewed also acknowledged that sleep habits and social factors 
could contribute to the development of insomnia. It was suggested that some poor sleep 
hygiene practices including late sleeping time and daytime sleeping were normalized 
by culture and due to that they were often acceptable. Similarly, other habits such as 
stimulants consumption at night were also considered to be common among insomnia 
patients. This was also shown in previous research studies which suggested that 
differences in sleeping habits between different countries, races and ethnicities could 
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be explained by the cultural differences (248–250). Yet, the extent of Arabic culture’s 
influence on sleep habits has not been explored previously.  
There was a consensus among HCPs in this study that insomnia management 
should be initiated at primary care settings which were believed to be qualified to 
manage simple insomnia cases. However, a predominant sense of lack of preparedness 
was also detected among the HCPs interviewed. This was mainly related to the lack of 
knowledge and resources including guidelines, training, and medications to help with 
insomnia management. Therefore, referral to specialized institutions such as the mental 
health hospital was a preferred option for most HCPs, especially for complicated 
insomnia cases that fail to respond to the initial therapy. The referral was also 
recommended to provide patients with the chance of meeting a specialist who could do 
further assessment and prescribe insomnia specific treatments which are not available 
at PHCCs. In contrast, referral to specialized institutions was not common among Saudi 
physicians despite their reported poor knowledge of sleep problems’ management 
(251). These findings highlight the need for professional training on the importance of 
screening for sleep problems and the recommended management strategies.  
Some physicians also indicated that they refer their patients internally to the 
mental health clinics which were recently opened at PHCCs to receive CBT. The mental 
health clinic is run by a psychiatrist who comes once weekly to meet patients referred 
to the clinic. Additionally, some PHCCs now have a support clinic which is run by a 
team that consists of a psychologist and a social worker who provide patients with 
psychological therapy including rehabilitation to enable them to function optimally 
within the community (75). Yet, many of the HCPs interviewed were unaware about 
the availability of this service, which suggests that more work is needed to spread the 
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awareness about mental health services among HCPs working at PHCCs. On the other 
hand, those who knew about the service thought that it was useful as they perceived 
that it may help in reducing the stigma associated with mental illnesses. Interestingly, 
studies from primary care practices in Australia and the UK have also suggested that 
physicians rarely refer their patients to receive behavioral therapy at specialized clinics 
(e.g. sleep clinics or mental health clinics) (195,198). The few referrals to these clinics 
mostly involved individuals with sleep apnea or comorbid psychiatric illnesses (58). To 
enhance the utilization of mental health services available at PHCCs it is recommended 
to familiarize HCPs with the role of these clinics in the management of mental disorders 
including psychological and behavioral therapies available through lectures, posters 
and flyers.  
The identification of sleep problems could happen during the history taking 
process, as some of the HCPs indicated that they might ask briefly about sleep as part 
of their general patient assessment. History taking is also important to help in 
determining the underlying cause of insomnia (252). HCPs acknowledged the 
importance of building a rapport with patients before asking about sleep. This was 
mainly because questions about sleep and lifestyle could be too personal for some 
patients; especially that sleep problems are often linked to mental illnesses. Other HCPs 
suggested that discussing sensitive issues with patients might require more than one 
appointment (199).  
It was suggested that the identification of insomnia in patients attending PHCCs 
might be difficult due to the absence of reliable diagnostic tools and questionnaires for 
insomnia assessment in clinical practice. Due to that, the assessment of insomnia is not 
part of the routine practice at PHCCs and is only explored if sleep problems were 
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suspected. Lack of screening services and resources for sleep problems has also been 
reported in other countries such as Australia and Saudi Arabia (191,251). The current 
health assessment practices followed at PHCCs often fail to identify insomnia patients 
and were found to be less effective than validated instruments in diagnosing insomnia 
(253,254). Diagnostic tools are important to provide HCPs with standardized criteria 
for insomnia assessment and diagnosis thus, eliminating subjective differences in the 
diagnostic process. Other studies from primary care have also recommended the 
incorporation of simple diagnostic instruments such as the ISI into the routine history 
taking conducted by primary care physicians (191). The evidence available also 
suggests that the accuracy of insomnia assessing questionnaires is comparable to that 
of polysomnography (255). Regular integration of these tools into the assessment 
process would help in the early recognition of sleep complaints, which in turn may 
improve individual’s health, cognitive function and quality of life hence avoiding 
deterioration to chronic insomnia (256). 
HCPs reported that medications specifically indicated for insomnia treatment 
were not available at PHCCs in Qatar, and that other classes of psychiatric disorders’ 
medications including antidepressants and anxiolytics were often dispensed for 
insomnia patients. Interestingly, the interviewees were generally satisfied with the 
treatment options available at PHCCs as they believed that hypnotics should only be 
available at more specialized health institutions. This finding supports the notion that 
HCPs’ view insomnia as a symptom which could improve if the underlying cause was 
treated, but also suggests that there is suboptimal insomnia management as some 
participants indicated that they prefer using antidepressants or antipsychotics for 
insomnia management. Despite the fact that these agents are not approved for insomnia 
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treatment and most guidelines do not recommend their use, as the benefits of these 
agents do not outweigh the associated risks including side effects  (191). 
Overall, HCPs interviewed expressed hesitance about prescribing and 
dispensing hypnotics, and suggested that prescribing authority for these agents should 
only be granted to individuals with enough knowledge and experience in dealing with 
these medications. In addition, many HCPs believed that medications were not the 
solution for insomnia, and only worked as a quick fix without lasting effects. HCPs 
were also specifically worried about the safety of hypnotics which are also known to 
cause dependence and tolerance (195). This was consistent with the findings of 
previous studies which reported that HCPs often hold negative perceptions on the use 
of hypnotics for insomnia management (191,195,198,257,258).  
Due to the lack of hypnotics at PHCCs, some HCPs indicated that other 
medications including antidepressants and antihistamines were often prescribed for 
transient insomnia. Other studies have also shown that some HCPs prefer prescribing 
sedative antidepressants because of the perceived safety with long term use as 
compared to hypnotics (191,258). While others were not comfortable with the use of 
these medications (i.e. antidepressants and antihistamines) for insomnia because they 
were not approved for this indication and due to lack of evidence on efficacy in the 
literature. This contrasts with the findings of a study from the UK which indicated the 
preference of antihistamines for insomnia management due to the safety of these 
medications (258). It was previously reported that  HCPs  expect that patient coming 
with a sleep complaints to have tried other simple treatment options and therefore might 
feel obliged to prescribe medications (199). Generally, HCPs in this study were aware 
that pharmacological therapies should be used for short term only.   
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However, there were also concerns raised regarding the limited medications 
available at PHCC to treat insomnia and was viewed as problematic for patients who 
will need to go through the lengthy referral process before they can get appropriate 
treatment. Consistent with findings from similar studies, some of the interviewed HCPs 
indicated that prescribing hypnotics was a direct result of  patients’ pressure and 
demand for medications, and highlighted  the need for regular follow-ups with insomnia 
patients to monitor their response to therapy (191,195,198,257). However, maintaining 
regular follow-ups was perceived to be difficult since most patients come looking for a 
quick solution and many of them do not return after referral to specialized institutions. 
These findings, coupled with the prescribing hesitancy described above, further 
highlight the need to develop local clinical guidelines that include patients’ treatment 
expectations for improving physicians’ therapeutic skills at PHCCs. 
Among the HCPs interviewed, there was a predominant preference for the use 
of non-pharmacological therapies for managing insomnia, in particular, sleep hygiene 
education. The preference for non-pharmacological therapies for insomnia 
management seems to be a common treatment pattern in primary care settings 
(191,195,198,254). Previous studies have consistently shown that HCPs at primary care 
usually provide advices related to healthy sleep habits while medications are used only 
when non-pharmacological therapies are not effective (195). However, some 
physicians from previous studies expressed their concerns about patients’ acceptance 
of sleep hygiene advices as some worried  that patients may perceive that their 
physicians are not taking their complaints seriously, while others doubted that their 
patients would follow sleep hygiene recommendations (195,199). Studies from primary 
care settings are collectively suggesting that behavioral therapies are more efficacious 
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for insomnia management than sleep hygiene alone (259). One study in particular has 
shown that 6 weeks of CBT-I was sufficient to treat  insomnia in 88% of patients who 
received the therapy (200). Likewise, A meta-analysis of 22 trials which evaluated the 
effects of CBT-I on insomnia management concluded that of CBT-I delivery  for 4-6 
weeks helped in improving almost all sleep outcomes including sleep quality (63). CBT 
for insomnia was proven to be effective not only in treating sleep problems but also in 
improving symptoms of comorbid psychiatric illnesses (200,247,260,261). 
Additionally, CBT-I reduces the need for sleep medications as compared to sleep 
hygiene alone (200,261). These findings suggest that the efficacy of sleep hygiene alone 
is limited, and that CBT-I is more effective for insomnia management.  
However, there was an overall perception among HCPs in this study that CBT-
I, despite being the first line treatment for insomnia according to most guidelines, is 
rarely used in practice; a finding that has also been consistently reported in the literature 
(10,11,13,191,195). Only few of the HCPs referred their patients to the support clinic 
where CBT services are offered by a certified psychologist, simply because many of 
them were unaware about the availability of this new service, a finding that was also 
reported in a previous study (75).  Inadequate knowledge about insomnia treatments 
and guidelines’ recommendations may also be responsible for the suboptimal 
utilization of this service (195). These findings suggest that the development of local 
policies to guide insomnia management should recommend the use of sleep hygiene 
not as a monotherapy but rather as a component of other more effective behavioral 
therapies such as CBT-I. One benefit of the CBT-I, as reported by patients, is that it 
enables deeper understanding of sleep hygiene and helps people in changing their old 
habits though trying different techniques until they find the best approach for them 
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(262).  
The themes that emerged in regards to the HCPs’ perceptions of their role in 
insomnia management were mostly in line with traditional practice models by which 
insomnia’s assessment, diagnosis and treatment were considered the physicians’ role, 
and medication dispensing along with some counselling were regarded as the role for 
pharmacists. This was also reported in other studies, indicating that primary care 
settings being the first point of contact with the healthcare system, patients often tend 
to discuss their sleeping problems with physicians rather than pharmacists (194). 
However, previous studies have also reported that pharmacists often thought that 
physicians were not spending sufficient time educating their patients about healthy 
sleep or on the adequate use of hypnotic (198). In this study it was also suggested that 
physicians should have a greater role in providing non-pharmacological treatment 
options for insomnia patients. Pharmacist respondents highlighted that they respond to 
questions mostly from physicians about drug specific information including 
availability, efficacy, safety or the choice of therapy in specific clinical situations. 
However, pharmacists perceived consultations relating to insomnia management were 
generally rare at their practice sites. Nevertheless, there is still a potential role for 
pharmacists in the detection and management of sleep problem especially those 
involving medications. Research in other countries have shown that pharmacists could 
be trained to contribute to the detection, management and promotion of public 
awareness regarding insomnia (263,264). Pharmacists involvement in screening of 
patients with sleep complaints would help in the early identification of insomnia 
patients who would then be referred to physicians for in-depth assessment and 
treatment. Pharmacists from a previous study indicated that they often refer their 
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patients with sleep complaints back to physicians for further assessment and 
management (198). Expanding the pharmacists’ role would also help in reducing the 
workload on physicians at primary care, thus giving them with more time to spend with 
patients having serious health problems.   
Pharmacists indicated that they have several opportunities which they could use 
to identify sleep problems and manage them. The most common opportunity of 
interaction between pharmacists and patients is during medication dispensing in which 
pharmacists could identify drug related problems. Medication related problems 
affecting sleep could also be identified during the intensive medication reconciliation 
process in which the pharmacists engage with patients to take their medications’ 
history. When such problems are identified, pharmacists contact physicians and 
recommend modifying the treatment regimen. pharmacists also address patients’ 
questions relating to the safety of medications including issues about the dependence 
and withdrawal syndrome. Addressing patients’ concerns and solving their drug related 
problems could contribute to enhancing the patients’ medication adherence and 
improving their treatment outcomes. 
 Interestingly, it was suggested that pharmacists could also play a role in 
addressing patients’ concerns and supporting them psychologically while dispensing 
medications. Additionally, some patients may develop a trusting relationship with a 
specific pharmacist with whom they discuss their problems and concerns. Considering 
the short duration of interaction between pharmacists and patients at PHCCs, it seems 
surprising that a relationship could be developed.  However, it was suggested that 
mutual personal disclosure between patients and HCPs plays an in important role in 
building trust between the two. This could happen during short conversations through 
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which the patient connect with pharmacists on a personal level and as a result opens up 
to them (265). In fact, patient’s perceptions of their pharmacists’ trustworthiness 
influences their willingness to collaborate and share personal information (266). It was 
also noted that patients’ satisfaction with pharmacists’ expertise is also influenced by 
the relationship quality and the level of trust in the pharmacist. This suggests that 
patients who trust their pharmacists are more willing to discuss sensitive issues with 
them and tend to view their pharmacists as competent and knowledgeable. Studies from 
primary care settings in Qatar showed that patients view pharmacists as a reliable 
source for medication related information but they did not expect them to have a role 
in the management of their health problems (267). Additionally, most patients indicated 
they trusted physicians more than pharmacists and therefore they mostly consulted 
physicians for  drug related questions (267,268). The lower trust in pharmacists could 
be related to lack of public’s awareness of the broader role of pharmacists in the 
healthcare system which extends beyond medication dispensing to the provision of 
patient care. Also, the current system in PHCCs in which pharmacists only dispense 
medications prevents patients from having meaningful interactions with pharmacists.  
It is worth noting that pharmacists frequently talked about physicians’ role 
during their discussion of insomnia management while physicians rarely discussed the 
role of pharmacists in relation to insomnia treatment. These findings suggest that 
overall, physicians in Qatar support more traditional roles for pharmacists. This  was 
also reported in a previous study conducted at a primary care setting in Qatar which 
discovered that physicians often perceived pharmacists’ role to be limited to medication 
counselling and checking for prescription accuracy, rather than involving any 
consultative role relating to optimization of patients’ drug therapy (269).  In another 
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study physicians indicated that pharmacists’ role should not exceed responding to drug 
related questions and patient education (198). These observations may also help in 
explaining the low number of consultations reported by pharmacists in this study.  
HCPs interviewed identified several challenges which limit their ability to 
manage insomnia adequately in PHCCs. One of the important challenges identified was 
related to the lack of time, as both physicians and pharmacists agreed that the amount 
of time they spend with patients is often not enough to address sleep problems, a finding   
that was also reported in previous studies (198,199). As a result, insomnia may not be 
discovered and managed appropriately leading to the development of chronic insomnia 
which is more difficult to treat. One of the proposed solutions for this problem was to 
increase the duration of the appointments for patients presenting with sleep complaints. 
This problem could also be addressed by delegating some of the physicians’ duties to 
other healthcare professionals (e.g. pharmacists, nurse or health educator) as part of a 
new service model that targets patients with complicated disease conditions including 
insomnia. Additionally, assigning the medication dispensing duties to pharmacy 
technicians would give the pharmacists more time to provide clinical services  (e.g. 
medication history taking, identification of drug related problems and patient 
counselling) for the management of various health conditions (270). 
Pharmacists also indicated that their opportunity for managing insomnia in the 
pharmacy is often limited by the lack of privacy. This was also identified in a previous 
study in which pharmacists suggested that their work environment  prevents them from 
providing optimal care for insomnia patients (198). This was also supported by the 
findings of a study that was conducted in Qatar in which patients indicated that lack of 
privacy at the pharmacy was one of the barriers that prevented them from asking 
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questions (267). Despite the availability of consultation rooms in some healthcare 
centers, only few patients are referred to these rooms. Referrals are mostly restricted to 
patients with complex medication regimens and multiple comorbidities, thus excluding 
a wide range of insomnia patients who might not fit in this category. Importantly, 
pharmacists acknowledged the need for additional patient education in relation to sleep 
problems.  
Furthermore, pharmacists’ contribution to the management of insomnia was 
often limited due to their worries about crossing the professional boundaries with 
physicians. Pharmacists believed that physicians had the lead role in the management 
of insomnia at PHCCs and felt that their advices and consultations might be considered 
as an additional and unnecessary intervention. Nevertheless, the collaboration between 
pharmacists and physicians is necessary to enhance patients’ treatment outcomes. In 
fact, the interprofessional collaboration between physicians and pharmacists at primary 
care settings could help in improving the identification and management of insomnia. 
Particularly, one study reported that the integration of pharmacists into family medicine 
practice model resulted in the identification of drug related problems in around 94% of 
the patients assessed (271).  
Another important barrier to the management of insomnia which was reported 
by HCPs in this study was related to the unavailability of guidelines for insomnia in 
PHCCs in Qatar. This is consistent with the findings of previous studies which 
recommended developing guidelines for insomnia in primary care settings (191,198). 
It was also suggested that some physicians may avoid asking about sleep problems due 
their uncertainty about the optimal treatment approaches for insomnia, especially in the 
absence of  clear guidelines (191).  However, the findings have shown that some of the 
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pharmacists were unaware about the lack of insomnia guidelines in their practice site 
which suggests that they may not have had the chance to search for these guidelines 
and use them in practice.  
A direct result to the lack of insomnia guidelines is the variability in the 
management approaches between different HCPs which increases the chance of using 
inappropriate treatments which could be ineffective. This was evident in the present 
study, in which the lack of evidence-based guidelines resulted in the frequent use of 
medications not known to be effective for insomnia, whereas the first line treatment for 
insomnia, CBT-I, which is proven to be effective was rarely recommended. 
Additionally, insomnia might be perceived as being unimportant problem by some 
HCPs due to the absence of local treatment policies, which could result in prioritizing 
the management of other health problems leading to insomnia deterioration. Thus, the 
introduction of clear guidelines focusing on the latest, evidence-based approaches for 
insomnia assessment and treatment might help in encouraging the early recognition and 
treatment of insomnia. Moreover, evidence available emphasized the need for 
enhancing physicians capacity and skills to provide the required non-pharmacological 
insomnia therapies in general practice settings (270).  
Another important challenge highlighted was related to patients’ attitudes and 
beliefs about sleep problems. Recounting their previous experiences, the HCPs 
interviewed indicated that insomnia is mostly a hidden complaint and is rarely 
presented as the chief complaint during patients’ presentation. The  lack of insomnia 
reporting  by patients at primary care has been repeatedly reported in previous studies 
(15,48,192,193). Possible explanations for this include patients’ view of insomnia as a 
trivial problem and their fear of linking their sleep problems with mental health issues. 
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This is consistent with the findings of other studies which reported that patients with 
insomnia tend to avoid seeking professional help due to their worry about how the 
society would view them (193). It was also suggested that the stigma against insomnia 
and mental illnesses influences treatment choices, as some treatment alternatives might 
be considered invalid because of  the stigma associated with them (194,272,273). 
Stigmatizing beliefs and attitudes against mental illnesses and their treatments are also 
common among Arabic populations (274). As a result, patients may refuse referral to 
specialized institutions such as the mental health hospital due to their fear of being 
labelled as mentally ill individuals by the society. Considering that sleep assessment is 
not part of the routine medical examination at PHCCs, sleep problems not reported by 
patients would probably be missed and untreated (191). These findings indicate that 
patients tend to delay seeking professional help for sleep problems while guidelines are 
recommending the early recognition and management of insomnia (256). Therefore, it 
is the responsibility of the healthcare system to account for patients’ expectations and 
experiences while developing guidelines for insomnia management to optimize the 
patient care (270).  Also, HCPs should be encouraged to be more proactive in the 
assessment of sleep problems which should be done routinely.  
Overall, all HCPs interviewed recognized the need for training physicians to 
prepare them for the diagnosis and treatment of sleep problems. Physicians suggested 
that this training could be offered as part of their regular CME sessions. The need for 
HCPs training on insomnia management was also identified in other studies 
(195,198,251). The findings of this study have consistently shown that physicians are 
often reluctant to use pharmacological treatments for insomnia and rather prefer 
offering non-pharmacological management in the form of sleep hygiene education. 
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However, patients were only given counselling on sleep hygiene and not CBT-I. Some 
HCPs also expressed their uncertainty about the effectiveness of CBT when used for 
insomnia treatment. These findings suggest that despite the perceived benefits of non-
pharmacological treatment options, HCPs at PHCCs require additional training and 
resources to enable them to use these interventions.  
Moreover, HCPs recommended opening sleep clinics at PHCCs to improve the 
management of sleep problems. It was suggested that these clinics should be managed 
physicians specifically trained in sleep medicine. Sleep health education currently 
provided for health sciences students seems to be insufficient worldwide and in Arab 
countries, therefore there is a need to focus on improving  sleep related content of health 
sciences’ curricula to enhance the awareness of future HCPs about the importance of 
sleep problems and their management (275–277).  
 
 
5.3.1. Strengths and limitations 
 Insomnia and its management have not been explored in sufficient detail in 
previous studies conducted in Qatar. To our knowledge, this is the first qualitative study 
in the published literature that has been undertaken to investigate the perspectives and 
experiences of HCPs with insomnia management in Arab countries. The study has 
helped in clarifying the current approaches for management of sleep problems at 
primary care settings and highlighted important gaps and practice barriers which may 
limit how insomnia is prioritized and managed in primary care.  
This study has also included a diverse group of healthcare providers from 
various PHCCs including individuals with additional mental health qualifications (i.e. 
  
180 
 
psychiatrist) and training. The number of participants included in the study was enough 
to achieve the saturation. Moreover, exploring the perspectives of two professions 
within the primary care setting has helped in viewing the insomnia problem from two 
different perspectives, enabling the comparison between the perceptions and roles of 
the two different healthcare professionals.  
Another strength of this study was related to the coding process, which was 
done by one researcher, thoroughly reviewed together with a second researcher and 
then reached consensus through discussion with a set of three researchers. However, 
this study is limited in that patients’ perspectives of insomnia and their experiences 
with treatment were not explored and only HCPs points of view were described. 
Additionally, perspectives of community pharmacists who are easily accessible by 
members of the community were not included in this study due to time constraints. 
Since this study is qualitative, the findings are not in any way generalizable and only 
represent the perspectives of the sample interviewed.  
Another potential limitation to this study is related to the interviewer bias, as it 
expected that the interviewer’s perceptions and expectations might have influenced the 
way of asking questions and guiding the interview. However, considering that all the 
interviews were conducted by the same researcher, the effect of this factor was probably 
uniform throughout the interviews.  
 
 
5.3.2.  Recommendations for future research 
This study has helped in clarifying how HCPs at PHCCs manage insomnia and 
identified the barriers they face in their practice. However, future investigations 
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utilizing quantitative methods would provide more objective information in regards to 
the prevalence of insomnia at PHCCs, the associated risk factors, and specific 
management strategies for insomnia. The findings of this study suggested that many 
insomnia patients are referred to secondary institutions, therefore conducting future 
studies to investigate the management of sleep problems at those institutions can 
provide a more insight into current pharmacological and non-pharmacological 
strategies in the management of insomnia in Qatar.  
Overall, the interviews conducted highlighted important gaps in the current 
diagnosis and management approaches for insomnia at PHCCs in Qatar. First of all, the 
assessment and management of sleeping problems in the current practice is highly 
variable and depends on HCPs clinical judgment as no clear guidelines are available in 
these settings. Additionally, HCPs lack confidence in insomnia management at PHCCs 
primarily because they perceive their knowledge and experience with these issues as 
insufficient. To improve the management of sleep problem at primary care HCPs 
should receive adequate training and they should be supported with the development of 
clear guidelines and the provision of diagnostic tools for insomnia.  
Expanding the role of other HCPs (e.g. pharmacists) to be involved in the assessment 
of sleeping problems and patient monitoring is also important. There is also a need to 
enhance the collaboration between HCPs and psychologists at PHCCs to facilitate 
patients’ referral for behavioral therapies. Considering the important role of patients in 
the identification of sleep problems it would be important to enhance the public 
awareness about the importance of sleep and the consequences of sleep problems 
through launching campaigns and initiatives focusing on sleep.  
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5.3.3. Conclusion 
In conclusion, HCPs in this study viewed insomnia as an important health 
problem, yet several gaps preventing the adequate provision of insomnia 
assessment and management at PHCCs in Qatar emerged from the interviews. 
HCPs appear to be hesitant to prescribe medications and prefer educating patients 
on sleep hygiene. Additionally, hypnotics are not available at PHCCs and therefore 
medications not indicated for the management of insomnia are sometimes 
prescribed. Overall, there was a general sense among HCPs at PHCCs of being 
inadequately prepared for providing treatments as recommended in guidelines, such 
as CBT-I, and preference was to refer patients to specialized settings. Time 
constraints, lack of clinical guidelines and patient attitudes are some of the 
challenges to insomnia management identified by the HCPs in this study. 
Developing guidelines for insomnia, training HCPs and implementation of a sleep 
clinic were some of the suggestions provided to improve the management of sleep 
problems in PHCCs.  Future research is warranted, particularly to explore strategies 
that can close the gaps in insomnia care that have been identified through this 
investigation at PHCCs in Qatar. 
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APPENDIX A. COMPLETE DATABASE SERACH   
 
Table 1. PubMed (1966- April 2018) 
Date 
Combination of terms used  
Results  Limitations Results 
after 
limitation  
28/3 (sleep disorders AND insomnia*) AND 
(Instrument OR questionnaire OR measure OR 
scale) 
3786 Observational studies, 
validation studies  
human studies 
English  
Arabic  
Adults (19-65+) 
99  
 
28/3 (Insomnia OR sleep deprivation) AND 
(Instrument OR subjective measure OR 
questionnaire) 
 
6387 Validation studies  
Observational studies  
Human 
English 
Arabic  
Adults (19-65+)  
148 
 
7/4 (sleep quality OR dyssomnias OR daytime 
sleepiness) AND (instrument OR questionnaire 
OR scale) 
23529 Validation studies  
Human  
English  
Arabic 
Adults (19-65+) 
394 
 
 
7/4 
(Sleep hygiene OR sleep habits OR sleep 
practices) AND (Instrument OR questionnaire 
OR measure*) 
3258 Validation studies  
Observational studies  
Human 
English  
Arabic 
Adults (19-65+) 
40 
 
 
28/3  
(("sleep arousal disorders" OR "sleep 
disturbance") AND insomnia* OR sleepiness) 
AND (Instrument OR questionnaire OR scale OR 
measure) 
15989 
 
Validation studies  
Human 
English   
Arabic 
Adults (19-65+) 
135 
 
 
7/4 
("sleep efficiency" OR "sleep dissatisfaction") 
AND (Instrument OR questionnaire OR scale OR 
measure) 
1480 
 
Validation studies 
Observational studies  
Human 
English  
Arabic 
Adults (19-65+) 
41 
 
7/4 ("sleep disorders" OR " sleep quality" OR " sleep 
deprivation" OR "sleepiness" OR " insomnia" OR 
"sleep dysfunction" OR "dyssomnias" OR "sleep 
arousal disorders") AND (instrument OR tool OR 
scale OR questionnaire OR survey OR "patient-
reported outcomes") AND ("validation studies" 
OR "psychometric properties") 
451 No study limits  
 
Human  
English  
Arabic  
Adults (19-65+) 
 
320 
Total number of articles = 1,197  
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Table 2.  Complete Database search. Embase (1980- April 2018) 
Date 
Combination of terms used  
Results  Limitations Results 
after 
limitation  
26/3 ('sleep arousal disorder'/exp OR 'sleep arousal 
disorder' OR 'insomnia'/exp OR 'insomnia' OR 'sleep 
quality'/exp OR 'sleep quality' OR 'daytime 
somnolence'/exp OR 'daytime somnolence') 
 AND 
 ('questionnaire'/exp OR 'questionnaire' OR 
'scale'/exp OR scale OR measure) 
 AND 
 ('validation study'/exp OR 'validation study') 
204  Diseases: 
Insomnia, daytime 
somnolence and sleep 
disorders  
Somnolence  
 
-Human  
-questionnaire  
Validation studies 
Observational studies 
 
-cross sectional  
-Validation process  
- 
Age (young adults to 
very elderly)  
 
Publication type: 
Articles  
Conference abstracts 
Conference papers 
Reviews  
 
109 
27/3 ('sleep hygiene'/exp OR 'sleep hygiene' OR 'sleep 
habit' OR 'sleep practices') 
 AND  
(instrument OR 'questionnaire' OR scale OR measure
)  
AND 
 'validation' 
26 Diseases: 
Insomnia, daytime 
somnolence and sleep 
disorders  
Somnolence  
 
-Human  
-questionnaire  
Validation studies 
 
-Instrument validation  
 
-Validation process 
-cross-sectional, 
retrospective studies  
 
Age (young adults to 
very elderly)  
 
Publication type: 
-Articles  
 
-Conference abstracts  
7 
(alert) 
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27/3 
('sleep habit'/exp OR 'sleep habit' OR 'sleep 
hygiene'/exp OR 'sleep hygiene') 
 AND 
 ('questionnaire'/exp OR 'questionnaire' OR 
'survey'/exp OR 'survey')  
*The option (search as broadly as possible was 
selected from the Embase mapping options) 
864 
 
(525 
articles 
from 
Embase, 
116 from 
Medline)  
 
223 
(both) 
Diseases: 
Insomnia, daytime 
somnolence and sleep 
disorders  
Somnolence  
 
Study type:  
-Human  
-questionnaire  
-longitudinal studies  
-structured 
questionnaires  
-cross-sectional,  
-Prospective studies 
 
Publication type: 
All (including 
conference abstracts, 
conference papers and 
review)  
 
(except letter and 
editorials)  
 
Age (young adults to 
very elderly)  
 
258 
 
(91 from 
Embase)  
 
27/3  
('insomnia'/syn OR 'sleep quality'/syn OR 'sleep 
disturbance'/syn)  
AND  
'questionnaire'/syn  
AND 
 'validation'/syn 
980 Diseases: 
Insomnia, daytime 
somnolence and sleep 
disorders  
Somnolence  
Drowsiness  
 
 
Study type:  
-Human  
-questionnaire  
-validation studies 
-validation process  
- Instrument validation  
-cross-sectional,  
-Prospective studies 
 
 
 
Publication type: 
Articles, conference 
abstracts, conference 
papers  
330 
(Alert) 
EMBASE Total =706  
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APPENDIX B. INTERVIEW GUIDES  
  Physician’s Interview Guide (English version) 
Theme: Overall perspective and experience related to insomnia 
1) From your experience, please describe the type of insomnia presentations in 
your everyday practice?  
• Approximate number of patients who present with insomnia symptoms every 
week. 
• The proportion of patients for whom insomnia is the primary reason to come 
to PHCC (how many patients presenting with insomnia as their only problem). 
• Proportion of patients who present with different types of insomnia (e.g. 
transient or persistent/chronic, primary, comorbid, etc.). 
• What is your view of insomnia as a medical condition? (Is it an important 
health problem which must be solved immediately or is it a problem that the 
patient should manage on their own, there is no need for medical attention? 
• What comes to your mind when a patient complains of insomnia? 
• In your opinion, should insomnia be managed at primary healthcare centers or 
at more specialized institutions (e.g. mental health hospital, HMC…etc.)? 
 
Theme: Assessment and diagnoses of insomnia 
2) What are the difficulties you face when diagnosing a patient with insomnia at 
your practice site? 
• Is the assessment of sleep problems part of the routine practice at PHCCs?  
• How do you diagnose insomnia? 
• Do you follow a specific diagnostic algorithms or local guidelines to 
diagnose insomnia? 
• What is your opinion about the usefulness of the guidelines available at your 
institution? (e.g. Are these guidelines useful for distinguishing between 
different sleep problems and accurately diagnosing the condition?) 
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- If no guidelines are available at your center are you aware of any other 
guidelines?  
- If no guidelines are available at your center for insomnia management, 
what are the reasons for that?   
• Which are the complaints patients present with when they come to see you 
for insomnia?  
• What do you feel makes patients decide to visit a healthcare professional for 
insomnia complaint? 
• What causes of sleep problems do you commonly consider in your assessment 
of patients with insomnia? 
• What strategies do you use to determine the underlying cause? 
• From your experience, when a patient presents their sleeping problem along 
with other complaints (e.g. chronic pain or other medical conditions), how do 
you prioritize these problems? (e.g. would you manage insomnia first or the 
medical condition first?)  
- In such cases how often do you decide to treat insomnia first?  
- In what case scenarios do you delay the management of insomnia and for 
what reasons?  
 
Theme: Treatment Approaches 
3) What treatment options do you discuss with your patients? 
• What makes you decide to provide a treatment option (pharmacological or 
non-pharmacological)?  
• What is your opinion about the treatment options available for insomnia at 
your institution? 
• What are the challenges you face when treating a patient with insomnia? 
• Some medications for sleep problems might be available at HMC pharmacies 
only. Is it possible for you to prescribe these medications for your patients? 
- What is the process that you follow to prescribe these medications for 
your patients?  
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• Do you prescribe medications available in community pharmacies only? (e.g. 
OTC products, non-prescription products) 
• Considering that sleeping problems are common, in your opinion should 
physicians at PHCCs be given more authority to manage sleeping problems on 
their own?  
• What is your opinion about adding benzodiazepines, Z-drugs and other 
hypnotics to the PHCC’s formulary? 
• Is the care provided to patients with sleeping problems continuous (follow-ups 
with doctors or referral to other healthcare providers e.g. psychologists)? 
• When do you decide to refer a patient with insomnia to a different healthcare 
provider?  
- Who are the healthcare providers available to whom patients could be 
referred?  
- What is the referral process?  
- Does the referral process move smoothly? (Is the referral to healthcare 
provider in the same institution or in a different institution?) 
- Approximately how long is the waiting time before the referral to the other 
healthcare providers?  
• What do you know about sleep hygiene? (What are the components?) 
- What is your opinion about the usefulness of sleep hygiene?  
- How frequently do you provide patients who complain of insomnia with 
sleep hygiene advise?  
• What is your knowledge about cognitive behavioral therapy for insomnia 
(CBT-I)?  
- What are the components of CBT-I?  
- Is this service available at your primary healthcare center? (Who provides 
the service, when is it provided and proportion of patients with insomnia 
that receive this service) 
- In your opinion do you believe that you can provide CBT for patients 
with insomnia? (If YES “how”? If NO, “why not”?) 
- Have you ever referred a patient for CBT for insomnia? 
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4) Which educational or training needs do you believe are essential for healthcare 
providers at primary healthcare centers to identify and manage sleeping 
problems? 
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Pharmacist’s Interview Guide (English version) 
Theme: Overall perspective and experience related to insomnia 
1) From your experience, could you describe the profile of patients presenting with 
insomnia complaints?  
• Number of insomnia presentations per week   
• Patient profile: age, gender, other medical conditions 
• Which type of concerns do patients with sleeping problems voice when they 
come to the pharmacy 
• In your opinion, what makes the patient decide to visit a healthcare 
professional to discuss sleeping problems? (Health beliefs, Self-help tried, 
Impact on lifestyle, Work, Relationships, Safety, Feelings, Other people like 
the family, Expectations) 
 
2) What is your view of insomnia as a medical condition? (Is it an important health 
problem which must be solved immediately or is it a problem that the patient 
should manage on their own, there is no need for medical attention?) 
• What comes to your mind when a patient complains of insomnia? 
• In your opinion, should insomnia be managed at primary healthcare centers or 
at more specialized institutions? 
- Is it an important health problem which must be solved immediately or is it 
a problem that the patient could manage it at home?). 
- How serious is insomnia as a condition?  
- Should sleep problems receive more attention from healthcare 
professionals?  
Theme: Treatment approaches 
3) In general, what do you know about the treatment approaches for insomnia? 
4) What are the available treatment options for insomnia management at you setting? 
(Pharmacological treatments and Non-pharmacological means of therapy). 
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• What is your opinion on the variability of treatments available for insomnia 
management at your center?  
• Are the treatments available at your center enough or is there a need for 
adding more treatments for patients suffering from insomnia?  
• Sleep medicines such as Z-drugs and BDZs are not included in PHCC 
formulary, as a pharmacist and a healthcare provider what is your opinion on 
that?   
• Some of OTC treatments for insomnia (melatonin, herbal products such as 
valerian) are not included in PHCC formulary (2017), in your opinion what is 
the reason for that?  
- Do you think including these medications in the formulary might help 
some patients?  
- What is your opinion about these medicines, are they effective, necessary?   
• Which are the most common treatments that physicians recommend for 
managing insomnia at your site? (including pharmacological and behavioral)? 
5) What do you know about sleep hygiene? (What are the components?) 
• What is your opinion about the usefulness of sleep hygiene?  
• How frequently do you provide patients who complain of insomnia with 
sleep hygiene advise?  
6) What do you know about cognitive behavioral therapy for insomnia (CBT-I)?  
• What are the components of CBT-I?  
• Is this service available at your primary healthcare center? (Who provides the 
service, when is it provided and proportion of patients with insomnia that 
receive this service). 
• In your opinion do you believe that you can provide CBT for patients with 
insomnia? (If YES “how”? If NO, “why not”?). 
• Have you ever referred a patient for CBT for insomnia? 
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Theme: Pharmacist’s role in the management of insomnia 
7) What type of consultations do you receive from other health care providers 
regarding managing sleeping problems? (e.g. drug information, management 
strategies, side effects of medications). 
• How commonly do you receive such questions? 
• If the questions relate to medication, are these most often regarding those for 
treating sleeping problems or those that cause/worsen sleeping problems). 
8) Have you ever done an intervention related to a sleep medicine? (e.g. Consulted a 
healthcare provider on removing a medication that worsens sleep, consulted a 
healthcare provider on adding a medication to manage a sleep problem). 
9) Have you ever referred a patient with insomnia complaint to a different 
healthcare provider for further assessment or treatment?  
10) What are the counselling points you provide to a patient complaining of 
insomnia? (e.g. Side effects, indication, other medications, etc.) 
• On average, how often do you provide counseling on sleep medications in a 
week? 
11) What type of counseling do you mostly provide?   (e.g. Sleep hygiene, Cognitive 
behavioral therapy, medication usage, medication side effects, alternative 
medicine, natural products…etc.)  
12)  What are the guidelines available on sleep medicine at your site?  
• If available, how useful are these guidelines?  
• If not available, are you aware of any other local or international guidelines on 
insomnia management?  
• If not available, in your opinion what is the reason for that?  
- Cases of insomnia are not common?  
- Insomnia is not a serious health problem? 
- Patients are expected to manage these problems elsewhere (e.g. at home, 
community pharmacies)?  
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13) Which educational or training needs do you believe are needed for healthcare 
providers at primary healthcare centers to identify and manage sleeping 
problems. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 232
 
   )cibarA( ediug weivretni s’naicisyhP
 
 طباءالأ دليل مقابلة
 
 ة النظر العامة لهذه المشكل خبرة الطبيب مع الأرق و وجهة :الموضوع
ي تراها خلال  خبر تك، صف لنا طبيعة حالات الأرق  ) من1
 ؟ ممارستك اليومية لمهنتك  الت 
  التقريتر ي  العدد •
 .أسبوعيا الأرق أعراض يحض  ون مع  الذين للمرض 
هو السبب الرئيسي لزيارتهم المركز الصحي (كم عدد المرض  الذين  الذين يكون الأرق المرض   نسبة •
 يعانون من الأرق فقط؟). 
، المزمنرق (على سبيل المثال:أرق مؤقت، أرق الأ من مختلفة أنواع مع يأتون الذين المرض   نسبة •
  .الخ) راض اخرى... أرق غبر مصاحب لأمراض اخرى، أرق مضاحب لأم
كيف ترى الأرق كحالة مرضية؟ (هل تعتبر ها مشكلة صحية هامة يجب أن تتم معالجتها  فورا ، أم  •
 طيع المريض حلها بنفسه  دون الحاجة الى تدخل طتر ي ؟هل تعتقد أنها مشكلة يست
 ؟ الأرق  من ما مريض عندما يشكو ذهنك الى يتبادر ماذا  •
ي مراكزبرأيك هل يجب أن تتم  •
ي المؤسسات   الأولية الصحية الرعاية معالجة حالات الأرق ف 
أم ف 
 الطب النفسي ، مؤوسسة حمد الطبيةالأكبر تخص
 ؟ ...الخ)صا (على سبيل المثال: مستشف 
 
 الأرق  وتشخيص حالات تقييم :الموضوع 
ي مكان عملك؟  مريض ما بالأرق تشخيص  عند تواجهها  الت   الصعوبات هى )  ما 2
 ف 
ي مراكز الرعاية الصحية هل السؤال عن مشاكل النوم و  •
تقييمها جزء من الفحص المعتاد للمرض  ف 
  الأولية؟
 تشخص عادة حالات الأرق؟ كيف •
 رق؟الأ لتشخيص المحلية تستعمل الارشادات  أو معينة خيصية ش ت عملية تتبع هل •
ي رأيك، ما مدى الاستفادة من  •
 ف   الموجودة senilediug tnemtaert (ية (الارشادات العلاجف 
المختلفة و   النوم بير  مشاكل للتميبر   الارشادات مفيدة مؤسستكم؟(على سبيل المثال: هل هذه
 التشخيص بدقة). 
ي  كهنا تكن لم اذا -
 اخرى؟ ارشادات هل تعرف أي  المركز الذي تعمل به،  ارشادات متوفرة ف 
ي ارشادات  تكن توجد لم اذا -
 أسباب هى  ما الذي تعمل به،  المركز لتشخيص وعلاج الأرق ف 
   ك؟ذل
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ي تتلقاها من المرض  عندما  •
  الأرق؟ يأتون لعلاج مشكلة  ماهىي الشكاوي المعتادة الت 
زيارة متخصصي الرعاية الصحية ( الأطباء و الصيادلة) عندما ض  يقررون برأيك مالذي يجعل المر  •
 ؟ يعانون من  الأرق
ي الاعتبار عادة عند النوم مشاكل أسباب هى ما •
ي تضعها ف 
 من يشكون الذين  المرض   فحص الت 
 الأرق؟
 وراء مشكلة الأرق؟  الكامن السبب لتحديد تستخدمها الت   الاسب  اتيجيات هى ما •
يفصح لك المريض عن معاناته من مشكلة الأرق بالاضافة الى مشاكله الصحية الأخرى  دمانع خبر تك،  من •
، كيف تقرر أولوية علاج هذه المشاكل؟(مثلا: هل او الحالات المرضية الأخرى) المزمنة الالام (مثلا: 
 تعالج مشكلة االأرق أولا أم تقدم علاج المشاكل الصحية الأخرى على علاج الأرق)؟
ي  -
ي تقرر تقريبا كم  الحالات هذه مثل وف 
 اولا؟ الأرق فيها معالجة هىي عدد المرات الت 
ي تقرر فيها تأخبر علاج مشكلة الأرق ولماذا؟ ما هىي الح -
 الات الت 
 العلاجية الطرق :الموضوع 
ي تناقشها  العلاج خيارات هى )  ما 3
 مرضاك؟  مع الت 
ي  يجعلك الذي ما •
ي )؟ بر غ أو تقرر اختيار علاج معير  (علاج دوائ 
  الدوائ 
 مؤسستكم؟ ف   الأرق المتاحة لعلاج تنوع الخيارات رأيك ما •
 الارق؟ مريض علاج عند تواجهها الت   التحديات هى ما •
 الممكن من  هل .الصيدليات التابعة لمؤسسة حمد الطبية فقط أدويةعلاج الأرق متوفرة ف   بعض •
 مرضاك؟ لمعالجة الأدوية بالنسبة لك أن تقوم بوصف هذه
ي يجب أن تتبعها لوصف هذه الأدوية لمرضاك؟الخ ماهىي  -
  طوات الت 
ي الصيدليات الخارجية (الصيدليات الأدوية المتوفرةهل تقوم بوصف  •
 (مثل:  المجتمعية) فقط؟ ف 
ي يمكن أن تعطى بدون وصفة طبية(الأ 
 ...الخ). senicidem CTO(دوية الت 
ي  الأطباء نح هل يجب أن يم برأيك شائعة، النوم مشاكل أن اعتبارحقيقةب •
المراكز الصحية الأولية  ف 
 لمعالجة  السلطة
 ؟  النوم بأنفسهمأمراض 
ي  رايك ما •
-Zو senipezaidoznebالاضافة بعض أنواع الأدوية المنومة(على سبيل المثال:  ف 
 الى قائمة أدوية المراكز الصحية الأولية؟ المنومات من  غبر هاو  sgurd
 مع متواصلة (بمعت  : المتابعة النوم  مشكلات من نونيعا الذين للمرض   الرعاية المقدمة هل •
 الأخصائيير  النفسيير  )؟ مثل مختصير   الى الاحالة أو الأطباء
 الى  أحد متخصصي الرعاية الصحية الاخرين ؟  الارق مريض احالة  تقرر مت   •
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 من هم مقدمي خدمات الرعاية الصحية الذين يمكن  تحويل المرض  اليهم؟  -
 ؟المرض  تحويل  عملية كيف تتم  -
 الصحية الرعاية مقدمي   الى م تحويل المرض  ؟ (هل يت تم عملية تحويل المرض  بسلاسة هل -
ي  او المؤسسة نفس  ف  
 مختلفة؟) مؤسسة ف 
  الصحية الاخرين؟ الرعاية موفري تحويل المرض  الى قبل الانتظار وقت  تقريبا كم -
 اته؟مكون هى مانظافة النوم (عادات النوم الصحية)؟ عن تعرف ماذا •
ي رأيك مامدى فائدة عادات النوم  -
  الصحية؟ف 
الأرق(ما  من يشكون الذين تعطىي عادة نصائح متعلقة بعادات النوم الصحية للمرض  هل  -
  عدد المرات)؟
ي  السلوكي  العلاج عن معرفتك  مدى ما •
 ؟ للأرق  المعرف 
ي  السلوكي  العلاج  مكونات هى ما -
 ؟  للأرق  المعرف 
ي مركزك الصحي ؟(من -
 المصابير   المرض   نسبةما  الخدمة، يقدم هل هذه الخدمة متوفرة ف 
 الخدمة).  هذه  الذين يتلقون بالأرق
ي  السلوكي  خدمة العلاج توفبر  بامكانك  ان تعتقد هل برايك -
 من يعانون الذين للمرض    المعرف 
 "لا؟ لم" ممكنا ذلك يكن لم  اذا كيف"؟" نعم الاجابة  كانت اذا( ?الأرق
ي  هل -
ي  السلوكي  العلاجقمت من قبل بتحويل أحد مرضاك من أجل تلف 
 ؟  للأرق  المعرف 
ورية أو ماهىي الاحتياجات التعليمية  )5
 الصحية الرعاية  مراكز ف   الصحية الرعاية خدمات لمزودي  التدريبية الض 
 ليتمكنوا من تشخيص مرض  الأرق وتقديم العلاج المناسب لهم؟  الاولية
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 مقابلة الصيادلة  دليل
 خبر ة الصيدلي مع الأرق و وجهة النظر العامة لهذه المشكلة  :الموضوع 
  حالات المرض  الذين يشتكون من الأرق؟  تصف ان يمكن هل، تجربتك ) من1
 أسبوعيا.  الأرق أعراض يحض  ون مع  الذين المرض    عدد •
 الأخرى.  الطبية الحالات الجنس و السن، :صفات المرض   •
 الأرق و الاهتمامات المخاوف هىي  ما •
ي يبديها مرض 
 الصيدلية؟ الى ياتون عندما الت 
الصحية(الطبيب،  الرعاية على زيارة أحدمقدمي   يحث مريض الأرق الذي ما برأيك •
ي منها؟
ي يعائ 
ي ..الخ)لمناقشة مشاكل النوم الت 
ي الصحية، طرق  المعتقدات ( الصيدلائ 
العلاج الذائ 
المرض على حياة المريض، العمل،العلاقات،الأمن و السلامة،المشاعر، ضغط المستعملة، أثر 
 الأخرين مثل افراد الاسرة، التوقعات). 
) كيف ترى الأرق كحالة مرضية؟ (هل تعتبر ها مشكلة صحية هامة يجب أن تتم معالجتها  فورا ، ام هل تعتقد أنها 2
 خل طتر ي ؟)حلها بنفسه  دون الحاجة الى تدمشكلة يستطيع المريض 
 ؟ الأرق  من ما مريض عندما يشكو ذهنك الى يتبادر ماذا  ▪
ي مراكز ▪
ي المؤسسات   الأولية الصحية الرعاية برأيك هل يجب أن تتم معالجة حالات الأرق ف 
أم ف 
 الطب النفسي ، مؤوسسة حمد الطبية...الخ)الأكبر تخص
 ؟ صا (على سبيل المثال: مستشف 
 تمكن المريض ان مشكلة هى هل او الفور على تحل ان يجب هامة صحية مشكلة هو هل -
 بالمب   ل؟ 
 كحالة صحية؟ الارق خطورة مدى -
  الصحية؟ الرعاية هل يجب أن تحصل مشاكل النوم على المزيد من الاهتمام من أخصائتر  -
 الأرق  وتشخيص حالات تقييم :الموضوع
 الأرق؟  لمختلفة لعلاج الطرق ا  عن  تعرف ماذا  عامة،  ) بصفة 3
ي مركزك الصحي ؟(العلاجات   الأرق خيارات المتاحة لعلاج هى ما ) 4
 الدوائية وغبر الدوائية)  ف 
ي مركزك الصحي  تنوع العلاجات ف   رأيك ما •
 ؟ المتوفرة للأرق ف 
ي مركزك الصحي كافية أم هل هناك حاجة لاضافة المزيد من  •
هل العلاجات المتوفرة للأرق ف 
 العلاجات؟
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ي قائمة أدوية المراكز  senipezaidozneb و sgurd-Z بعض أدوية النوم مثل ال   •
غبر موجودة ف 
ي ما رأيك بهذا؟ 
 الصحية الأولية ، كصيدلائ 
ي تعطى دون وصفة طبية  للأرق بعض •
 مثل الاعشاب ومنتجات ,الميلاتونير  ) العلاجات الت 
ي قائمة أدوية المراكز الصحية الأ متضمنة غبر  nairelav(
 ذلك؟ ف   السبب ما برأيك )7102ولية (ف 
 المرض  ؟  بعض يساعد قد قائمة أدوية المراكز الصحية هذه الأدوية الى أن اضافة تعتقد هل -
 الادوية، هل هىي فعالة أو مهمة؟ هذه  ف   رايك ما -
ي يصفها الشائعة العلاجات هى ما •
العلاجات  ؟(سواء مركزك الصحي  ف   لعلاج الأرق الأطباء الت 
 أو السلوكية)؟  الدوائية
 مكوناته؟  هى  نظافة النوم (عادات النوم الصحية)؟ما  عن تعرف  ) ماذا 5
ي رأيك مامدى فائدة عادات النوم الصحية؟ -
  ف 
الأرق(ما  من يشكون الذين تعطىي عادة نصائح متعلقة بعادات النوم الصحية للمرض  هل  -
  عدد المرات)؟
ي  السلوكي  العلاج عن  معرفتك مدى  ) ما 6
 ؟  للأرق  المعرف 
ي  السلوكي  العلاج  مكونات هى ما -
 ؟  للأرق  المعرف 
ي مركزك الصحي ؟(من -
 المصابير   المرض   ما نسبة الخدمة، يقدم هل هذه الخدمة متوفرة ف 
 الخدمة).  هذه الذين يتلقون بالارق
ي  السلوكي  خدمة العلاج توفبر  بامكانك  ان تعتقد هل برايك -
 من يعانون الذين للمرض    المعرف 
 "لا؟ لم" ممكنا ذلك يكن لم  اذا كيف"؟" نعم الاجابة كانت اذا( ?الارق
ي العلاج هل -
ي  السلوكي  قمت من قبل بتحويل أحد مرضاك من أجل تلف 
 للأرق؟  المعرف 
 
ي علاج الأرق:   :الموضوع 
 
ي ف
 دور الصيدلان 
ي  نوع  ) ما 7
النوم  مشاكل علاج  بخصوص  الاخرين الصحية الرعاية  مقدم  من  تتلقاها عادة  الاستشارات الت 
 للادوية).  الجانبية  الاثار العلاج، الدوائية،اسب  اتيجيات المعلومات (مثال: 
 مامدى تكرار تلقيك لمثل هذه الأسئلة؟ •
اذا كان السؤال بخصوص الأدوية، هل يكون السؤال عادة متعلق  بالادوية المستخدمة لعلاج الأرق  •
ي تسبب/تفاقم مشكلة الأرق؟ 
 أم بالأدوية الت 
لأحد مزودي الرعاية  تقديم استشارة المثال سبيل ؟(على النومبقمت من قبل بالتدخل لحل مشكلة متصلة  ) هل8
 بخصوص دواء  الصحية  الرعاية  أحد مزودي  مع أو التشاور دواء يسبب مشكلة الأرق،ايقاف  الصحية الاخرين بخصوص
 النوم).  يعالج مشكلة
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أحد مزودي الرعاية الصحية الاخرين (على سبيل المثال: طبيب،  الى رقالأ  مريض يشتكي من قمت من قبل بتحويل  ) هل9
ي نفسي ) 
 لتقييم حالة المريض أوللعلاج؟ أخصائ 
ي تقدمها  هى ) ما 01
 ،دواع الاستخدام الجانبية للأدوية،  الأثار الارق (على سبيل المثال:  من يشكو لمريض النصائح الت 
 .الاخرى وغبر ها) الأدوية 
 المنومة اسبوعيا؟ الادوية حول المشورة بتقديم تقوم رةم كم ,المتوسط وف   •
ي الغالب؟  نوع ) ما 11
 
ي تقدمها ف
ي ، استخدام  السلوكي  المثال: عادات النوم الصحية، العلاج على سبيل )الاستشارة الت 
 
المعرف
 الأعراض الجانبية للأدوية، البدائل العلاجية للأدوية ، منتجات طبيعية وغبر ها). الأدوية، 
  المتوفرة لعلاج مشاكل النوم الارشادات ا ) م21
 
 مركزك الصحي ؟  ف
 اذا كانت هذه الارشادات متوفرة، ما مدى الاستفادة منها ؟  •
ي  لم اذا •
محلية اخرى  ارشادات هل تعرف أي المركز الذي تعمل به،  تكن هذه الارشادات متوفرة ف 
 أو مبادئ توجيهية دولية بخصوص علاج الأرق؟
ي  السبب ما  رة، برأيكمتواف تكن لم اذا •
  ذلك؟ ف 
 شائعة.  ليست الأرق حالات -
 خطبر ة.  صحية مشكلة ليس الأرق -
ي  المشاكل يتوقع من المرض  أن يعالجو هذه -
ي  المثال:  سبيل (على اخرى أماكن ف 
أو  المب   ل ف 
 الصيدليات المجتمعية). 
ورية أو ) ماهىي الاحتياجات التعليمية31
ي  الصحية ةالرعاي خدمات لمزودي التدريبية الض 
الاولية  الصحية الرعاية  مراكز ف 
 ليتمكنوا من تشخيص مرض  الأرق وتقديم العلاج المناسب لهم؟ 
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APPENDIX C: QUESTIONNAIRES  
Pittsburgh Sleep Quality Index (PSQI) English:  
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Pittsburgh Sleep Quality Index (Arabic version)  
 
 
Appendix 2: Arabic version of the PSQI 
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Sleep Hygiene Index (SHI) English version:  
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 مؤشر عادات النوم الصحية 
  اختيارك.  لتحديد . استخدم المقياس حول الرقم المناسب  وضع دائرة يرجى تقييم مدى صحة كل عبارة لك عن طريق  بالأسفل،   قائمة من العبارات توجد
 4 3 2 1 0
 دائما   غالبا   أحيانا   نادرا    داأب 
 
 -------------- 4 3 2 1 0 آخذ قيلولة (غفوة) أو أكثر في النهار تستمر لمدة ساعتين أو أكثر 1
 -------------- 4 3 2 1 0 إلى السرير للنوم في أوقات مختلفة من يوم لآخر  أذهب 2
 -------------- 4 3 2 1 0 أستيقظ من النوم في أوقات مختلفة من يوم لآخر 3
أمارس الرياضة حتى التعرق خلال الساعة التي تسبق ذهابي  إلى  4
 السرير للنوم
 -------------- 4 3 2 1 0
نائما ًفي السرير(بعد استيقاظي) أطول مما يجب مرتين أو ثلاث أبقى  5
 مرات أسبوعياً 
 -------------- 4 3 2 1 0
التبغ خلال الساعات الأربع التي تسبق  الشاي أو القهوة أو أدخن أتناول 6
 ذهابي إلى السرير للنوم أو بعد ذهابي إليه
 -------------- 4 3 2 1 0
ربما يبقيني مستقيظا ًقبل موعد النوم (على سبيل المثال: أمارس نشاطا ً 7
 ممارسة ألعاب الفيديو، تصفح الإنترنت، التنظيف)
 -------------- 4 3 2 1 0
النوم ولدي شعور بالتوتر أو الغضب أو الانزعاج أو أذهب إلى  8
 العصبية
 -------------- 4 3 2 1 0
النوم أو ممارسة العلاقة الزوجية أستعمل سريري لأشياء آخرى غير  9
(على سبيل المثال: مشاهدة التلفزيون، القراءة، تناول الطعام أو 
 الدراسة)
 -------------- 4 3 2 1 0
ر غير مريح (على سبيل المثال : فراش أو وسادة غير أنام على سري 01
 عدم توفر عدد كاف من الأغطية أو البطانيات ) –مريحة 
 -------------- 4 3 2 1 0
 –أنام في غرفة نوم غير مريحة (على سبيل المثال: شديدة الإضاءة 11
 عالية الضوضاء) –شديدة البرودة  –شديدة الحرارة  –سيئة التهوية 
 -------------- 4 3 2 1 0
أقوم بأداء أعمال مهمة قبل موعد النوم (على سبيل المثال: دفع  21
 الفواتير، جدولة مواعيدي، الدراسة )
 -------------- 4 3 2 1 0
 -------------- 4 3 2 1 0 أو أكون قلقا ًعندما أكون في السرير  –أو أخطط  –أفكر  31
 ---------------مجموع النقاط =
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APPENDIX D: ETHICAL APPROVAL LETTERS 
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